ലോഡിംഗ്

Slzii.com തിരയുക

തിരയുക (വാർത്ത)

From Strategy to Value: Neutech's 2026 Interim Results Confirm the Growth Logic of Its "Education-Healthcare-Wellness" Ecosystem
HONG KONG and DALIAN, China , Aug. 26, 2026 /PRNewswire/ -- On 26 August 2026 , Neutech Group Limited (Stock Code: 9616.HK) released its interim results. For the first half of 2026, the Group firmly implemented its core strategy of "education-healthcare-wellness", continued to deepen business deployment, and delivered steady improvement in overall performance. During the Reporting Period, the Group recorded revenue of approximately RMB961.1 million, representing a 1.7% increase compared with the same period last year. Net profit attributable to owners of the Company was approximately RMB209.7million, up 2.8% year‐on‐year. Notable Achievements in Education Business Mark New Development Heights The education business serves as the core cornerstone of the Group and underpins its fundamental performance base. In the first half of 2026, each segment within the Group's education business delivered strong results. The three IT application‐oriented undergraduate universities under the Group achieved steady improvement in teaching quality, with admissions exceeding expectations. As at 30 June 2026, the total number of student enrollment in our three universities combined reached approximately 59,000, representing a year‐on‐year increase of 2% compared with the same period in 2025. During the Reporting Period, the Group's three universities received multiple honors. In the 2026 Shanghai Ranking's China Ranking of Private Colleges (Main List) (中國民辦高校排名(主榜)) , Dalian College ranked 5th among private universities nationwide and 2nd among national private universities focused on science and technology. Its course General Artificial Intelligence III ( 《人工智能通識III》 ) was selected as a Typical Case for General Artificial Intelligence Courses( 人工智能通識課程典型案例 ), an initiative organized by the Information‐based Teaching Steering Committee for Vocational Colleges under the Ministry of Education ( 教育部職業院校信息化教學指導委員會 ). In the 2026 Shanghai Ranking's China Ranking of Private Colleges ( 中國民辦高校排名 ), Chengdu University took the 1st spot among science and technology focused private universities in Sichuan Province. The university was also approved as a pilot institution for Systematic Competency Development in Computer‐related Majors( 計算機類專業系統能力培養 ) by the Computer‐related Majors Teaching Steering Committee of Higher Education Institutions under the Ministry of Education ( 教育部高等學校計算機類專業教學指導委員會 ). Guangdong University won the Grand Prize for Teaching Cases at the 2026 National University Software Engineering Education Conference ( 2026全國高校軟件工程教育大會 ). In addition, the three universities posted impressive admission results for the 2026/2027 school year. In Dalian University, the enrollment plan was fully completed in one go, and the highest admission score of physics stream is 125 scores higher than the university cut-off scores of Liaoning Province; in Chengdu University, the undergraduate enrollment plan completion rate reached 100%, and the highest admission score of physics stream is 83 scores higher than the university cut-off scores of Sichuan Province; in Guangdong University, the first-choice admission rate reached 100%, and the highest admission score of physics stream is 79 scores higher than the university cut-off scores of Guangdong Province. In terms of education resource, in the first half of 2026, the Group continued to advance the implementation of AI education and technology, actively exploring how AI can empower discipline teaching reform and innovation in talent cultivation models. During the Reporting Period, the smart education platform underwent a comprehensive AI‐driven upgrade, adding practical tools for AI model optimization and evaluation, and launching a new smart teaching APP. Concurrently, the Group developed the "Smart Agriculture Practical Training Lab" and the "MES Flexible Intelligent Manufacturing Practical Training Lab", while also upgrading the Intelligent and Connected Vehicle-to-Everything (V2X) Practical Training Lab, the Information Technology Innovation Practical Training Lab, the Embodied Intelligent Training Lab, and the Artificial Intelligence Innovation Application Training Lab. As of 30 June, 2026, the Group's education resource business cooperated with 49 institutions in joint establishment of academic majors and industrial colleges, covering nearly 15,600 students. Since 2021, the total number of cooperative institutions has reached 662. Notably, during the Reporting Period, the Group was successfully selected as a member of the China-Central Asia Industry-Education Integration Alliance, demonstrating its strong comprehensive strength and brand influence. During the reporting period, the continuing education business has established a training product and curriculum system covering four major categories: IT, management, education, and examination and certification, providing comprehensive training services to government agencies, enterprises, and educational institutions. To date, it has served a cumulative total of over 300 institutional clients, with long-term clients having cooperation periods exceeding three years accounting for 31% of the total. In addition, the Group has obtained 93 training base qualifications, of which 30 are at the national level. Accelerating Deployment of Elderly Care Technology and Services, with Business Footprint Continuing to Broaden As a key growth driver of the Group, elderly care technology and services also represent the Group's second growth curve. To date, the Group's citywide smart wellness platforms have been launched and are operational in 10 cities, including Shenyang, Dalian, Guangzhou, and Nanning, covering 30 core elderly care scenarios such as meal assistance, bathing assistance, home-based care, rehabilitation nursing, and residential care. These platforms have cumulatively served over 1 million person‐times, gathered more than 4,000 quality service providers, and offered over 12,000 elderly‐friendly products and services online. In addition, the Group has also established partnerships with cross-sector brands such as FlashEx, DiDi, JD.com, SF Express, CCB, and CMBC, jointly creating new consumption scenarios for elderly care. The platform model has been expanded to 23 cities, with Shanghai, Liuzhou, and several other cities set to go online soon, and is expected to complete its nationwide deployment in 30 cities by the end of 2026. These moves signify a transition of the Group's smart wellness service model from "pilot exploration" to a new phase of "scalable replication". At Wecare Family Nursing Home ( 睿康之家頤養院 ), the occupancy rate remained at 100% throughout the first half of 2026, with elderly residents aged 80 and above accounting for 94% of the total, the majority of whom required semi-disabled or higher-level care. Meanwhile, "Yixin Home" ( 頤心院 ) — positioned as a "premium life nursing and elderly care center within a tertiary hospital" with a focus on intensive medical care and hospice medical care — was officially opened and commenced operations in June 2026. During the Reporting Period, Wecare Family Nursing Home launched the "Ruikang Yizhi Experimental Class ( 睿康頤智實驗班 )" for students majoring in "geriatric care and management" from three universities, achieving deep integration within the "education-healthcare-wellness" ecosystem. In terms of elderly education services, as of the Reporting Period, Neutech Phoenix College has established a network comprising "three university branches and eight wellness tourism campuses", offering distinctive programmes featuring "AI and artistic creation + health and rehabilitation + mind tour". During the Reporting Period, the Guangdong Phoenix Academy officially commenced enrolment. Nearly 2,000 elderly participants attended offline paid courses across the three university-based Phoenix Academies. Among them, participants aged below 50 accounted for 26%, those aged between 50 and 70 accounted for 65%, and those who enrolled in three or more elderly education courses accounted for 21%, demonstrating robust growth potential. Continuously Enhancing Medical Service Quality, with Brand Soft Power Steadily Rising The medical services business serves as a crucial pillar for the Group's elderly care technology and services segment, laying a solid foundation for the long-term development of medical and elderly care services. In the first half of 2026, the Group's Ruikang Cardiovascular Hospital launched a new "Healthy Lifestyle" department, providing lifestyle medicine interventions for sub-health populations, individuals with hypertension, hyperglycemia, and hyperlipidemia, high-risk cardiovascular patients, and post-cardiac surgery patients. During the Reporting Period, Ruikang Cardiovascular Hospital received nearly 30,000 outpatient and emergency visits, and nearly 6,000 inpatient and surgical admissions. Meanwhile, Ruikang Stomatological Hospital became the first in Dalian to introduce the Swedish Nobel X-Guide 3D blue-light dynamic navigation system ( 瑞典諾貝爾X-Guide3D藍光動態導航 ). In the first half of 2026, Ruikang Stomatological Hospital received nearly 12,000 outpatient visits. In addition, the Ruixin Rehabilitation Hospital, positioned as a fifth-generation rehabilitation hospital, is expected to be completed in 2027, which will further enhance the Group's system of medical care, rehabilitation, nursing and elderly care. In addition, in terms of campus living services, as of the Reporting Period, the three universities housed 150 merchants. The industrial company aims to build an integrated complex of creative, cultural, and service industries, serving as a high-quality campus support services provider within the "education-healthcare-wellness" ecosystem. In the future, through resource integration and complementary advantages, the Group will deeply promote the synergistic integration of multiple business sectors, creating a new framework for the integrated development of "Education, Healthcare and Wellness", providing digital and intelligent education, healthcare, and wellness products and services that cover the entire lifecycle. In terms of higher academic education services, we will continue to adhere to "stabilizing scale and consolidating foundations, while enhancing quality and strengthening core competencies" development strategy. Leveraging comprehensive AI-empowered teaching, we will stay committed to a connotative development path of quality enhancement and cultivation improvement, and continuously enhance the education services ability. Meanwhile, we are accelerating the nationwide deployment of citywide smart wellness platforms, systematically building a standardized business system of "one platform, two centers", striving to cover more cities and becoming a "booster" for the high-quality development of China's silver economy. Additionally, the Group is advancing from single-disease treatment to full-cycle health management, building a full-chain proactive health management system that includes "early screening and treatment of chronic diseases + personalized lifestyle prescriptions + functional medicine interventions". Through resource integration and complementary advantages, the Group will deeply promote the synergistic integration of multiple business sectors, creating a new framework for the integrated development of "Education, Healthcare and Wellness", so as to comprehensively meet the diverse needs of clients. CONTACT: WeiLin weilin@neuedu.com +852 37953236
2026-08-26 11:24:00

LightInTheBox Reports Second Quarter 2026 Financial Results
SINGAPORE , Aug. 26, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consumer lifestyle company, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Total Revenues were $56.8 million, a modest 4% decrease year over year, as the company optimized its product mix through phasing out long-tail products. Gross Profit was $37.6 million, compared with $38.8 million in the same quarter last year. Gross Margin was 66.1%, compared with 65.9% in the same quarter last year, which remained stable. Operating Expenses were $35.5 million, compared with $36.9 million in the same quarter last year. Fulfillment Expenses decreased by 3% year over year to $4.2 million. Selling and Marketing Expenses decreased by 4% year over year to $26.7 million. General and Administrative Expenses decreased by 5% year over year to $4.6 million, of which Research and Development expenses were $2.3 million. Net Income reached $1.6 million, compared with $2.0 million in the same quarter last year, marking sustained profitability amidst industry challenges. Adjusted EBITDA was $1.9 million, compared with $2.3 million in the same quarter last year. First Half 2026 Financial Highlights Total Revenues were $108.8 million, a 3% increase year over year. Gross Profit was $71.4 million, compared with $69.4 million in the same period last year. Gross Margin was 65.6% compared with 65.6% in 2025, which remained stable. Operating Expenses increased by 1% year over year to $68.2 million . Fulfillment Expenses increased by 1% year over year to $8.3 million. Selling and Marketing Expenses increased by 3% year over year to $51.3 million. General and Administrative Expenses decreased by 10% year over year to $8.8 million, of which Research and Development expenses were $4.6 million. Net Income reached $2.7 million, compared with $2.1 million in 2025, showcasing sustainable profitability. Adjusted EBITDA was $3.3 million, compared with $3.0 million in the same period last year. Jian He, Chairman and CEO of LightInTheBox, commented, "In the second quarter, we continued to execute with discipline amid geopolitical disruptions, higher logistics costs and foreign exchange headwinds. Revenue decreased modestly as we deliberately phased out some long-tail products, while gross margin remained stable at 66%. Through disciplined expense management, we remained profitable, generating net income of $1.6 million and Adjusted EBITDA of $1.9 million." "Our first-half results provide a clearer indication of the progress we are making. Revenue increased by 3% year over year to $108.8 million, net income grew by approximately 28% to $2.7 million, and Adjusted EBITDA improved by $0.4 million year over year to $3.3 million. This performance demonstrates the increasing resilience and efficiency of our business model." "On August 10, 2026, we announced the closing of a private placement financing that raised approximately $5.49 million in gross proceeds. The proceeds will support and accelerate the Company's strategic transformation to strengthen its competitiveness in the AI era." "While the external environment remains uncertain, we are encouraged by the progress achieved during the first half of the year. We are also pleased to have successfully completed our private placement, which supports the execution of our strategic priorities and better positions the Company for the AI era." Mr. He concluded. Share Repurchase Program On March 31, 2025, the Company's board of directors authorized a share repurchase program under which the Company may repurchase up to $0.7 million of its ordinary shares in the form of ADSs no later than June 30, 2025. The Company has since extended the share repurchase program through December 31, 2025, then further to June 30, 2026, and then to December 31, 2026, with total repurchase amount up to $3.0 million. As of August 21, 2026, the Company has repurchased 657,305 ADSs with a total aggregate value of approximately $1.5 million. CFO Transition Update The Company is pleased to announce the appointment of Ms. Wenyu Liu (Wendy) as Chief Financial Officer, effective on August 21, 2026, succeeding Mr. Suhai Ji, who resigned for personal reasons. "On behalf of the Company, I would like to extend our special thanks to Suhai for his valuable contribution over his tenure and wish him all the best in his future endeavors." said Mr. Jian He, Chairman and CEO of LightInTheBox. Wendy has served as LightInTheBox's Chief Growth Officer since August 2020. Prior to joining LightInTheBox, Wendy was a co-founder of Ezbuy, a Singapore-based leading cross-border e-commerce platform founded in 2010 and acquired by LightInTheBox in 2018. Ms. Liu concurrently leads its Singapore team as Chief Executive Officer. Ms. Liu has been working in the e-commerce sector since she was in university where she has developed a deep understanding and appreciation for the convenience and savings consumers enjoy from online shopping. Ms. Liu has spearheaded the development of technology to reduce the reliance on heavy upfront investments and improve corporate flexibility to operate anywhere and at any time. Ms. Liu holds a first-class honor degree in Electrical & Electronics Engineering with a minor in Business from the Nanyang Technological University of Singapore and a Master's Degree in Industrial & Systems Engineering from the National University of Singapore. Conference Call The Company will hold an earnings conference call to discuss the results at 8:00 a.m. Eastern Time August 26, 2026 (8:00 p.m. Hong Kong/Singapore Time on the same day). Preregistration Information Participants can register for the conference call by going to https://s1.c-conf.com/diamondpass/10056871-fngk6z.html . Upon registration, participants will receive dial-in numbers, an event passcode, and a unique access PIN. To join the conference, simply dial the number in the calendar invite you receive after preregistering, enter the event passcode followed by your unique access PIN, and you will be connected to the conference instantly. A telephone replay will be available two hours after the conclusion of the conference call through September 2, 2026. The dial-in details are: US/Canada: +1-855-883-1031 Singapore: 800-101-3223 Hong Kong, China: 800-930-639 Replay PIN: 10056871 Additionally, a live and archived webcast of the conference call will be available on the Company's Investor Relations website at https://ir.ador.com . About LightInTheBox Holding Co., Ltd. Founded in 2007, LightInTheBox is a global direct-to-consumer (DTC) e-commerce company dedicated to delivering a joyful lifestyle to consumers worldwide. Leveraging AI-driven market insights and agile supply chain systems, it aims to capture consumer preferences and sentiment to offer differentiated products, driving consumer engagement through deep emotional resonance. LightInTheBox also adopts a brand matrix strategy by launching its own apparel brands such as Ador to further strengthen its position as a consumer lifestyle company. Additionally, LightInTheBox offers a comprehensive suite of services to e-commerce companies, including advertising, supply chain management, payment processing, order fulfillment, and shipping and delivery solutions. For more information, please visit https://ir.ador.com . Non-GAAP Financial Measure In evaluating the business, the Company considers and uses a non-GAAP measure, Adjusted EBITDA, as a supplemental measure to review and assess operating performance. The presentation of this non-GAAP financial measure is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The Company's non-GAAP financial measure excludes share-based compensation expenses, depreciation and amortization expenses, interest income, interest expenses and income tax benefit / (expense). The Company presents this non-GAAP financial measure because it is used by management to evaluate operating performance and formulate business plans. The Company believes that the non-GAAP financial measure helps identify underlying trends in its business. The Company also believes that the non-GAAP financial measure could provide further information about the Company's results of operations and enhance the overall understanding of the Company's past performance and future prospects. The non-GAAP financial measure is not defined under U.S. GAAP and is not presented in accordance with U.S. GAAP. The non-GAAP financial measure has limitations as an analytical tool. The Company's non-GAAP financial measure does not reflect all items of income and expenses that affect the Company's operations and does not represent the residual cash flow available for discretionary expenditures. Further, the non-GAAP measure may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for the limitations by reconciling the non-GAAP financial measure to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages you to review the Company's financial information in its entirety and not rely on a single financial measure. For more information on the non-GAAP financial measure, please see the table captioned "Unaudited Reconciliations of GAAP and Non-GAAP Results" set forth at the end of this press release. Safe Harbor Statement This press release contains forward-looking statements that involve risks and uncertainties. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "potential," "continue," "ongoing," "targets" and similar statements. Among other things, statements that are not historical facts, including statements about LightInTheBox's beliefs and expectations, the business outlook and quotations from management in this announcement, as well as LightInTheBox's strategic and operational plans, are or contain forward-looking statements. LightInTheBox may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: LightInTheBox's goals and strategies; LightInTheBox's future business development, results of operations and financial condition; the expected growth of the global online retail market; LightInTheBox's ability to attract customers and further enhance customer experience and product offerings; LightInTheBox's ability to strengthen its supply chain efficiency and optimize its logistics network; LightInTheBox's expectations regarding demand for and market acceptance of its products; competition; fluctuations in general economic and business conditions; changes in tariffs and trade policies; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in LightInTheBox's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and LightInTheBox does not undertake any obligation to update any forward-looking statement, except as required under applicable law. Investor Relations Contact Investor Relations LightInTheBox Holding Co., Ltd. Email: ir@ador.com Serena Huang Octans Capital Group Email: litb@octanscap.com LightInTheBox Holding Co., Ltd. Unaudited Condensed Consolidated Balance Sheets (U.S. dollars in thousands, or otherwise noted) As of December 31, As of June 30, 2025 2026 ASSETS Current Assets Cash and cash equivalents 23,629 15,969 Restricted cash 2,319 1,540 Accounts receivable, net 1,355 1,639 Inventories 4,943 5,514 Prepayments and other current assets, net 1,884 2,164 Total current assets 34,130 26,826 Property and equipment, net 1,313 1,042 Intangible assets, net 2,180 1,893 Goodwill 27,800 28,632 Operating lease right-of-use assets 6,068 4,592 Long-term rental deposits 434 453 Long-term investments 77 77 TOTAL ASSETS 72,002 63,515 LIABILITIES AND SHAREHOLDERS' DEFICIT Current Liabilities Short-term borrowings 715 737 Accounts payable 12,309 8,779 Advance from customers 9,194 9,684 Operating lease liabilities 2,818 1,901 Accrued expenses and other current liabilities 48,956 42,259 Total current liabilities 73,992 63,360 Operating lease liabilities 1,886 1,087 Deferred tax liabilities 107 84 TOTAL LIABILITIES 75,985 64,531 SHAREHOLDERS' DEFICIT Ordinary shares 17 17 Additional paid-in capital 280,646 280,598 Treasury shares (29,392) (30,067) Statutory reserves 396 396 Accumulated other comprehensive loss (1,723) (764) Accumulated deficit (253,927) (251,196) TOTAL SHAREHOLDERS' DEFICIT (3,983) (1,016) TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT 72,002 63,515 LightInTheBox Holding Co., Ltd. Unaudited Condensed Consolidated Statements of Operations (U.S. dollars in thousands, except per share data, or otherwise noted) Three Months Ended June 30, Six Months Ended June 30, 2025 2026 2025 2026 Revenues Product sales 56,671 55,058 101,471 105,116 Services and others 2,211 1,757 4,429 3,675 Total revenues 58,882 56,815 105,900 108,791 Cost of revenues Product sales (19,635) (18,822) (35,484) (36,620) Services and others (445) (427) (967) (802) Total Cost of revenues (20,080) (19,249) (36,451) (37,422) Gross profit 38,802 37,566 69,449 71,369 Operating expenses Fulfillment (4,355) (4,221) (8,225) (8,302) Selling and marketing (27,849) (26,743) (49,745) (51,332) General and administrative (4,857) (4,610) (9,819) (8,819) Other operating income, net 163 77 367 287 Total operating expenses (36,898) (35,497) (67,422) (68,166) Income from operations 1,904 2,069 2,027 3,203 Interest income 3 - 5 - Interest expense (5) (5) (9) (9) Other income / (expense), net 12 (490) 5 (481) Total other income / (expense) 10 (495) 1 (490) Income before income taxes 1,914 1,574 2,028 2,713 Income tax benefit / (expense) 107 (2) 107 18 Net income 2,021 1,572 2,135 2,731 Net income attributable to LightInTheBox Holding Co., Ltd. 2,021 1,572 2,135 2,731 Weighted average numbers of shares used in calculating net income per ordinary share -Basic 219,963,072 214,538,028 220,320,143 215,227,363 -Diluted 220,156,552 214,704,348 220,567,883 215,388,604 Net income per ordinary share -Basic 0.01 0.01 0.01 0.01 -Diluted 0.01 0.01 0.01 0.01 Net income per ADS (12 ordinary shares equal to 1 ADS) -Basic 0.11 0.09 0.12 0.15 -Diluted 0.11 0.09 0.12 0.15 LightInTheBox Holding Co., Ltd. Unaudited Reconciliations of GAAP and Non-GAAP Results (U.S. dollars in thousands, or otherwise noted) Three Months Ended June 30, Six Months Ended June 30, 2025 2026 2025 2026 Net income 2,021 1,572 2,135 2,731 Interest income (3) - (5) - Interest expense 5 5 9 9 Income tax (benefit) / expense (107) 2 (107) (18) Depreciation and amortization 426 292 866 610 EBITDA 2,342 1,871 2,898 3,332 Share-based compensation 1 3 87 7 Adjusted EBITDA* 2,343 1,874 2,985 3,339 * Adjusted EBITDA represents net income before share-based compensation expense, interest income, interest expense, income tax expense / benefit and depreciation and amortization expenses.
2026-08-26 11:00:00

Alebund Pharmaceuticals Announces 2026 Interim Results
SHANGHAI , Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period"). During the Reporting Period and up to the date of the interim results announcement, the Company made significant progress on four fronts: clinical development, external collaborations, commercialization in China, and the capital markets. Highlights of the Reporting Period Clinical Development AP301 — patient enrollment completed in the global Phase III pivotal multi-regional clinical trial; the New Drug Application in China accepted for review by the National Medical Products Administration of China (the "NMPA"). In May 2026, RESPOND-2, the global Phase III pivotal multi-regional clinical trial (the "MRCT") conducted in the United States and China, completed patient enrollment. On August 7, 2026, subsequent to the Reporting Period, the New Drug Application submitted by the Company for AP301 for the treatment of hyperphosphatemia in chronic kidney disease ("CKD") patients receiving maintenance dialysis was accepted for review by the NMPA as a Class 1 chemical drug in China. AP306 — the global Phase IIb multi-regional clinical trial has been initiated. The trial is co-sponsored by the Company and R1 Therapeutics, Inc. ("R1"), with the Company leading the conduct of the trial in the Chinese Mainland. The trial plans to enroll a total of approximately 168 participants with hyperphosphatemia receiving maintenance hemodialysis, and the first participant was randomized and dosed in July 2026, subsequent to the Reporting Period, as announced by the Company. The trial is expected to be completed in the second quarter of 2027, and the Company will announce topline results in due course. AP303 — the data from three completed Phase I/Ib clinical trials have been published in Kidney International Reports in August 2026, demonstrating that AP303 was safe and well tolerated; the expected dose-related hemodynamic effects were observed in healthy participants and patients with diabetic kidney disease (DKD). AP308 — preclinical results published in May 2026 in Kidney International . In humanized IgA (immunoglobulin A) nephropathy mouse models, AP308 reduced circulating human IgA1 by approximately 90% after a single dose, and eight weeks of treatment achieved near-complete clearance of glomerular IgA deposits with significant improvement in renal pathology and no treatment-related adverse effects; in a separate paired design, a single dose completely cleared established glomerular IgA and complement C3 deposits. External Collaborations Licensing and equity agreements in respect of AP306 entered into with R1 Therapeutics. In March 2026, the Company announced that it had entered into licensing and equity agreements in respect of its product candidate AP306 with R1. The Company retains all rights to AP306 in Greater China and holds an equity interest in R1 as a principal shareholder, while R1 has obtained an exclusive license to develop, manufacture, and commercialize AP306 outside Greater China. R1's shareholders include DaVita (NYSE: DVA) and U.S. Renal Care, leading global kidney care providers. During the Reporting Period, the Company recognized licensing revenue of RMB79.3 million from the transaction. Commercialization in China Sales revenue of Mircera® increased by approximately 105.0% year-on-year. During the Reporting Period, Mircera® generated sales revenue of RMB24.8 million (corresponding period of 2025: RMB12.1 million), representing a year-on-year increase of approximately 105.0%. Capital Markets Listing of the H Shares on the Main Board of the Stock Exchange. The H Shares of the Company were listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") on June 29, 2026 (stock code: 09637). Together with the full exercise of the Over-allotment Option under the Global Offering on July 24, 2026, subsequent to the Reporting Period, the aggregate net proceeds from the Global Offering amounted to approximately HK$1,355.8 million, of which approximately HK$184.7 million in additional net proceeds was attributable to the exercise of the Over-allotment Option. Financial Overview Revenue growth with narrowing losses. Revenue for the first half of 2026 grew to RMB104.2 million from RMB12.1 million for the first half of 2025, representing an increase of RMB92.1 million, or 761.2%, primarily reflecting licensing revenue of RMB79.3 million recognized under the licensing and equity agreements entered into with R1 in respect of AP306, as well as sales revenue of RMB24.8 million from the commercialized product Mircera®; loss for the period was RMB162.6 million, narrowing by 22.5% year-on-year, and adjusted net loss for the period (non-International Financial Reporting Standards ("IFRS") measure) was RMB130.1 million, narrowing by 12.6% year-on-year. As of June 30, 2026, the aggregate balance of cash and cash equivalents, time deposits, and wealth management products was RMB1,392.8 million, representing an increase of RMB861.6 million. Financial Summary RMB'000 (UNAUDITED) SIX MONTHS ENDED JUNE 30, 2026 SIX MONTHS ENDED JUNE 30, 2025 REVENUE 104,159 12,112 GROSS PROFIT 91,089 5,262 RESEARCH AND DEVELOPMENT EXPENSES 141,404 110,061 LOSS FOR THE PERIOD 162,550 209,662 ADJUSTED NET LOSS FOR THE PERIOD (NON-IFRS MEASURE)* 130,098 148,851 * Adjusted net loss for the period (non-IFRS measure) represents loss for the period after adding back (i) interest on redemption liabilities on ordinary shares; (ii) share-based payment; and (iii) listing expenses. Product sales. During the Reporting Period, Mircera®, the Company's commercialized product, generated sales revenue of RMB24.8 million, representing an increase of approximately 105.0% from RMB12.1 million in the corresponding period of 2025; the gross profit of Mircera® was RMB11.7 million, representing an increase of RMB6.4 million, or 120.8%, from RMB5.3 million in the corresponding period of 2025, and the gross profit margin improved from 43.4% for the first half of 2025 to 47.3% for the first half of 2026. Licensing value. In March 2026, the Company completed its performance obligations under the licensing and equity agreements entered into with R1 in respect of AP306 and recognized licensing revenue of RMB79.3 million; the consideration was received in the form of unlisted class B common shares of R1 as upfront, non-monetary, and non-refundable consideration. Together with the sales revenue of Mircera®, revenue for the first half of 2026 grew to RMB104.2 million from RMB12.1 million for the first half of 2025, representing an increase of RMB92.1 million, or 761.2%. Narrowing of losses. Net loss for the first half of 2026 narrowed by RMB47.1 million, or 22.5%, to RMB162.6 million from RMB209.7 million for the first half of 2025. The narrowing was primarily driven by (i) the increase in licensing revenue during the Reporting Period and (ii) the termination, prior to the Listing, of the redemption liabilities in respect of certain shares of the Company (which is one-off in nature), following which no related interest was accrued during the Reporting Period. Adjusted net loss for the first half of 2026 was RMB130.1 million, a decrease of RMB18.8 million, or 12.6%, from RMB148.9 million for the first half of 2025, likewise primarily due to the increase in licensing revenue during the period. R&D investment. Research and development (R&D) expenses increased by RMB31.3 million, or 28.4%, to RMB141.4 million for the first half of 2026 from RMB110.1 million for the first half of 2025. The increase primarily reflected progress across the R&D pipeline during the Reporting Period, including the completion of patient enrollment in the AP301 MRCT, the initiation of the global Phase IIb multi-regional clinical trial of AP306, and the continued advancement of preclinical and chemistry, manufacturing, and controls (CMC) studies of AP308. Liquidity. As of June 30, 2026, the aggregate balance of cash and cash equivalents, time deposits, and wealth management products was RMB1,392.8 million, representing an increase of RMB861.6 million, or 162.2%, from December 31, 2025. Business Progress AP301: A Best-in-Class Oral Iron-Based Phosphate Binder for the Treatment of Hyperphosphatemia AP301 is a best-in-class oral iron-based phosphate binder (registered as a Class 1 chemical drug in China), offering a very high phosphate-binding capacity, no need for chewing, minimal volume expansion in gastric fluid, and no systemic absorption. These characteristics help reduce the amount of medication patients need to take each day and lower the incidence of gastrointestinal adverse events such as nausea, vomiting, constipation, and intestinal obstruction, thereby delivering better safety and gastrointestinal tolerability and enhancing patients' long-term treatment adherence. Global Phase III pivotal multi-regional clinical trial (RESPOND-2, NCT06933472) underway. The trial is a randomized, double-blind, global multi-regional Phase III clinical trial conducted in the United States and China. It planned to enroll 264 CKD patients aged 12 years and above with hyperphosphatemia receiving maintenance dialysis, and ultimately enrolled a total of 282 patients (138 in the United States and 144 in China). Based on the existing clinical data for AP301, the Company and the FDA have agreed that this global Phase III multi-regional clinical trial will serve as the single pivotal study to support the U.S. registration of AP301. The trial completed patient enrollment in May 2026. Registration progress, catalysts and future milestones. On August 7, 2026, subsequent to the Reporting Period, the New Drug Application submitted by the Company for AP301 for the treatment of hyperphosphatemia in CKD patients receiving maintenance dialysis was accepted for review by the NMPA as a Class 1 chemical drug in China. The application is supported primarily by the results of RESPOND-1, the China pivotal Phase III clinical trial, together with other accumulated clinical data; the Company will actively cooperate with the NMPA's review and expects to obtain approval in 2027, subject to the progress of the regulatory review. The global Phase III multi-regional clinical trial is expected to be completed in the second quarter of 2027, following which the Company plans to submit a New Drug Application to the FDA. AP306: First-in-Class Oral Pan-Phosphate Transporter Inhibitor with the Potential to Reshape the Treatment Landscape of Hyperphosphatemia AP306 (formerly known as EOS789, originally discovered by Chugai) is an oral pan-phosphate transporter inhibitor that simultaneously inhibits three key sodium-dependent intestinal phosphate transporters: phosphate transporter type IIb (NaPi-IIb), phosphate transporter-1 (PiT-1), and phosphate transporter-2 (PiT-2). As of the Latest Practicable Date (August 20, 2026), AP306 is the world's first and only pan-phosphate transporter inhibitor to have entered clinical development — the only oral agent that simultaneously targets these three key intestinal phosphate transporters. The global Phase IIb multi-regional clinical trial underway. The trial (NCT06712654) is a multicenter, randomized, double-blind, placebo-controlled, fixed-dose study conducted at multiple clinical sites in the United States and China and co-sponsored by the Company and R1, designed to evaluate the safety, tolerability, and serum phosphate-lowering effect of AP306. The trial plans to enroll approximately 168 participants with hyperphosphatemia receiving maintenance hemodialysis, randomized across six fixed-dose AP306 regimens and placebo over an eight-week treatment period. The primary endpoint is the change in serum phosphate level from baseline to the end of treatment, and the secondary endpoints include the proportion of participants reaching the target phosphate range and the time to phosphate control. The trial has been approved by the Office of Human Genetic Resources Administration of China. As announced by the Company on July 21, 2026, subsequent to the Reporting Period, the first participant in the trial was randomized and dosed. Catalysts and future milestones. The global Phase IIb multi-regional clinical trial described above is expected to be completed in the second quarter of 2027, and the Company will announce topline results in due course. The Company also plans to initiate a global Phase III multi-regional clinical trial in the second half of 2027. Regulatory designation. In June 2024, AP306 was granted Breakthrough Therapy Designation by the NMPA for the treatment of hyperphosphatemia in patients with chronic kidney disease. AP303: A First-in-Class Oral Dual PPAR Agonist Intended to Delay or Halt the Progression of Chronic Kidney Disease AP303 is a first-in-class oral small-molecule dual peroxisome proliferator-activated receptor (PPAR) α/γ agonist discovered and developed in-house, and the Company holds the global rights to develop, manufacture, and commercialize it. A differentiated disease-modifying agent, AP303 is intended to delay or halt the progression of chronic kidney disease, with target indications spanning multiple high-value therapeutic areas, including DKD, IgA nephropathy (IgAN), autosomal dominant polycystic kidney disease (ADPKD), and focal segmental glomerulosclerosis (FSGS). Clinical development progress. AP303 has completed three Phase I clinical trials, which enrolled a total of 80 healthy participants and 18 DKD patients with impaired renal function and showed that AP303 was safe and well tolerated. The expected dose-related hemodynamic effects were observed in both healthy participants and patients with DKD. These Phase I results support the initiation of Phase II studies in patient populations. The Phase I/Ib clinical data were published in Kidney International Reports in August 2026. [1] Regulatory progress: Phase II clinical trial approvals obtained. In China, the Company submitted an Investigational New Drug application for the Phase II clinical trial to the NMPA and obtained approval for the pan-CKD indication, which can cover subsequent Phase II clinical trials in patients with DKD, IgAN, ADPKD, and FSGS. In the United States, the Company has communicated with the FDA regarding DKD, IgAN, ADPKD, and FSGS and received positive feedback. Among these, the ADPKD indication has been granted Orphan Drug Designation (ODD), and Phase II clinical trial approvals have been obtained for the DKD and IgAN indications. Subsequent development plan. The Company expects to begin site selection for the Phase II basket trial in DKD and IgAN in the second half of 2026, while preparing in parallel for the initiation of the Phase II multi-regional clinical trials in ADPKD and FSGS and maintaining ongoing communication with the relevant regulatory authorities. AP308: A First-in-Class Engineered Recombinant IgA Protease Aiming for Functional Cure of IgA Nephropathy AP308 is an engineered recombinant IgA protease derived from Thomasclavelia ramosa , a human commensal bacterium, and specifically cleaves human IgA1 at a site upstream of the hinge region. Unlike existing therapies that reduce upstream IgA production by modulating B-cell pathways (such as APRIL/BAFF), AP308 acts by directly cleaving and clearing pathogenic IgA and IgA immune complexes that have already formed, including IgA deposited in the glomeruli. Preclinical data. In the humanized mouse model of IgA nephropathy, a single dose reduced circulating human IgA1 by approximately 90% relative to controls, and circulating IgA1 remained low throughout the eight-week treatment period of weekly subcutaneous dosing; at the end of treatment, histological examination confirmed that glomerular IgA deposits were almost completely cleared, proteinuria decreased significantly, and kidney pathology improved markedly, while repeated dosing produced no treatment-related adverse reactions and no increase in anti-drug antibody titers. In a separate paired pre- and post-treatment design, a single dose completely cleared pre-existing glomerular IgA and complement C3 deposits. As of the Latest Practicable Date, no IgA protease drug candidate globally has entered the clinical stage. These results were published in May 2026 in Kidney International , the official journal of the International Society of Nephrology (ISN). [2] Development stage, catalysts and future milestones. As of the Latest Practicable Date, AP308 is at the preclinical stage. The Company plans to submit Investigational New Drug applications for AP308 to the NMPA and the FDA, respectively, in the second half of 2026, and will initiate the Phase I clinical trial of AP308 upon obtaining the relevant clearances. External Collaboration In March 2026, the Company announced that it had entered into licensing and equity agreements in respect of its product candidate AP306 with R1; the agreements were entered into in December 2025. The Company retains full rights and control over AP306 in Chinese Mainland, Hong Kong, Macau and Taiwan (collectively, "Greater China"), while R1 has obtained an exclusive license to develop, manufacture, and commercialize AP306 outside Greater China (the "R1 Territory"). R1 and the Company are co-sponsors of the global Phase IIb clinical trial; each party is responsible for clinical trial execution and regulatory submissions in its respective territory and provides the other party with relevant data and support required for regulatory purposes. During the Reporting Period, the Company recognized licensing revenue of RMB79.3 million from the transaction. Commercialization in China: Mircera® Mircera® (generic name: methoxy polyethylene glycol-epoetin beta) is a long-acting erythropoiesis-stimulating agent (ESA) of the continuous erythropoietin receptor activator (CERA) class and the world's first and only ESA approved for once-monthly administration. As of the Latest Practicable Date, no biosimilar of Mircera® has been approved or is under review anywhere in the world. In October 2023, the Company entered into a supply and marketing agreement with Roche Hong Kong, Ltd. ("Roche", a subsidiary of Roche Holding AG), obtaining the exclusive rights to sell, distribute, and otherwise commercialize Mircera® in the Chinese Mainland (excluding Hong Kong, Macau, and Taiwan); Roche is responsible for supply and for maintaining the drug registration certificate, while the Company is responsible for obtaining the permits required for promotion. Mircera® was included in the National Reimbursement Drug List (Category B) through the national medical insurance negotiations in 2023 and its listing was renewed in 2025 with no price reduction. In the first half of 2026, revenue of Mircera® reached RMB24.8 million, an increase of approximately 105.0% from RMB12.1 million in the corresponding period of 2025, at a gross profit margin of approximately 47.3%. The Company has built a dedicated in-house nephrology sales team comprising 43 sales personnel as of the Latest Practicable Date to conduct academic promotion. The commercial availability of Mircera® has given the Company proven access channels to public hospitals, an established distribution network, and dedicated nephrology academic promotion capabilities ahead of the approval of AP301 — ready-made infrastructure for the commercialization of AP301 and subsequent products. Integrated R&D, Manufacturing, and Commercialization Capabilities Manufacturing capabilities. Construction of the Company's in-house manufacturing facility in Yangzhou is complete, and the facility has obtained a Drug Manufacturing License (Category B) issued by the Jiangsu Provincial Drug Administration. It has completed pilot-scale production and is preparing for scale-up, to support future commercial-scale production of product candidates such as AP301 and AP306. Intellectual property. As of the Latest Practicable Date, the Company held 39 granted patents and 117 pending patent applications worldwide, spanning major jurisdictions including China, the United States, and Europe, and together covering the key inventions that underpin the Company's product pipeline. During the Reporting Period, the Company was granted 7 new patents and filed 22 new patent applications. Outlook The Company is committed to bringing better treatment options, covering the full course of disease, to patients with chronic kidney disease and related diseases worldwide. In the treatment of complications in patients with end-stage renal disease, the New Drug Application for the Company's core product AP301 in China was accepted for review by the NMPA on August 7, 2026, subsequent to the Reporting Period. We will give the review process our full cooperation and, following completion of the global Phase III multi-regional clinical trial in the second quarter of 2027, will submit a New Drug Application to the FDA. In parallel, we will press ahead with capacity preparation at the Yangzhou manufacturing facility and continue building out our nephrology commercialization system, so that AP301 can benefit patients as soon as possible. For AP306, we will work with R1 to advance enrollment and execution of the global Phase IIb multi-regional clinical trial and will disclose topline results in due course. In delaying the progression of CKD, we have now obtained all Phase II clinical trial approvals for AP303. In the second half of 2026, we will begin site selection for the Phase II basket trial in DKD and IgAN, prepare in parallel for initiation of the Phase II multi-regional clinical trials in ADPKD and FSGS, and map out the later-stage registration pathway for IgAN. For AP308, we will advance the submission of its Investigational New Drug applications and, once the relevant clearances are obtained, initiate the Phase I clinical trial. We will disclose these developments in due course. In addition, we will continue to strengthen our integrated capabilities across R&D, manufacturing, and commercialization, advance capacity preparation at the Yangzhou manufacturing facility as planned, and continue to expand our product pipeline in kidney disease through a two-pronged approach of internal R&D and external collaboration. References [1] Perkovic V, et al. Randomized clinical trials of deutaleglitazar in healthy participants and in patients with diabetic kidney disease. Kidney Int Rep. Published online August 20, 2026. doi:10.1016/j.ekir.2026.107037 [2] Shen X, et al. Therapeutic efficacy and antigenicity of a novel PEGylated IgA protease in preclinical models of IgA nephropathy. Kidney Int. 2026;110:463–476. doi:10.1016/j.kint.2026.04.020 About Alebund Pharmaceuticals Alebund Pharmaceuticals (09637.HK) is a biopharmaceutical company focused on kidney disease and related chronic conditions, aiming to bring better therapies to patients worldwide. It has one of the broadest renal-focused pipelines and an integrated platform spanning R&D, manufacturing and commercialization. Its portfolio comprises seven investigational drug candidates and one commercialized product, Mircera®. Three of the candidates are at the clinical stage: AP301 (Phase III; China pivotal Phase III trial completed, New Drug Application accepted for review by the NMPA in China, global MRCT ongoing), AP306 (Phase II) and AP303 (Phase I). Together they address chronic kidney disease (CKD) and its complications, including hyperphosphatemia, renal anemia, IgA nephropathy, diabetic kidney disease, FSGS and ADPKD. Alebund has built a manufacturing site in Yangzhou, Jiangsu to support the future commercial manufacturing of AP301 and other pipeline products, has obtained a Drug Manufacturing License (Category B) issued by the Jiangsu Provincial Drug Administration, and has completed pilot-scale production and is preparing for scale-up. The Company has also established a dedicated nephrology sales team responsible for the commercialization of relevant products in China. For more information, visit www.alebund.com . Forward-Looking Statements This press release contains certain forward-looking statements relating to the Company's future plans, clinical development and registration progress, commercialization prospects and industry trends, among other matters. These statements are based on the Company's judgments and assumptions as of the date of this press release and are subject to various risks and uncertainties; actual results may differ materially from such forward-looking statements. For further details of the Company's 2026 interim results, please refer to the interim results announcement published on the websites of the Stock Exchange ( www.hkexnews.hk ) and the Company ( www.alebund.com ), and the interim report of the Company to be made available in due course.
2026-08-26 10:59:00

MiniMax Announces First Half 2026 Financial Results
HONG KONG , Aug. 26, 2026 /PRNewswire/ -- MiniMax Group Inc. ("MiniMax" or the "Company"; HKEX: 00100), a leading global artificial intelligence company, today announced its unaudited financial results for the six months ended June 30, 2026. 1H2026 Key Highlights Total revenue increased by 283.1% year over year from US$30.4 million to US$116.6 million, exceeding our total revenue of US$79.0 million for the full year of 2025. Revenue from Open Platform and other AI-based enterprise services increased by 703.1% year over year from US$9.2 million to US$73.9 million and represented 63.4% of our total revenue, compared with 30.3% in the corresponding period of 2025. Revenue from AI-native products increased by 100.9% year over year from US$21.2 million to US$42.6 million. Gross profit improved by 464.8% year over year from US$3.7 million to US$20.8 million. Gross profit margin increased from 12.1% for the six months ended June 30, 2025 to 17.9% for the six months ended June 30, 2026. Adjusted net loss (1) was US$293.0 million for the six months ended June 30, 2026, compared with US$138.7 million for the six months ended June 30, 2025. As of June 30, 2026, our cash balance (2) was US$1,322.8 million, compared to cash balance of US$1,050.3 million as of December 31, 2025. Dr. Yan Junjie, Co-founder and CEO of MiniMax, commented, "Intelligence can scale almost without limit; energy and compute cannot. By July 2026, Token consumption on MiniMax had grown to 20 times its January level. That reinforces a belief we've held since day one: the long-term competition in AI is not just about building more powerful models, but about delivering higher levels of intelligence to more people at lower cost. 'Minimize the Cost, Maximize the Intelligence' is how we make 'Intelligence with Everyone' possible." 1H2026 Financial Review Revenue increased by 283.1% from US$30.4 million for the six months ended June 30, 2025 to US$116.6 million for the six months ended June 30, 2026. This was primarily driven by the continued expansion of our global customer and user base, rapidly increasing demand for model inference, and our ability to convert advances in model capabilities into products and services used by global enterprises, developers and individual users. Revenue from AI-native products increased by 100.9% from US$21.2 million for the six months ended June 30, 2025 to US$42.6 million for the six months ended June 30, 2026, primarily driven by higher user engagement and increased user willingness to pay for our products, as well as the continued adoption and monetization of products such as Hailuo AI and our other AI-native products. Revenue generated from Open Platform and other AI-based enterprise services increased by 703.1% from US$9.2 million for the six months ended June 30, 2025 to US$73.9 million for the six months ended June 30, 2026, primarily fueled by the growth in paying individual users and enterprise users, the increase in API call volumes, and the rapid adoption of our Token Plan. Gross profit improved by 464.8% from US$3.7 million for the six months ended June 30, 2025 to US$20.8 million for the six months ended June 30, 2026. Gross profit margin increased from 12.1% for the six months ended June 30, 2025 to 17.9% for the six months ended June 30, 2026, which was primarily driven by improving infrastructure efficiency. Selling and distribution expenses decreased by 17.9% from US$32.8 million for the six months ended June 30, 2025 to US$27.0 million for the six months ended June 30, 2026, mainly due to a decrease in promotional expenses as a result of our continued pursuit of an organic user growth strategy. Administrative expenses increased by 103.7% from US$14.8 million for the six months ended June 30, 2025 to US$30.2 million for the six months ended June 30, 2026, mainly driven by (i) an increase in headcount of management departments in line with the rapid development of our business and higher share-based payment expenses; and (ii) an increase in service fees to external professional service providers. As a result of our continued revenue growth and increased focus on enhancing administrative efficiency, administrative expenses as a percentage of total revenue decreased from 48.8% for the six months ended June 30, 2025 to 25.9% for the six months ended June 30, 2026. Research and development expenses increased by 138.8% from US$124.3 million for the six months ended June 30, 2025 to US$296.9 million for the six months ended June 30, 2026, mainly attributable to an increase in cloud services expenses related to training activities, driven by the increased model iteration and upgrades as we continued to develop and refine our foundation models and multi-modal capabilities. The year-on-year growth rate of our research and development expenses was significantly lower than our revenue growth rate of 283.1% during the period, demonstrating our improved research and development efficiency. Adjusted net loss (1) was US$293.0 million for the six months ended June 30, 2026 and US$138.7 million for the six months ended June 30, 2025, by adding back share-based payments, fair value loss on financial liabilities and listing expenses for the respective periods. Cash balance (2) was US$1,322.8 million as of June 30, 2026, compared to US$1,050.3 million as of December 31, 2025. Notes: (1) We define "adjusted net loss" as net loss adjusted by adding back share-based payment expenses, fair value loss on financial liabilities and listing expenses. (2) Cash balance included but not limited to cash and cash equivalents, financial assets at amortised cost, financial assets at fair value through profit or loss, restricted cash and time deposit. 1H2026 Business Review We continued to advance our mission of "Intelligence with Everyone" by delivering frontier model performance and making advanced intelligence affordable at scale. We view inference efficiency not only as essential to making advanced intelligence affordable at scale, but also as a critical enabler of further scaling model capabilities through more extensive post-training, experimentation and deployment. We continued to improve the capabilities and full-stack efficiency of our foundation models, translate technological progress into AI-native products and harnesses such as MiniMax Code, and enhance our Open Platform for enterprise customers and developers. Our model capabilities continued to advance across language and multi-modality, while our products and services reached an increasingly broad global user base. During the Reporting Period, we upgraded our core model offerings through the release of MiniMax M3, further strengthening our capabilities in coding, agentic workflows and professional work. Shortly after the Reporting Period, we also released MiniMax H3 with open weights, advancing video generation for commercial creation and widening the paths for enterprise deployment and developer innovation. As demand for inference and agentic workloads continued to grow, our Open Platform served an expanded base of enterprise customers and developers and became an increasingly important driver of our business. We continued to deepen our global footprint, serving enterprise customers, developers and individual users across more than 230 countries and regions with increasingly capable and cost-efficient intelligence offerings. For the six months ended June 30, 2026, our total revenue increased by 283.1% year-on-year from US$30.4 million to US$116.6 million, exceeding our total revenue of US$79.0 million for the full year of 2025. This growth reflected the continued expansion of our global customer and user base, rapidly increasing demand for model inference, and our ability to convert edges in model capabilities into products and services used by global enterprises, developers and individual users. Revenue from our Open Platform and other AI-based enterprise services increased by 703.1% year-on-year from US$9.2 million to US$73.9 million and represented 63.4% of our total revenue, compared with 30.3% in the corresponding period of 2025. The increase was driven by growth in paying users and enterprise customers, the increase in API call volumes, and the rapid adoption of our Token Plan. This performance demonstrated the growing demand for our models in production environments and the increasing contribution of enterprise and developer workloads to our business. Revenue from our AI-native products increased by 100.9% year-on-year from US$21.2 million to US$42.6 million, driven by higher user engagement, stronger willingness to pay and the continued commercialization of Hailuo AI and our other AI-native products. We continued to upgrade our AI-native product portfolio and harness products, enabling users to apply frontier model capabilities more directly to productivity. We maintained our commitment to long-term technological innovation while improving the efficiency with which research and development translated into business growth. Our research and development expenses increased by 138.8% year-on-year during the Reporting Period, significantly lower than our revenue growth of 283.1%. Gross profit increased by 464.8% year-on-year from US$3.7 million to US$20.8 million. We believe our continued investment in model capability, infrastructure efficiency and productization provides the foundation for sustainable growth over the long term. Conference call The Company's management will host a conference call on Wednesday, August 26, 2026, at 8:00 PM Beijing Time (8:00 AM U.S. Eastern Time) to discuss the results. Participants are required to pre-register for the conference call. Please register for the Chinese line to participate in the Q&A session; the English simultaneous interpretation line will be in listen-only mode. Chinese Line (Mandarin): https://s.comein.cn/m2dt2u6b English Simultaneous Interpretation Line (listen-only mode): https://s.comein.cn/g3uj92rq Alternatively, participants may dial into the Chinese conference call via the following dial-in details: Dial-in Numbers for Mainland China: Mainland China: +86 4001510269 Global: +86 01021377168 Dial-in Numbers for Outside Mainland China: Hong Kong, China: +852 51089680 Taiwan, China: +886 277083288 United States: +1 2087016888 Global: +86 1021377168 Meeting password: 691793 About MiniMax MiniMax is a leading global artificial intelligence company with a mission of "Intelligence with Everyone." The company is committed to advancing the frontiers of AI and building toward artificial general intelligence (AGI). MiniMax develops its own general-purpose foundation models across text and multimodal intelligence, and brings these capabilities to users worldwide through AI-native products and an Open Platform for enterprises and developers. Today, MiniMax's models and AI products serve more than 300 million users across over 200 countries and regions, as well as more than one million enterprises and developers across over 100 countries. For more information, please visit https://ir.minimaxi.com/en . Forward-Looking Statements Certain statements included in this press release, other than statements of historical fact, are forward-looking statements relating to our business outlook, estimates of financial performance, forecast business plans, growth strategies and projections of anticipated trends in our industry. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may", "might", "can", "could", "will", "would", "anticipate", "believe", "continue", "estimate", "expect", "forecast", "intend", "plan", "seek", or "timetable". These forward-looking statements are based on information currently available to the Company and are stated herein on the basis of the outlook at the time of this press release. They are based on certain expectations, assumptions and premises, many of which are subjective or beyond our control. These forward-looking statements may prove to be incorrect and may not be realized in the future. Underlying these forward-looking statements are a large number of risks and uncertainties. In light of the risks and uncertainties, the inclusion of forward-looking statements in this press release should not be regarded as representations by the Board or the Company that the plans and objectives will be achieved, and investors should not place undue reliance on such statements. Except as required by law, the Company, the Board, the employees or the Agencies are not obligated, and undertake no obligation, to release publicly any revisions to these forward-looking statements that might reflect events or circumstances occurring after the date of this press release or those that might reflect the occurrence of unanticipated events. Furthermore, they assume no obligations to whatsoever for any loss arising from the failure of any forward-looking statements to materialize or from their becoming inaccurate. For investor and media inquiries, please contact MiniMax Investor Relations Email: ir@minimax.io Media Relations Email: pr@minimax.io Piacente Financial Communications E-mail: Minimax@thepiacentegroup.com INTERIM CONDENSED CONSOLIDATED INCOME STATEMENT For the six months ended June 30, 2026 Six months ended June 30, 2026 2025 USD'000 USD'000 (Unaudited) (Unaudited) REVENUE 116,573 30,429 Cost of sales (95,760) (26,744) Gross profit 20,813 3,685 Other income and gains, net 8,039 20,339 Selling and distribution expenses (26,973) (32,843) Administrative expenses (30,230) (14,843) Research and development expenses (296,870) (124,333) Fair value loss on financial liabilities (31,025) (253,876) Finance costs (647) (325) Impairment (losses)/reversal on financial assets, net (1,104) 8 LOSS BEFORE TAX (357,997) (402,188) Income tax expense - - LOSS FOR THE PERIOD (357,997) (402,188) Attributable to: Owners of the parent (357,997) (402,188) Non-controlling interests - - (357,997) (402,188) LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE PARENT Basic and diluted – For loss for the period (USD) (1.18) (3.70) INTERIM CONDENSED CONSOLIDATED BALANCE SHEET As at As at June 30, December 31, 2026 2025 USD'000 USD'000 (Unaudited) (Audited) NON-CURRENT ASSETS Property, plant and equipment 74,913 1,571 Right-of-use assets 3,869 2,357 Prepayments, other receivables and other assets 100,817 887 Financial assets at amortised cost 29,629 - Financial assets at fair value through profit or loss 69,129 69,965 Financial assets at fair value through other comprehensive income 7,653 6,224 Restricted cash 41 41 Total non-current assets 286,051 81,045 CURRENT ASSETS Trade receivables 39,144 10,730 Prepayments, other receivables and other assets 165,431 16,319 Financial assets at fair value through profit or loss 278,347 438,525 Restricted cash 752 20,377 Time deposits 14,038 13,787 Cash and cash equivalents 930,905 507,621 Total current assets 1,428,617 1,007,359 CURRENT LIABILITIES Interest-bearing bank borrowings 133,555 35,452 Trade and bills payables 170,121 57,677 Other payables, accruals and other liabilities 38,934 34,068 Contract liabilities 18,287 7,541 Lease liabilities 2,035 1,318 Convertible redeemable preferred shares - 3,597,566 Total current liabilities 362,932 3,733,622 NET CURRENT ASSETS/(LIABILITIES) 1,065,685 (2,726,263) TOTAL ASSETS LESS CURRENT LIABILITIES 1,351,736 (2,645,218) NON-CURRENT LIABILITIES Deferred tax liabilities 812 - Lease liabilities 1,833 638 Other non-current liabilities 2,408 2,334 Total non-current liabilities 5,053 2,972 Net assets/(liabilities) 1,346,683 (2,648,190) EQUITY Share capital 20 - Reserves/(Deficits) 1,346,663 (2,648,190) Total equity 1,346,683 (2,648,190) Reconciliation of Non-IFRS Measures For the six months ended June 30, 2026 Six months ended June 30, 2026 2025 USD'000 USD'000 (Unaudited) (Unaudited) Loss for the period (357,997) (402,188) Adjusted for: Share-based payment expenses 28,208 6,634 Fair value loss on financial liabilities 31,025 253,876 Listing expenses 5,733 2,943 Adjusted net loss (non-IFRS measure (3) ) (293,031) (138,735) Note: (3) Please refer to section headed " Non-IFRS Measure" in the Interim Results Announcement for more details.
2026-08-26 10:55:00

JinkoSolar Announces Second Quarter 2026 Financial Results
SHANGRAO, China , Aug. 26, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), a global leader in clean energy technology, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Business Highlights Core Solar and Energy Storage Business Highlights Total module shipments for the first half of 2026 were 29.6 GW, with approximately 70% shipped to overseas markets. By the end of the second quarter, we became the first module manufacturer in the world to have delivered a total of over 420 GW of solar modules, with total shipments of the Tiger Neo series surpassing 250 GW, making it the best-selling module series in our history. In June 2026, we set new performance benchmarks for our TOPCon modules with the launch of the next-generation Tiger Neo 5.0 module, featuring power output of over 700 W and module efficiency of up to 25.91%. Shipments of energy storage system for the first half of 2026 increased significantly year-over-year, accompanied by an expansion in gross margin. Strategic Investment Highlights During the second quarter, the Company, together with investment funds in which it participates, completed strategic investments across 13 projects in renewable energy, advanced materials, AI, and other frontier technologies. During the first half of 2026, the Company disposed of a substantial portion of its equity interest in LAPLACE Renewable Energy Technology Co., Ltd., generating over RMB300 million in cash proceeds. Since our initial investment, the cumulative realized gain on this disposal (net of cost and transaction fees) exceeded RMB250 million. This gain was recognized over multiple periods through fair value adjustments following its IPO in late 2024, with over RMB100 million recorded in change in fair value of long-term investment upon settlement in the first half of 2026. Additionally, our portfolio company, Hangzhou Gold Electronic Equipment Co., Ltd., successfully completed its public listing during the second quarter, marking an important milestone in the development of our strategic investment portfolio. Second Quarter 2026 Operational and Financial Highlights Quarterly shipments of solar modules were 15,961 MW, up 16.7% sequentially and down 34.4% year-over-year. Total revenues were RMB12.36 billion (US$1.82 billion), up 0.9% sequentially and down 31.3% year-over-year. Gross profit was RMB 513.1 million (US$75.6 million), down 49.6% sequentially and 2.5% year-over-year. Gross profit margin was 4.2%, compared with gross profit margin of 8.3% in Q1 2026 and gross profit margin of 2.9% in Q2 2025. Net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders was RMB697.3 million (US$102.8 million), compared with net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB463.5 million in Q1 2026 and net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB876.4 million in Q2 2025. Adjusted net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders was RMB910.8 million (US$134.2 million), which excludes the impact of (i) the change in fair value of long-term investment, (ii) gain from disposal of a subsidiary, and (iii) share-based compensation expenses, compared with adjusted net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB549.3 million in Q1 2026 and adjusted net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB856.4 million in Q2 2025. Basic and diluted losses per ordinary share were RMB3.30 (US$0.49) and RMB3.30 (US$0.49), respectively. This translates into basic and diluted losses per ADS of RMB13.19 (US$1.94) and RMB13.19 (US$1.94), respectively. Mr. Dimi Du, JinkoSolar's Chief Executive Officer, commented, "Module shipments increased sequentially to approximately 16 GW during the quarter, bringing first half module shipments to approximately 29.6 GW, once again at the forefront of industry. By the end of the second quarter, cumulative shipments of our high-efficiency N-type Tiger Neo series surpassed 250 GW, making it the best-selling module series in our history. Leveraging a sales network covering nearly 200 countries and regions and 35 service centers globally, shipments to overseas markets accounted for around 70% of the first half total. Supply and demand across the PV industry remain dynamic and with policy shifts in both domestic and overseas markets, prices along the supply chain and industry profitability continued to be under pressure. The cost of ramping up production of our high-efficiency products remained elevated during the quarter and impacted our gross margin and bottom line when combined with the delivery of certain low-value orders. In response, we optimized our order book and geographic mix, managed utilization rates, and continued to increase the proportion of high-efficiency products within our total shipments while introducing technologies that lower costs. The PV industry is gradually shifting its focus from production capacity and shipment scale toward effective supply, product value, and earnings quality. The mandatory national energy efficiency standard for modules and inverters, released in July 2026, will take effect in January 2027 and sets minimum energy efficiency thresholds for market access. We are already seeing this shift in customer behavior, with the share of tenders for high-efficiency modules increasing significantly which also command a premium. The distributed PV market is likewise transitioning from scale-driven growth toward scenario-based and operational value. We believe these changes will benefit industry leaders such as ourselves, allowing us to capitalize on our advanced manufacturing capacity, technological expertise, established brands and global delivery capabilities. We expect to have more than 40 GW of TOPCon 3.0 production capacity by the end of 2026. Based on the current standard requirements, the relevant products are expected to meet the Level 1 energy-efficiency requirements. In June, we unveiled our next-generation Tiger Neo 5.0 modules, which, through the optimization of multiple core technologies, achieved mass-produced efficiency of 25.91% and power output of over 700 W, once again setting a new benchmark for TOPCon product performance. We are also extending our technology into scenario-based applications, most recently through Sunny 365, a suite of integrated solar-plus-storage solutions designed for retail, AIDC and manufacturing scenarios. Our energy storage systems (ESS) business maintained its momentum, with shipments in the first half of the year increasing significantly year-over-year and gross margin improving year-over-year. Given uncertainties in the timing of project delivery and other factors, recognized revenue remains in the ramp-up stage. As project deliveries increase, alongside the ongoing enhancement of our proprietary PCS, EMS and other capabilities, we expect to improve the recognition contribution and profit realization and to drive higher-quality growth in this business. Alongside our core businesses, we are building an investment platform as a complementary driver of long-term value creation. Over the past several years, we have made selective investments in more than 40 projects through direct investments and investment funds in which we participate, initially focusing on the solar and energy storage value chains and more recently extending into AI and other frontier technologies. During the first half of 2026, we divested a substantial portion of our equity interest in LAPLACE Renewable Energy Technology Co., Ltd., generating cash proceeds of over RMB300 million, while Hangzhou Gold Electronic Equipment Co., Ltd., one of our portfolio companies, successfully completed its listing on the ChiNext Market of the Shenzhen Stock Exchange. These milestones demonstrate the progress we are making in realizing value from our investment portfolio. We will continue to allocate capital prudently, with the long-term development of our core solar and energy storage businesses remaining our top priority, while selectively pursuing strategic investments that can support sustainable long-term value creation. Looking ahead, we expect our annual integrated production capacity to reach approximately 100 GW by year-end 2026, including approximately 14 GW from overseas facilities. Considering demand dynamics in certain markets, we will place greater emphasis on balancing shipment volume, profitability, cash flow and order quality, and are adjusting our full year 2026 module shipment guidance to between 60 GW and 70 GW, with high-efficiency products accounting for over 60% of the total shipments. For the third quarter of 2026, we expect module shipments to be between 15 GW and 17 GW." Second Quarter 2026 Financial Results Total Revenues Total revenues in the second quarter of 2026 were RMB12.36 billion (US$1.82 billion), representing an increase of 0.9% from RMB12.25 billion in the first quarter of 2026 and a decrease of 31.3% from RMB17.99 billion in the second quarter of 2025. The sequential and year-over-year changes were mainly due to the fluctuations in the shipment volume of solar modules. Gross Profit and Gross Margin Gross profit in the second quarter of 2026 was RMB513.1 million (US$75.6 million), compared with gross profit of RMB1.02 billion in the first quarter of 2026 and gross profit of RMB526.5 million in the second quarter of 2025. Gross profit margin was 4.2% in the second quarter of 2026, compared with gross profit margin of 8.3% in the first quarter of 2026 and gross profit margin of 2.9% in the second quarter of 2025. The sequential decrease was mainly due to a lower average selling price of solar modules, while the year-over-year increase was primarily due to the higher average selling price of solar modules, partially offset by a higher unit cost of products sold. Loss from Operations and Operating Margin Loss from operations in the second quarter of 2026 was RMB1.44 billion (US$211.7 million), compared with loss from operations of RMB588.2 million in the first quarter of 2026 and loss from operations of RMB1.38 billion in the second quarter of 2025. The sequential increase was primarily attributable to the decrease in our gross margin in the second quarter of 2026, while the year-over-year increase was primarily due to the increase in our operating expenses in the second quarter of 2026. Operating loss margin was 11.6% in the second quarter of 2026, compared with operating loss margin of 4.8% in the first quarter of 2026 and operating loss margin of 7.7% in the second quarter of 2025. Total operating expenses in the second quarter of 2026 were RMB1.95 billion (US$287.3 million), representing an increase of 21.3% from RMB1.61 billion in the first quarter of 2026 and an increase of 2.3% from RMB1.91 billion in the second quarter of 2025. The sequential and year-over-year increases were primarily due to higher expected credit losses in the second quarter of 2026. Total operating expenses accounted for 15.8% of total revenues in the second quarter of 2026, compared to 13.1% in the first quarter of 2026 and 10.6% in the second quarter of 2025. Interest Expenses and Interest Income Interest expenses were RMB386.9 million (US$57.0 million), and interest income was RMB113.6 million (US$16.7 million) in the second quarter of 2026. Net interest expenses in the second quarter of 2026 were RMB273.3 million (US$40.3 million), representing an increase of 0.9% from RMB270.7 million in the first quarter of 2026 and an increase of 45.9% from RMB187.3 million in the second quarter of 2025. The year-over-year increase was primarily attributable to new lease liabilities recognized in connection with lease contracts executed in late 2025. Subsidy Income Subsidy income in the second quarter of 2026 was RMB201.8 million (US$29.7 million), compared with RMB331.9 million in the first quarter of 2026 and RMB12.0 million in the second quarter of 2025. The sequential and year-over-year changes were primarily attributable to the changes in government grants related to income. Exchange Loss/Gain The Company recorded a net exchange loss of RMB325.4 million (US$48.0 million) in the second quarter of 2026, compared to a net exchange loss of RMB482.8 million in the first quarter of 2026 and a net exchange gain of RMB276.7 million in the second quarter of 2025. The sequential and year-over-year changes were mainly attributable to fluctuations in the exchange rates of the US dollar and euro against RMB in the second quarter of 2026. Change in Fair Value of Forward Contracts and Commodity Futures The Company recorded a net loss from change in fair value of forward contracts and commodity futures of RMB48.4 million (US$7.1 million) in the second quarter of 2026, compared to a net loss of RMB354.7 million in the first quarter of 2026 and a net loss of RMB178.8 million in the second quarter of 2025. The sequential improvement was mainly due to the decrease of loss from change in fair value of commodity futures in the second quarter of 2026, while the year-over-year improvement was primarily due to the decrease of loss from change in fair value of forward contracts in the second quarter of 2026. Change in Fair Value of Long-term Investment The Company holds certain equity interests in several companies operating across the photovoltaic, energy storage, and artificial intelligence sectors, which are recorded as long-term investment and available-for-sale securities and reported at fair value with changes in fair value recognized as gains or losses. As of June 30, 2026, the Company had RMB1.99 billion (US$294.0 million) in long-term investment (excluding the investments accounted for under the equity method and held-to-maturity debt securities) and available-for-sale securities, compared with RMB1.10 billion as of March 31, 2026. The Company recognized a gain from change in fair value of long-term investment of RMB 370.3 million (US$54.6 million) in the second quarter of 2026, compared with a gain of RMB124.4 million in the first quarter of 2026 and a gain of RMB42.3 million in the second quarter of 2025. The sequential and year-over-year improvements were primarily due to fair value gains from a previously invested company that went public in the second quarter of 2026, reflecting both post-IPO share price appreciation on the original investment and the incremental fair value from additional investments made during the second quarter of 2026. Other Loss/Income, Net Net other loss in the second quarter of 2026 was RMB23.9 million (US$3.5million), compared with net other income of RMB34.9 million in the first quarter of 2026 and net other loss of RMB204.7 million in the second quarter of 2025. The sequential and year-over-year changes were mainly due to the changes in the fair value of financial instruments in the second quarter of 2026. Gain from disposal of a subsidiary On May 31, 2026, we completed the transfer of 75.1% equity interest in Jinko Solar (U.S.) Industries Inc. to FH JKV Holdings Limited for total cash consideration of RMB1.31 billion (US$191.5 million). The transaction resulted in a pre-tax disposal gain of approximately RMB236.6 million (US$34.9 million). Effective upon closing, the subsidiary's financial results are no longer consolidated in our financial statements, and our retained 24.9% equity interest is subsequently measured and recognized using the equity method. Equity in Loss of Affiliated Companies The Company indirectly holds equity interests in several affiliated companies engaged in solar business, which are accounted for using the equity method. The Company recorded equity in loss of affiliated companies of RMB78.6 million (US$11.6 million) in the second quarter of 2026, compared with equity in loss of affiliated companies of RMB54.5 million in the first quarter of 2026 and equity in loss of affiliated companies of RMB70.9 million in the second quarter of 2025. The fluctuations in equity in loss of affiliated companies primarily arose from the changes in net losses incurred by the affiliated companies. Income Tax Benefit The Company recorded an income tax benefit of RMB163.7 million (US$24.1 million) in the second quarter of 2026, compared with income tax benefit of RMB379.3 million in the first quarter of 2026 and income tax benefit of RMB288.8 million in the second quarter of 2025. Net Loss Attributable to Non-Controlling Interests Net loss attributable to non-controlling interests amounted to RMB569.9 million (US$84.0million) in the second quarter of 2026, compared with net loss attributable to non-controlling interests of RMB449.4 million in the first quarter of 2026 and net loss attributable to non-controlling interests of RMB546.6 million in the second quarter of 2025. The sequential and year-over-year changes were mainly attributable to the fluctuations in net loss of Jiangxi Jinko, the Company's majority-owned principal operating subsidiary. Net Loss and Losses per Share Net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders was RMB697.3 million (US$102.8 million) in the second quarter of 2026, compared with net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB463.5 million in the first quarter of 2026 and net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB876.4 million in the second quarter of 2025. Excluding the impact of (i) the change in fair value of the long-term investment, (ii) gain from disposal of a subsidiary, and (iii) share-based compensation expenses, adjusted net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders was RMB910.8 million (US$134.2 million) in the second quarter of 2026, compared with adjusted net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB549.3 million in the first quarter of 2026 and adjusted net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB856.4 million in the second quarter of 2025. Basic and diluted losses per ordinary share were RMB3.30 (US$0.49) and RMB3.30 (US$0.49), respectively, in the second quarter of 2026, compared to basic and diluted losses per ordinary share of RMB2.21 and RMB2.21, respectively, in the first quarter of 2026, and basic and diluted losses per ordinary share of RMB4.20 and RMB4.20, respectively, in the second quarter of 2025. As each ADS represents four ordinary shares, this translates into basic and diluted losses per ADS of RMB13.19 (US$1.94) and RMB13.19 (US$1.94), respectively, in the second quarter of 2026; basic and diluted losses per ADS of RMB8.85 and RMB8.85, respectively, in the first quarter of 2026; and basic and diluted losses per ADS of RMB16.82 and RMB16.82, respectively, in the second quarter of 2025. Financial Position As of June 30, 2026, the Company had RMB16.94 billion (US$2.50 billion) in cash, cash equivalents, and restricted cash, compared with RMB22.81 billion as of March 31, 2026. As of June 30, 2026, the Company's net accounts receivable was RMB12.61 billion (US$1.86 billion), compared with RMB13.77 billion as of March 31, 2026. As of June 30, 2026, the Company's inventories were RMB16.47 billion (US$2.43 billion), compared with RMB17.71 billion as of March 31, 2026. As of June 30, 2026, the Company's total interest-bearing debts were RMB44.90 billion (US$ 6.62 billion), compared with RMB47.27 billion as of March 31, 2026. Operations and Business Outlook Highlights Third Quarter and Full Year 2026 Guidance The Company's business outlook is based on management's current views and estimates with respect to market conditions, production capacity, the Company's order book and the global economic environment. This outlook is subject to uncertainty on final customer demand and sale schedules. Management's views and estimates are subject to change without notice. For the third quarter of 2026, the Company expects its module shipments to be in the range of 15.0 GW to 17.0 GW. Taking into account changes in demand in certain markets, as well as the Company's increased focus on balancing shipment volume with profitability, cash flow and order quality, the Company now expects its full-year 2026 module shipments to be in the range of 60.0 GW to 70.0 GW. For full year 2026, the Company expects its ESS shipments to be more than doubled year-over-year. Solar Products Production Capacity The Company expects its annual integrated production capacity to reach approximately 100 GW, including approximately 14 GW from overseas facilities, by the end of 2026. Recent Business Developments In June 2026, JinkoSolar's board of directors declared a cash dividend of US$0.375 per ordinary share of US$0.00002 each of the Company, or US$1.50 per ADS. In June 2026, JinkoSolar was recognized as an Overall Highest Achiever in the 2026 PV Module Index (PVMI) Report, published by RETC, part of the VDE Group . In June 2026, JinkoSolar's Tiger Neo 3.0 modules achieved TÜV Rheinland's "A+ Shading Score" under the PfG 2926/05.25 test methodology, while also successfully completing advanced hail resistance verification according to VKF standards. Conference Call Information JinkoSolar's management will host an earnings conference call on Wednesday, August 26, 2026 at 8:30 a.m. U.S. Eastern Time (8:30 p.m. Beijing / Hong Kong the same day). Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, passcode and unique access PIN by a calendar invite. Participant Online Registration: https://s1.c-conf.com/diamondpass/10056808-i852sd.html It will automatically direct you to the registration page of "JinkoSolar Second Quarter 2026 Earnings Conference Call", where you may fill in your details for RSVP. In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration. A telephone replay of the call will be available 2 hours after the conclusion of the conference call through 23:59 U.S. Eastern Time, September 2, 2026. The dial-in details for the replay are as follows: International: +61 7 3107 6325 U.S.: +1 855 883 1031 Passcode: 10056808 Additionally, a live and archived webcast of the conference call will be available on the Investor Relations section of JinkoSolar's website at http://www.jinkosolar.com . About JinkoSolar Holding Co., Ltd. JinkoSolar (NYSE: JKS) is a global leader in clean energy technology. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, Netherlands, Poland, Austria, Switzerland, Greece and other countries and regions. JinkoSolar had over 10 production facilities globally, over 20 overseas subsidiaries in Japan, South Korea, Vietnam, India, Turkey, Germany, Italy, Switzerland, the United States, Mexico, and other countries, and a global sales network with sales teams in China, the United States, Canada, Brazil, Chile, Mexico, Italy, Germany, Turkey, Spain, Japan, the United Arab Emirates, Netherlands, Vietnam and India, as of June 30, 2026. To find out more, please see: www.jinkosolar.com Currency Convenience Translation The conversion of Renminbi into U.S. dollars in this release, made solely for the convenience of the readers, is based on the noon buying rates in the city of New York for cable transfers of Renminbi as certified for customs purposes by the Federal Reserve Bank of New York as of June 30, 2026, which was RMB6.7851 to US$1.00. No representation is intended to imply that the Renminbi amounts could have been, or could be, converted, realized, or settled into U.S. dollars at that rate or any other rate. The percentages stated in this press release are calculated based on Renminbi. Safe Harbor Statement This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and the Company's operations and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in JinkoSolar's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. For investor and media inquiries, please contact: In China: Ms. Stella Wang JinkoSolar Holding Co., Ltd. Tel: +86 21-5180-8777 ext.7806 Email: ir@jinkosolar.com Mr. Christian Arnell Christensen Tel: +852 2117 0861 Email: christian.arnell@christensencomms.com In the U.S.: Email: jinko@christensencomms.com JINKOSOLAR HOLDING CO., LTD. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except ADS and Share data) For the quarter ended For the six months ended Jun 30, 2025 Mar 31, 2026 Jun 30, 2026 Jun 30, 2025 Jun 30, 2026 RMB'000 RMB'000 RMB'000 USD'000 RMB'000 RMB'000 USD'000 Revenues 17,988,725 12,249,048 12,356,951 1,821,189 31,832,365 24,605,999 3,626,476 Cost of revenues (17,462,264) (11,230,471) (11,843,858) (1,745,569) (31,658,778) (23,074,329) (3,400,735) Gross profit 526,461 1,018,577 513,093 75,620 173,587 1,531,670 225,741 Operating expenses: Selling and marketing (1,227,267) (901,688) (939,426) (138,454) (2,372,678) (1,841,114) (271,347) General and administrative (401,761) (476,564) (767,565) (113,125) (1,616,826) (1,244,129) (183,362) Research and development (251,598) (228,483) (231,363) (34,099) (403,400) (459,846) (67,773) Impairment of long-lived assets (24,536) - (11,145) (1,643) (24,536) (11,145) (1,643) Total operating expenses (1,905,162) (1,606,735) (1,949,499) (287,321) (4,417,440) (3,556,234) (524,125) Loss from operations (1,378,701) (588,158) (1,436,406) (211,701) (4,243,853) (2,024,564) (298,384) Interest expenses (332,800) (380,636) (386,897) (57,022) (674,403) (767,533) (113,120) Interest income 145,540 109,887 113,621 16,746 249,869 223,508 32,941 Subsidy income 12,033 331,911 201,820 29,745 547,990 533,731 78,662 Exchange gain/(loss),net 276,686 (482,808) (325,367) (47,953) 412,371 (808,175) (119,110) Change in fair value of forward contracts and commodity futures (178,816) (354,718) (48,414) (7,136) (232,779) (403,132) (59,414) Change in fair value of Long-term Investment 42,301 124,426 370,308 54,577 (3,855) 494,734 72,915 Other (loss)/income, net (204,748) 34,862 (23,880) (3,519) (384,110) 10,982 1,619 Gain from disposal of a subsidiary - - 236,585 34,868 - 236,585 34,868 Loss before income taxes (1,618,505) (1,205,234) (1,298,630) (191,395) (4,328,770) (2,503,864) (369,023) Income tax benefits 288,768 379,259 163,675 24,123 988,247 542,935 80,019 Equity in loss of affiliated companies (70,873) (54,470) (78,621) (11,587) (116,946) (133,090) (19,615) Net loss (1,400,610) (880,445) (1,213,576) (178,859) (3,457,469) (2,094,019) (308,619) Less: Net loss attributable to non- controlling interests 546,626 449,376 569,946 84,000 1,302,680 1,019,322 150,229 Less: Accretion to redemption value of redeemable non-controlling interests (22,438) (32,445) (53,623) (7,903) (40,512) (86,068) (12,685) Net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders (876,422) (463,514) (697,253) (102,762) (2,195,301) (1,160,765) (171,075) Net (loss)/income attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders per share: Basic (4.20) (2.21) (3.30) (0.49) (10.59) (5.52) (0.81) Diluted (4.20) (2.21) (3.30) (0.49) (10.59) (5.52) (0.81) Net (loss)/income attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders per ADS: Basic (16.82) (8.85) (13.19) (1.94) (42.34) (22.06) (3.25) Diluted (16.82) (8.85) (13.19) (1.94) (42.34) (22.06) (3.25) Weighted average ordinary shares outstanding: Basic 208,496,117 209,480,753 211,435,343 211,435,343 207,378,908 210,463,447 210,463,447 Diluted 208,496,117 209,480,753 211,435,343 211,435,343 207,378,908 210,463,447 210,463,447 Weighted average ADS outstanding: Basic 52,124,029 52,370,188 52,858,836 52,858,836 51,844,727 52,615,862 52,615,862 Diluted 52,124,029 52,370,188 52,858,836 52,858,836 51,844,727 52,615,862 52,615,862 JINKOSOLAR HOLDING CO., LTD. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) Dec 31, 2025 Jun 30, 2026 RMB'000 RMB'000 USD'000 ASSETS Current assets: Cash,cash equivalents, and restricted cash 22,938,381 16,941,252 2,496,831 Restricted short-term investments and short-term investments 7,487,415 8,766,415 1,292,009 Accounts receivable, net 13,587,215 12,606,756 1,858,006 Notes receivable, net 3,677,372 1,778,508 262,120 Advances to suppliers, net 1,325,633 1,322,526 194,916 Inventories, net 14,484,828 16,473,187 2,427,847 Forward contract and commodity future receivables 58,923 103,535 15,259 Prepayments and other current assets, net 4,909,826 5,609,364 826,718 Held-for-sale assets 344,553 128,848 18,990 Total current assets 68,814,146 63,730,391 9,392,696 Non-current assets: Restricted long-term investments 471,573 1,026,402 151,273 Long-term investments 1,441,683 3,934,684 579,900 Property, plant and equipment, net 36,644,813 35,764,854 5,271,087 Land use rights, net 2,140,953 2,014,358 296,880 Intangible assets, net 445,866 397,248 58,547 Right-of-use assets, net 3,617,900 3,612,536 532,422 Deferred tax assets 4,576,302 4,418,390 651,190 Advances to suppliers to be utilised beyond one year 605,525 717,178 105,699 Other assets, net 2,026,752 2,210,857 325,840 Available-for-sale securities-non-current 238,464 690,911 101,828 Total non-current assets 52,209,831 54,787,418 8,074,666 Total assets 121,023,977 118,517,809 17,467,362 LIABILITIES Current liabilities: Accounts payable 13,707,552 13,354,154 1,968,159 Notes payable 9,996,577 8,250,801 1,216,017 Accrued payroll and welfare expenses 2,645,041 1,924,052 283,570 Advances from customers 5,316,889 6,337,166 933,983 Income tax payables 177,580 262,355 38,666 Other payables and accruals 12,370,639 12,439,840 1,833,403 Forward contract and commodity future payables 56,129 72,487 10,683 Lease liabilities - current 118,363 38,659 5,698 Short-term borrowings, including current portion of long-term borrowings, and failed sale-leaseback financing 10,655,366 13,624,605 2,008,018 Total current liabilities 55,044,136 56,304,119 8,298,197 Non-current liabilities: Long-term borrowings 18,206,905 15,135,046 2,230,630 Convertible notes 10,594,637 8,876,294 1,308,204 Accrued warranty costs - non current 1,655,630 1,554,913 229,166 Lease liabilities-noncurrent 3,550,598 3,781,246 557,287 Deferred tax liability 29,974 114,072 16,812 Long-term Payables 4,371,333 3,921,737 577,993 Total non-current liabilities 38,409,077 33,383,308 4,920,092 Total liabilities 93,453,213 89,687,427 13,218,289 MEZZANINE EQUITY Redeemable non-controlling interests 1,545,058 3,539,877 521,713 SHAREHOLDERS' EQUITY Total JinkoSolar Holding Co., Ltd. shareholders' equity 15,726,132 14,604,359 2,152,417 Non-controlling interests 10,299,574 10,686,146 1,574,943 Total shareholders' equity 26,025,706 25,290,505 3,727,360 Total liabilities, non-controlling interest and shareholders' equity 121,023,977 118,517,809 17,467,362
2026-08-26 10:50:00

JinkoSolar Appoints New Chief Executive Officer
SHANGRAO, China , Aug. 26, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), a global leader in clean energy technology, today announced that Mr. Xiande Li has resigned as the chief executive officer of the Company, effective August 26, 2026. Mr. Wei "Dimi" Du will succeed Mr. Li as the chief executive officer of the Company, effective August 26, 2026. Mr. Li will continue serving as the chairman and chair of the compensation committee and the nominating and corporate governance committee of the board of directors. The resignation of Mr. Li was not due to any disagreement with the Company, and the Company does not believe this change to its senior management team will have any material impact on its business operations. Mr. Du served as vice president of strategic investment at JinkoSolar since April 2026, having previously been the general manager of strategic investment and assistant to the chairman of JinkoSolar between December 2021 and March 2026, and the assistant to the chairman of Jinko Power Technology Co., Ltd. from February 2021 to December 2021. Prior to this, Mr. Du served as the executive general manager of investor relations at Shanghai Yuyuan Tourist Mart (Group) Co., Ltd. from October 2018 to January 2021. Mr. Du holds a BSc degree in accounting and finance from the University of Bristol and an MSc degree in finance from Imperial College London, United Kingdom. "We are pleased to welcome Mr. Du as our chief executive officer," commented Mr. Xiande Li, Chairman of JinkoSolar, "This transition is part of a carefully planned succession process. As we enter the next phase of development, this arrangement allows me to focus on our long-term strategy, board governance, and major strategic decisions, while our new CEO will lead management in overseeing day‐to‐day operations, strategic execution, and capital allocation at the group level. Dimi's extensive experience in strategic investment and portfolio management ideally positions him to improve the quality of our operations and drive execution of our core solar and energy storage businesses and strategic investment activities." "I am honored to take on the role of chief executive officer," said Mr. Wei "Dimi" Du, "Under Mr. Li's leadership, JinkoSolar has generated sustainable growth and expanded its business globally. I am fully committed to driving the next chapter of our growth by further improving our operating quality and strategic execution, supporting the long-term development of our core solar and energy storage businesses, and pursuing disciplined capital allocation and strategic investment management. I look forward to working closely with the management team under the guidance of the board to create sustainable long-term value for our shareholders." About JinkoSolar Holding Co., Ltd. JinkoSolar (NYSE: JKS) is a global leader in clean energy technology. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, Netherlands, Poland, Austria, Switzerland, Greece and other countries and regions. JinkoSolar had over 10 production facilities globally, over 20 overseas subsidiaries in Japan, South Korea, Vietnam, India, Turkey, Germany, Italy, Switzerland, the United States, Mexico, and other countries, and a global sales network with sales teams in China, the United States, Canada, Brazil, Chile, Mexico, Italy, Germany, Turkey, Spain, Japan, the United Arab Emirates, Netherlands, Vietnam and India, as of June 30, 2026. To find out more, please see: www.jinkosolar.com Safe Harbor Statement This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and the Company's operations and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in JinkoSolar's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. For investor and media inquiries, please contact: In China: Ms. Stella Wang JinkoSolar Holding Co., Ltd. Tel: +86 21-5180-8777 ext.7806 Email: ir@jinkosolar.com Mr. Christian Arnell Christensen Tel: +852 2117 0861 Email: christian.arnell@christensencomms.com In the U.S.: Email: jinko@christensencomms.com
2026-08-26 10:48:00

With ropes and chants, thousands move Japanese castle

Hirosaki, Japan: Chanting in unison, hundreds of volunteers in northern Japan heaved on ropes on Wednesday to pull a 400-tonne castle back towards its original position.

The imposing fortified tower of Hirosaki Castle was shifted 80 metres (262 feet) in 2015 to allow for essential repairs to the stone walls that support it.


Visitors watch as participants pull Hirosaki Castle using ropes to its original position following repair works in Hirosaki, Aomori Prefecture on August 26, 2026. (Photo by Philip FONG / AFP)

Engineers at the time opted to reposition the three-storey wooden structure without dismantling it, hoisting it in one piece on metal rails to a temporary platform.

Since last Saturday, groups of about 80 people have been taking turns moving the tower a few precious centimetres at a time.

Local officials estimate that around 4,000 people in total -- some from overseas -- have participated, advancing the structure by nearly five metres.

"It's like trying to move a mountain," Takahiro Kogawa, a 56-year-old Hirosaki resident, told AFP, his forehead beaded with sweat after a few minutes of intense effort.


Participants take pictures after pulling Hirosaki Castle using ropes to its original position following repair works in Hirosaki, Aomori Prefecture on August 26, 2026. (Photo by Philip FONG / AFP)

Azusa Nimiya, a 46-year-old history and castle enthusiast, travelled from Shimane, almost on the other side of Japan's main island, to do her bit.

"It's the experience of a lifetime, a precious and unique memory," she said.

The municipality will deploy heavy machinery in September to complete the journey, aiming for a permanent installation in November.

Following further restoration work on the copper roof and facades, the full reopening to the public of this masterpiece from the Edo period (1603-1868) is scheduled for 2033.

Physical history

By involving the public, "we wanted everyone to be able to experience history physically," said Kensuke Hayasaka, the head of the restoration project.

"It's extremely significant for passing on the history of Hirosaki to future generations," he told AFP.

Lightning destroyed the tower in the 17th century, and it was rebuilt in the early 19th century.

But a few decades later, the stone foundations threatened to collapse, forcing the tower to be moved for the first time -- again thanks to muscle power.


Participants pull Hirosaki Castle using ropes to its original position following repair works in Hirosaki, Aomori Prefecture on August 26, 2026. (Photo by Philip FONG / AFP)

It was finally returned to its original position in 1915.

This large-scale, human-powered operation, known as "hikiya", "is a traditional technique for moving structures that has existed in Japan since ancient times," explained Hayasaka.

"Our goal is to preserve this unique heritage, while ensuring that the main tower is securely fixed to its base before the first snowfall," which is abundant in winter in this northern region.

"Seeing all these discussions and the methods devised by our predecessors and our teams finally come to fruition this year is extremely moving. We feel a profound sense of accomplishment," he added.


Participants pull Hirosaki Castle using ropes to its original position following repair works in Hirosaki, Aomori Prefecture on August 26, 2026. (Photo by Philip FONG / AFP)

Among the most enthusiastic pullers was Katsumi Terada, 82, who tucked two Japanese flags into his headband.

He recounted having participated 11 years earlier.

"I wondered then, with some anxiety, if I would still be around to see it return to its base. But look, I persevered. I'm alive and well."


2026-08-26 10:46:35

DPC Dash Ltd Announces 2026 Interim Financial Results
Revenue reached RMB3.13 billion, representing 20.8% year-over-year growth Transaction volume grew 33.7% YoY; same-store transaction count grew 7.1% Net profit reached RMB81.0 million, representing 22.9% year-over-year growth Net addition of 235 new stores in the first half; total network expanded to 1,550 stores across 75 cities HONG KONG , Aug. 26, 2026 /PRNewswire/ -- DPC Dash Ltd – Domino's Pizza China ("DPC Dash" or the "Company", together with its subsidiaries, the "Group") (1405.HK), Domino's Pizza's exclusive master franchisee in the Chinese Mainland, the Hong Kong Special Administrative Region of China, and the Macau Special Administrative Region of China, today announced its unaudited condensed consolidated interim financial results for the six months ended June 30, 2026 (the "Interim Results"). FIRST HALF OF 2026 HIGHLIGHTS [1] Revenue reached RMB3,133.8 million, representing an increase of 20.8% from RMB2,593.4 million in the same period of 2025. Opened 235 net new stores and entered 15 new cities during the first half of 2026. Total stores reached 1,550, across 75 cities, with 532 stores in Tier 1 cities and 1,018 stores in non-Tier 1 cities, as of June 30, 2026. New stores opened in 2026 New City markets [2] generated average daily sales of RMB28,230 during the first half of 2026, with a weighted average expected payback period of approximately 14.8 months. Transaction volume increased 33.7% YoY, supported by continued national store network expansion. Same-store transaction count grew 7.1%. Average Transaction Price (ATP) was RMB72.9, compared with RMB80.7 in the same period of 2025, primarily reflecting heavy consumer subsidies offered by third-party aggregator platform (3PP) campaigns from mid-2025. Average daily sales per store (ADS) declined by 8.4% during the first half of 2026 as compared to the same period of 2025, primarily due to lower realized average transaction prices (ATP), which declined by 9.6% during the period. Same-store Transaction Count Growth (SSTG) was 7.1%, compared to 3.9% in the same period of 2025. Initial City markets: SSTG was 8.5%, compared with 6.8% in the same period of 2025 and 12.0% in the second half of 2025. New City markets: SSTG was 2.2%, its first positive reading, compared with -19.1% in the same period of 2025 and -7.9% in the second half of 2025, negativity in SSTG gradually narrowing. Same-store Sales Growth (SSSG) was -4.8%, primarily reflecting lower realized ATP, compared with -1.0% in the same period of 2025 and -1.9% in the second half of 2025. Initial City markets: SSSG was -3.5%, compared with 1.1% in the same period of 2025 and 0.5% in the second half of 2025. New City markets: SSSG was -9.4%, showing consistent half-on-half narrowing compared with -19.6% in the same period of 2025 and -13.2% in the second half of 2025. Delivery sales grew 44.7% to RMB1,618.8 million, compared to RMB1,118.5 million in the same period of 2025. Total loyalty program membership reached 41.9 million, an increase of 39.2% from 30.1 million a year earlier. Loyalty members' revenue contribution was 60.1% in the six months ended June 30, 2026. Store-level EBITDA was RMB544.5 million, representing an increase of 8.3% from RMB502.8 million in the same period of 2025. Store-level EBITDA margin was 17.4%, compared to 19.4% in the same period of 2025. Store-level operating profit was RMB390.4 million, representing an increase of 2.9% from RMB379.2 million in the same period of 2025. Store-level operating profit margin was 12.5%, compared to 14.6% in the same period of 2025. Adjusted EBITDA was RMB350.7 million, representing an increase of 8.6% from RMB322.9 million in the same period of 2025. Adjusted EBITDA margin was 11.2%, compared to 12.4% in the same period of 2025. Adjusted Net Profit was RMB98.2 million, representing an increase of 7.4% from RMB91.4 million in the same period of 2025. Adjusted Net Profit margin was 3.1%, compared to 3.5% in the same period of 2025. Net Profit was RMB81.0 million, an increase of 22.9% from RMB65.9 million in the same period of 2025. Basic and Diluted EPS were RMB0.62 and RMB0.61, up 24.0% and 24.5% YoY respectively. As of June 30, 2026, the Group held RMB934.7 million in cash and bank balances , as compared to RMB1,001.5 million as of December 31, 2025. [1] Please refer to the "Key Definitions" and "Non-IFRS Measures" sections below for detailed definitions of certain terms used. [2] Refers to 15 new cities entered in 1H2026 and 12 cities with first stores opened in late 2025. Ms. Aileen Wang, CEO & Executive Director of DPC Dash , commented, "We delivered another period of strong growth in the first half of 2026, with revenue of RMB3.13 billion, up 20.8% year-over-year, and transaction volumes up 33.7%. Our national expansion accelerated, with 235 net new stores added and entry into 15 new cities, bringing our total network to 1,550 stores across 75 cities. Importantly, our same-store transaction counts grew 7.1%, reflecting healthy underlying customer demand and the continued resonance of the Domino's brand in China. Notably, same-store transaction growth in our New City markets turned positive for the first time. These stores had launched with exceptionally strong initial sales, and the ensuing normalization from that elevated base has been a meaningful contributor to our overall same-store sales softness. We benefited from the industry-wide 3PP subsidy dynamics since mid-2025 and saw our delivery penetration in our Initial City markets further lifted up and the delivery penetration in our New City markets accelerated when we choose to launch delivery services in these markets earlier than planned. However, the temporary downside is a lower ATP, which also weighed on same-store sales growth. Looking ahead, while we will continue our disciplined store expansion, we will also focus on initiatives to elevate the ATP and continue to grow the transaction volumes. We are confident in the long-term structural opportunity ahead as we build the leading pizza platform in China." Ms. Helen Wu, CFO of DPC Dash , added, "Our first-half results reflect the operating leverage of our scaled model even in a competitive pricing environment. Revenue grew 20.8% to RMB3.13 billion, Store-level EBITDA increased 8.3% to RMB544.5 million, and Adjusted EBITDA rose 8.6% to RMB350.7 million. Adjusted Net Profit was up 7.4% to RMB98.2 million and net profit attributable to owners grew 22.9% to RMB81.0 million. Store operating margin was squeezed, reflecting the impact on ATP decrease on the back of deep subsidies during 3PP campaign. With observed gradual rationalization on subsidies, we are also focused on our own efforts and initiatives to improve the ATP. Corporate-level cost efficiency continued to unfold, with total corporate-level cost charges declining from 8.1% to 7.5% of revenue. We ended the period with RMB934.7 million in cash and bank balances and a gearing ratio of 7.9%, positioning us well to continue investing in our store network, supply chain infrastructure, and digital capabilities while delivering sustainable long-term shareholder value." FIRST HALF OF 2026 Financial Results Six months ended June 30, 2026 (RMB '000) (Unaudited) 2025 (RMB '000) (Unaudited) change (%)/ percentage points change Revenue 3,133,808 2,593,390 20.8 % Store-level operating profit [1] 390,350 379,188 2.9 % Store-level operating profit margin [1] 12.5 % 14.6 % -2.1 Profit before income tax 116,176 110,097 5.5 % Profit for the period attributable to owners of the Company 81,045 65,924 22.9 % Basic Profit per share (RMB) 0.62 0.50 24.0 % Diluted Profit per share (RMB) 0.61 0.49 24.5 % Non-IFRS Measures Store-level EBITDA [1] 544,452 502,818 8.3 % Store-level EBITDA margin (%) [1] 17.4 % 19.4 % -2.0 Adjusted EBITDA [1] 350,675 322,877 8.6 % Adjusted EBITDA margin (%) [1] 11.2 % 12.4 % -1.2 Adjusted Net Profit [1] 98,153 91,420 7.4 % Adjusted Net Profit margin (%) [1] 3.1 % 3.5 % -0.4 [1] Please refer to the "Key Definitions" and "Non-IFRS Measures" sections below for detailed definitions of certain terms used. Recent Developments Based on store count, mainland China has become the second-largest international market within Domino's global system. Among Domino's network of more than 22,500 stores worldwide, Domino's Pizza China now holds all of the top 70 positions in the first 30-day sales ranking. DPC Dash further strengthened its marketing leadership with the appointment of Ms. Joanne Xie as Chief Marketing Officer in May 2026. Ms. Xie oversees brand building, digital and data-driven omni-channel marketing, and category innovation, and brings over 20 years of marketing management experience, having previously served as Vice President of Marketing at McDonald's China and held marketing roles at Coca-Cola and Mondelēz. On product innovation, DPC Dash continues to innovate product and collaborate with popular IP to engage with customers, including the Crispy Croissant Crust, American Inspired Pulled BBQ Pork Pizza, and football-themed Mexican Inspired Salsa Roast Chicken and Beef Rectangular Pizza, alongside the new "Energy Bowl" series and new beverages, offering customers a broader range of dining choices. The Company also partnered with Arknights (明日方舟) to drive sales and engage with more young customers. On 21 August, 2026, DPC Dash also commenced operations at its Wuhan Supply Chain Centre ("Wuhan SCC"), the Company's fourth SCC, with an annual production capacity to support over 200 stores. The facility will service stores in Wuhan and surrounding areas — previously supported jointly by the Shanghai, Beijing and Dongguan SCCs to optimize logistics costs for dough delivery. The Company has also secured sites for two additional SCCs in Chengdu and Nanjing, targeted to commence operations in the second half of 2027. Outlook The Group plans to open approximately 350 net new stores in 2026 (net of store closures). During the first half of 2026, the Group achieved a net opening of 235 new stores. As of 14 August 2026, the Group has opened an additional 27 stores, with 38 stores under construction and 36 stores signed or approved, keeping the Group well on track to deliver the 2026 full year opening target. Looking ahead, the Company will continue to expand its store network, targeting sales improvement at existing outlets as 3PP subsidies gradually abate. As of June 30, 2026, across the 75 cities where the Company has a presence, Domino's store density reached approximately 2.5 stores per million population, versus an estimated 13.9 pizza stores per million population in China overall, demonstrating considerable growth potential. Conference Call Information The Company will hold a conference call on Wednesday, August 26, 2026, at 7:00 pm Hong Kong Time (or Wednesday, August 26, 2026, at 7:00 am Eastern Time) to discuss the financial results. A live audio-only webcast of the call can be accessed directly at https://event.choruscall.com/mediaframe/webcast.html?webcastid=MpPkCWtq To participate by phone, participants are strongly encouraged to pre-register for the conference call, by using the link provided below. Upon registering, each participant will receive a set of participant dial-in numbers, the event passcode, and a unique access PIN, which can be used to join the conference call. Pre-registration Link: https://dpregister.com/sreg/10211056/1049e3b17b0 An audio-only replay of the call will also be accessible through September 2, 2026, by dialing the following numbers: USA/Canada Toll-Free: 1-855-669-9658 International Toll: 1-412-317-0088 Replay Access Code: 8351751 Key Definitions Store-level operating profit represents revenue less operational costs incurred at the store level, comprising salary-based expense, raw materials and consumables cost, depreciation of right-of-use assets, depreciation of plant and equipment, amortization of intangible assets, variable lease rental payment and short-term rental expenses, utilities expenses, advertising and promotion expenses, store operating and maintenance expenses and other expenses. Store-level operating profit margin is calculated by dividing store-level operating profit by revenue for the same period. Store-level EBITDA is defined as store-level operating profit for the period and adding back depreciation of plant and equipment and amortization of intangible assets in store-level. Store-level EBITDA margin is calculated by dividing Store-level EBITDA by revenue for the same period. Adjusted EBITDA is defined as Adjusted Net Profit for the period and adding back depreciation and amortization (excluding depreciation of right-of-use assets), income tax expense and interest income and expenses, net. Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by revenue for the same period. Adjusted Net Profit is defined as profit for the period and adding back share-based compensation. Adjusted Net Profit margin is calculated by dividing Adjusted Net Profit by revenue for the same period. Non-IFRS Measures To supplement the Group's consolidated financial statements that are presented in accordance with the International Financial Reporting Standards ("IFRS"), the Group also use Adjusted Net Profit (non-IFRS measure), Adjusted Net Profit margin (non-IFRS measure), Adjusted EBITDA (non-IFRS measure), Adjusted EBITDA margin (non-IFRS measure), Store-level EBITDA (non-IFRS measure) and Store-level EBITDA margin (non-IFRS measure) as additional financial measures, which are not required by, or presented in accordance with, IFRS. The Group believes that these non-IFRS measures facilitate comparisons of operating performance from period to period and company to company. The Group believes that these measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as they help our management. However, our presentation of Adjusted Net Profit (non-IFRS measure), Adjusted Net Profit margin (non-IFRS measure), Adjusted EBITDA (non-IFRS measure), Adjusted EBITDA margin (non-IFRS measure), Store-level EBITDA (non-IFRS measure) and Store-level EBITDA margin (non-IFRS measure) may not be comparable to similarly titled measures presented by other companies. The use of such non-IFRS measures has limitations as an analytical tool, and you should not consider them in isolation from, or as substitute for analysis of, our results of operations or financial condition as reported under IFRS. Forward-Looking Statements Certain statements in this document and/or the results announcement of the Company for the six months ended June 30, 2026 are forward-looking statements that are, by their nature, subject to significant risks and uncertainties. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions, future events, or performance (often, but not always, through the use of words or phrases such as "will", "expect", "anticipate", "estimate", "believe", "going forward", "ought to", "may", "seek", "should", "intend", "plan", "projection", "could", "vision", "goals", "aim", "aspire", "objective", "target", "schedules", and "outlook") are not historical facts, are forward-looking and may involve estimates and assumptions and are subject to risks (including but not limited to the risk factors detailed in this document and/or the results announcement of the Company for the six months ended June 30, 2026), uncertainties and other factors some of which are beyond the Company's control. Accordingly, these factors could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. The Company's forward-looking statements have been based on assumptions and factors concerning future events that may prove to be inaccurate. Those assumptions and factors are based on information currently available to the Company about the businesses that it operates. The risks, uncertainties and other factors, many of which are beyond the Company's control, that could influence actual results include, but are not limited to: the Company's operations and business prospects; its business and operating strategies and ability to implement such strategies; its ability to develop and manage its operations and business; its ability to control costs and expenses; its ability to identify and satisfy customer demands and preferences; the actions and developments of its competitors; general economic, political and business conditions in the markets in which it operates; and changes to regulatory and operating conditions in the industry and geographical markets in which it operates. Any forward-looking statement speaks only as of the date on which such statement is made, and, except as required by the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited or under applicable law, the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events. Since actual results or outcomes could differ materially from those expressed in any forward-looking statements, the Company's shareholders and potential investors are advised not to place undue reliance on the forward-looking statements and to exercise caution in dealing in securities in the Company. About DPC Dash – Domino's Pizza China DPC Dash is Domino's Pizza's exclusive master franchisee in the Chinese Mainland, the Hong Kong Special Administrative Region of China and the Macau Special Administrative Region of China. Domino's Pizza, Inc., DPC Dash's global franchisor, is one of the most widely-recognized global consumer brands and the world's largest pizza company. Led by a seasoned and visionary management team, DPC Dash is a market leader that differentiates from competitors with, among others, a continually innovated and localized pizza-focused menu, unique expertise and leadership in delivery, technology focus and scalable and replicable store economic model. As of June 30, 2026, DPC Dash operated 1,550 stores in 75 cities in the Chinese Mainland. For more information, please visit: www.dpcdash.com For official company announcements, please visit: www.hkexnews.hk Contacts Investor Relations: DPC Dash Ltd IR@dominos.com.cn Christensen Advisory dpcdash@christensencomms.com Media Relations: Christensen Advisory dpcdash@christensencomms.com CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME Six months ended June 30, 2026 2025 RMB'000 RMB'000 (Unaudited) (Unaudited) Revenue 3,133,808 2,593,390 Raw materials and consumables cost (865,444) (706,819) Staff compensation expenses (1,076,921) (877,384) Depreciation of right-of-use assets (230,984) (188,301) Depreciation of plant and equipment (153,721) (123,886) Amortization of intangible assets (31,695) (28,720) Utilities expenses (108,216) (87,438) Advertising and promotion expenses (156,677) (137,401) Store operation and maintenance expenses (189,378) (159,368) Variable lease rental payment, short-term rental and other related expenses (101,520) (70,870) Other expenses (84,848) (74,561) Other income 10,046 7,327 Other gains/(losses), net 2,939 (1,298) Finance costs, net (31,213) (34,574) Profit before income tax 116,176 110,097 Income tax expense (35,131) (44,173) Profit for the period attributable to equity holders of the Company 81,045 65,924 Other comprehensive loss Item that may be subsequently reclassified to profit or loss Currency translation differences 15,436 1,172 Item that may not be subsequently reclassified to profit or loss Currency translation differences (29,750) (3,112) Other comprehensive loss for the period, net of tax (14,314) (1,940) Total comprehensive income for the period attributable to equity holders of the Company 66,731 63,984 Earnings per share for profit attributable to equity holders of the Company - Basic earnings per share (RMB) 0.62 0.50 - Diluted earnings per share (RMB) 0.61 0.49 CONSOLIDATED BALANCE SHEET As at June 30, As at December 31, 2026 2025 RMB'000 RMB'000 (Unaudited) ASSETS Non-current assets Plant and equipment 1,154,963 1,038,359 Right-of-use assets 1,991,076 1,747,209 Intangible assets 1,201,744 1,208,671 Deposits 117,979 104,798 Deferred income tax assets 168,458 161,863 4,634,220 4,260,900 Current assets Inventories 129,038 132,065 Trade receivables 17,530 17,349 Prepayment, deposits and other receivables 259,810 234,766 Cash and bank balances 934,706 1,001,511 1,341,084 1,385,691 Total assets 5,975,304 5,646,591 EQUITY Equity attributable to equity holders of the Company Share capital 890,057 888,950 Share premium 2,335,061 2,324,731 Other reserves 141,024 148,368 Accumulated losses (844,077) (925,122) Shares held for restricted share units ("RSUs") (275) (525) Total equity 2,521,790 2,436,402 LIABILITIES Non-current liabilities Borrowings 199,200 199,400 Lease liabilities 1,592,489 1,413,606 Other payables 74,182 60,178 1,865,871 1,673,184 Current liabilities Borrowings 400 400 Lease liabilities 438,612 393,684 Trade payables 319,655 279,126 Contract liabilities 52,109 56,008 Accruals and other payables 757,544 778,543 Current income tax liabilities 19,323 29,244 1,587,643 1,537,005 Total liabilities 3,453,514 3,210,189 Total equity and liabilities 5,975,304 5,646,591 CONSOLIDATED CASH FLOW STATEMENT Six months ended June 30, 2026 2025 RMB'000 RMB'000 (Unaudited) (Unaudited) Cash flows from operating activities Cash generated from operations 556,553 440,379 Income tax paid (51,648) (79,233) Net cash generated from operating activities 504,905 361,146 Cash flows from investing activities Proceeds from withdrawals of financial assets 205,258 - Purchases of financial assets (205,258) - Purchases of plant and equipment (249,970) (174,059) Purchases of intangible assets (35,084) (25,114) Interest received 7,242 9,370 Proceeds from disposal of plant and equipment 12 19 Net cash used in investing activities (277,800) (189,784) Cash flows from financing activities Rental deposit payment (11,647) (13,932) Proceeds from borrowings - 200,000 Repayment to borrowings (200) (200,000) Payment of principal element of lease liabilities (233,309) (168,959) Payment of interest element of lease liabilities (35,344) (38,659) Interests paid (2,575) (4,007) Proceeds from exercise of share options 1,549 3,366 Net cash used in financing activities (281,526) (222,191) Net decrease in cash and cash equivalents (54,421) (50,829) Cash and cash equivalents at beginning of the period 1,001,311 1,069,102 Exchange difference on cash and cash equivalents (12,384) (1,637) Cash and cash equivalents at end of the period 934,506 1,016,636
2026-08-26 10:46:00

State Grid Changzhou Power Supply Company Strengthens Safe Power Supply Defenses Amid High Temperatures
CHANGZHOU, China , Aug. 25, 2026 /PRNewswire/ -- In recent days, Changzhou, Jiangsu, has experienced persistent high temperatures and scarce rainfall, with the power grid load remaining at high levels. State Grid Changzhou Power Supply Company has responded swiftly with coordinated deployments, conducting comprehensive and targeted inspection campaigns across various electricity consumption scenarios—including smart agriculture, residential distribution areas, and high-voltage transmission corridors—to thoroughly eliminate safety hazards and ensure diverse power supply demands. At the Jintan Muxi Farm Smart Agriculture Industrial Park, the company focused on inspecting greenhouse distribution lines, control cabinets, and leakage protection devices, utilizing infrared thermography to identify and address aging and overheating hazards, while also guiding farmers to shift electricity usage to off-peak periods to reduce production energy consumption. In residential concentration areas, inspections targeted transformer terminal connectors, leakage protectors, and internal meter-box wiring, with immediate rectification of loose, aging, or malfunctioning components and the establishment of a closed-loop ledger for tracking and control, fundamentally reducing tripping and outages at the source. Around the 500 kV substation, the company urged users to reinforce or remove lightweight floating objects such as plastic greenhouses and dust-control nets, and assisted with post-typhoon self-inspections to prevent foreign objects from tangling with overhead lines. From smart greenhouses to residential distribution areas and high-voltage transmission corridors, this series of inspections covers diverse domains, yet the core strategy remains highly consistent: leveraging precise "manual + instrument" inspections, maintaining a dynamic closed-loop ledger of potential hazards, strengthening safety notifications and risk warnings, and forming a full-chain "detection—rectification—prevention" management approach. These solid measures not only enhance equipment health but also raise user safety awareness and emergency response capabilities, providing robust support for agricultural production, residential life, and main grid security during high-temperature periods. Going forward, State Grid Changzhou Power Supply Company will continue to intensify inspection frequency during peak heat periods, optimize grid operation modes, and leverage more refined management and more reliable electricity to safeguard the stable economic and social development of the region, ensuring safe power consumption for both production and daily life.
2026-08-25 09:45:00

StarHub's Biggest-Ever 5G Wellness Festival Invites Singapore to Press Pause
Hosting its second edition at New Bahru, the expanded festival offers new ways to find connection, play, and growth beyond the screen SINGAPORE , Aug. 25, 2026 /PRNewswire/ -- StarHub is turning New Bahru into a playground for digital wellbeing this September, as its 5G Wellness Festival returns for its biggest edition yet from 12 to 13 September. Part of StarHub's The Power of Pause digital wellbeing movement, the expanded festival brings together two days of workshops, movement, play, music and shared experiences led by homegrown brands. Whether it is finding inspiration, unwinding, moving, playing or simply spending time together, the festival offers different ways to meet the needs we often turn to our screens for, this time beyond the screen. The festival builds on StarHub's latest Digital Wellbeing study, which found that more than two-thirds of people in Singapore struggle to disconnect.1 It also reflects StarHub's belief that better connectivity should enable better experiences, helping people make the most of the connections that matter both online and offline. Through The Power of Pause, StarHub is encouraging people to build a more intentional relationship with technology and create space for meaningful moments away from the screen. Five Ways to Press Pause Inspired by StarHub's five 5G Wellness Pillars, visitors can explore different ways to pause through self-care and play to mental enrichment, physical presence, and social connection. Glow: Express yourself with Soilboy 's Petite Garden Arrangement workshop and bring home a keepsake that reminds you to pause, long after the festival ends. Glide: Enjoy a friendly game of table tennis at TopTable , turning a simple match into a moment of connection fuelled by some light-hearted competition. Grow: Spark your creativity through a hands-on watercolour art workshop with Chalk N Pencils . Ground: Reconnect with your body and surroundings through outdoor yoga sessions by The Hush Retreats . Slow down, release tension, and be present. Gather: Spend quality time with family and friends at the Lawn , with community live music, curated booths by homegrown brands and interactive activities. The StarHub 5G Wellness Festival 2026 is open to the public from 12-13 September, 10am to 6pm, at New Bahru. Admission is free, with advance registration required for workshop participation. To learn more and register for workshops, visit www.starhub.com/digitalbmi/index.html#/festival . Note to editors: 1 Based on a national survey of 1,036 respondents in Singapore conducted by StarHub and YouGov in April 2026 About StarHub StarHub is a leading homegrown Singapore company that connects people, businesses and communities to the possibilities of the digital world. We deliver world-class communications, entertainment, and digital services through our fibre and wireless infrastructure, global partnerships and digital capabilities. For enterprises and government customers, we help accelerate digital transformation through connectivity, cloud, cybersecurity, AI, data and managed services. StarHub is committed to conducting its business sustainably, responsibly and with purpose. The company is recognised as a Champion of Good, the highest tier under Singapore's Company of Good Recognition System, reflecting its commitment to creating positive social impact. It is also named among TIME's World's Most Sustainable Companies 2025, ranked as the world's most sustainable wireless telecommunication provider on the Corporate Knights Global 100 (2025), and ranks 181 on the FORTUNE Southeast Asia 500 in 2026. Listed on the Singapore Exchange mainboard, StarHub is a component of the SGX iEdge Singapore Low Carbon Index, iEdge-OCBC Singapore Low Carbon Select 50 Capped Index and the FTSE4Good Index series. Visit www.starhub.com for more information.
2026-08-25 09:39:00

Smartee Denti-Technology Launches AG KIDS in Malaysia
KUALA LUMPUR, Malaysia , Aug. 25, 2026 /PRNewswire/ -- Smartee Denti-Technology launched Smartee AG KIDS, a craniofacial growth guidance system designed for growing patients, in Malaysia. The launch was accompanied by a one-day clinical course attended by 130 dental professionals, focusing on the fundamentals of craniofacial growth, along with the clinical screening protocols and the practical application of the AG KIDS system. The one-day course, titled "Airway & Growth," was led by Dr Yue Weng Cheu, Clinical Director of DP Dental in Singapore, who led the key clinical collaborators involved in the development of AG KIDS. The program opened with clinical cases illustrating dentofacial and airway-related growth changes in children. Subsequent sessions explored the science of craniofacial growth and the airway, including the dentist's role in early identification, followed by a three-domain screening approach covering screening for sleep-related breathing and bidirectional referral to sleep physicians or ENTs. The course also introduced the clinical application of AG KIDS, including case submission, treatment workflow, and clinical support. A Three-Dimensional Craniofacial Growth Guidance Framework AG KIDS is a craniofacial growth guidance system designed for growing patients aged 3 to 16 years. The system applies a three-dimensional framework to the management of arch form, vertical dimension and mandibular position, with alignment achieved within the broader growth-guidance process. Its integrated configuration includes the Smartee S8-SGHB PLUS for sagittal and vertical control, S11 Palatal Device for transverse expansion, and K4 JOY-JOY and K5 SMILEY-SMILEY for myofunctional support. Dentists using AG KIDS are also supported by a dedicated algorithm designed to assist with case planning on the SMARTEECHECK platform. Throughout the program, Dr. Yue emphasized the dentist's role in early identification and screening while maintaining a clear diagnostic boundary: formal diagnosis of sleep-related breathing disorders (SRBDs), including obstructive sleep apnoea, remains within the appropriate medical scope. Dr Yue Weng Cheu (center) with guests at the Smartee AG KIDS Launch in Malaysia Clinical Perspectives on Early Assessment and Interdisciplinary Collaboration Dr. Chen Ye Hong , Founding President of the Malaysian Dentofacial Sleep Society (MDSS) , who attended the course, highlighted the importance of looking beyond tooth alignment when evaluating children. "Early orthodontic care should move beyond simply straightening teeth to supporting healthy facial growth and function. Children should be assessed for breathing patterns, airway health, tongue function, and sleep quality as part of a broader clinical evaluation. Closer collaboration between orthodontists, sleep dentists, ENT specialists, and other healthcare professionals is essential," said Dr. Chen. His perspective reflected the course's focus on early identification, screening, and appropriate referral , as well as interdisciplinary collaboration between dental and medical professionals. Drawing on his involvement in the development of AG KIDS and his clinical experience with growing patients, Dr. Yue also emphasized the importance of keeping pace with developments in research and clinical practice while establishing appropriate interdisciplinary workflows. "We need to keep abreast of the research, clinical applications and treatment systems, while establishing clear workflows with our medical colleagues and allied health partners," said Dr. Yue. The Malaysia launch marks a further step in Smartee's development of its portfolio for growing patients and its ongoing clinical education initiatives. Through continued product development, professional education and collaboration with clinicians, Smartee aims to support clinicians in applying structured approaches to the management of craniofacial growth in growing patients.
2026-08-25 09:17:00

Longbridge Launches on ChatGPT and Claude
Available as a ChatGPT plugin and Claude connector, bringing personalised, institutional-grade investment intelligence into the AI services investors already use SINGAPORE , Aug. 24, 2026 /PRNewswire/ -- Longbridge Group, an AI-native financial technology company, today announced that Longbridge is now available as a plugin on ChatGPT and a connector on Claude. The launch brings personalised investing into the AI assistants that hundreds of millions of people use for work, learning and everyday decision-making. As AI assistants increasingly become a starting point for how people search, learn and make decisions, Longbridge believes investing should become part of those same conversations. Users can securely connect their Longbridge accounts and access personalised investment insights through natural conversation, based on their portfolios, watchlists and investment goals. There is no need to learn a separate AI application or manually upload portfolio screenshots. Once authorised, Longbridge can combine an investor's portfolio context with live, institutional-grade market data within ChatGPT or Claude. The launch reflects Longbridge's vision of making AI a natural part of every investor's daily life. Rather than asking investors to change their existing habits, Longbridge is bringing trusted investing experiences into the AI services they already use. "Hundreds of millions of people already use AI every day to find answers, solve problems and make decisions," said Nowa Zhu, Group CEO and Co-Founder of Longbridge. "Investing should be no different. By bringing Longbridge to ChatGPT and Claude, we are making investing a natural extension of the AI experiences people already know, rather than asking them to build new habits." Personalised Investing in the AI You Already Use Through Longbridge on ChatGPT and Claude, investors can: Securely connect their Longbridge accounts for a portfolio-aware investing experience. Review their portfolios and explore portfolio construction, asset allocation and investment ideas through natural conversation, without manually analysing individual holdings. Receive personalised insights based on their portfolios, watchlists and investment goals. Research investment and using institutional-grade market data covering the US, Hong Kong SAR , mainland China and Singapore markets. Understand company earnings, macroeconomic developments and market-moving factors in the context of their own investment strategies. Unlike general-purpose AI assistants, Longbridge AI combines institutional-grade market data, secure portfolio connectivity and personalised investment memory. This enables insights grounded in each investor's holdings and objectives. Instead of starting every conversation from scratch, Longbridge AI can understand what investors own, what they are watching and how market developments may affect their portfolios. Whether researching companies, screening investment opportunities, analysing earnings, reviewing portfolio performance or evaluating potential buy and sell opportunities, investors can access professional-grade market intelligence through natural conversation without leaving ChatGPT or Claude. Designed for everyone—from first-time investors to experienced investors managing global portfolios—Longbridge AI helps users spend less time searching for information and more time making informed investment decisions. Building the AI Infrastructure for the Future of Investing The launch represents more than an additional distribution channel. Just as app stores became a gateway to digital services during the smartphone era, AI assistants are emerging as a new way for people to discover and access specialised capabilities. For investors, this means AI assistants can move beyond discussing the market in general and begin providing insights informed by the investor's own circumstances. With secure authorisation, ChatGPT and Claude can use Longbridge to combine portfolio holdings, watchlists and investment goals with live, institutional-grade market data—without requiring users to download a new application or upload portfolio screenshots. For financial services, making these capabilities available through AI requires trusted connections to regulated financial infrastructure. This includes authorised access, secure connectivity and clear safeguards that keep investment decisions under the investor's control. For Longbridge, the launch is a natural extension of an architecture designed to make its investment capabilities securely available across different AI services and interfaces. Because these capabilities are not tied to a single interface, they can meet investors wherever they choose to use AI—through Longbridge's own services, ChatGPT and Claude today, and other emerging AI interfaces in the future. "This is more than opening another channel for Longbridge," Zhu added. "Our investment capabilities have been built so they can be securely accessed through the AI services investors choose to use. Whether through the Longbridge plugin on ChatGPT or the connector on Claude, authorised access and secure connectivity remain central to the experience, and investment decisions remain with the investor. As AI becomes an increasingly important interface for decision-making, we want Longbridge to provide the trusted financial infrastructure behind those experiences." By combining institutional-grade market data, secure portfolio connectivity, personalised investment intelligence and responsible execution capabilities, Longbridge is laying the foundation for the next generation of AI-powered investing—from AI assistants that help investors make better-informed decisions today to investment agents capable of supporting increasingly sophisticated investment workflows in the future. About Longbridge Group Longbridge Group is an AI-native financial technology company building trusted infrastructure that connects investors, financial institutions, AI and global financial markets. Its integrated ecosystem comprises Longbridge Securities, an AI-powered online brokerage; LongPort, an institutional-grade trading technology and infrastructure provider offering multi-market and multi-asset solutions; and Longbridge AI, a next-generation AI-native financial data and investing platform. Together, they are redefining how individuals and institutions access, understand and interact with financial markets. Founded in 2019, Longbridge operates licensed financial businesses across multiple jurisdictions. It holds 22 financial regulatory licences or qualifications across the US, Hong Kong SAR , Singapore and other markets, and has secured more than US$150 million in strategic investment from leading global financial institutions and investment firms. Longbridge's vision is to make investing a seamless part of how people use AI every day by building trusted infrastructure for the future of intelligent investing.
2026-08-24 08:00:00

OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
Taking place from 2–4 September, OGA 2026 will bring together more than 30,000 industry professionals, 2,000 participating brands and companies, and representatives from over 80 countries to unlock business opportunities, accelerate innovation and shape Southeast Asia's energy future. KUALA LUMPUR, Malaysia , Aug. 24, 2026 /PRNewswire/ -- Southeast Asia is strengthening its position as one of the world's fastest-growing energy markets, driven by rising demand, evolving supply dynamics and the need for secure, reliable and increasingly sustainable energy systems. The International Energy Agency (IEA) projects that the region will account for nearly one-fifth of global energy demand growth by 2035, reinforcing its strategic importance in the global energy landscape. OGA Show Floor As governments and businesses balance energy security, affordability and sustainability, greater collaboration across the energy ecosystem will be critical to unlocking investment, accelerating innovation and supporting long-term regional growth. As Southeast Asia's energy ambitions accelerate, Oil & Gas Asia (OGA) 2026, organised by Informa Markets Malaysia, returns to the Kuala Lumpur Convention Centre from 2 – 4 September 2026 , bringing together policymakers, energy companies, engineering firms, technology providers, investors and solution partners on one platform to connect, exchange market intelligence and turn opportunities into business. Held under the theme " Powering Progress, Shaping Tomorrow ," the 22nd edition of OGA puts meaningful connections at the heart of the experience. This year's enhanced networking campaign will make every interaction more rewarding, creating more ways for the energy community to engage, exchange insights and build valuable industry relationships. Beyond making connections, OGA delivers business impact. The previous edition facilitated more than USD42 million in business deals , demonstrating how conversations at OGA translate into tangible commercial outcomes that extend well beyond the exhibition floor. "Southeast Asia's energy sector is entering a pivotal period of growth and transformation. Meeting the region's future energy needs will require closer collaboration across the entire value chain – from policymakers and producers to technology providers, investors and innovators. OGA has long been where these connections are forged, bringing together the people, technologies and expertise that turn industry conversations into partnerships, investments and long-term business opportunities," said Mr Gerard Leeuwenburgh, Country General Manager of Informa Markets Malaysia . Once again, OGA proudly welcomes PETRONAS back as Corporate Partner for the fifth consecutive edition - a partnership driven by shared ambition and a commitment to moving the energy industry forward. "PETRONAS works alongside partners across the value chain to deliver energy safely, reliably and sustainably while advancing energy transition. Our integrated portfolio, from upstream to new energy, gives us the reach to support energy security and lower-carbon solutions in parallel, not as competing priorities. Visit the PETRONAS booth at Hall 1 to meet our team, explore licensing opportunities, and discuss how partnership and technology translate into value across the ecosystem." said PETRONAS representative. Reflecting the importance of collaboration and market access to Malaysia's OGSE sector, Malaysia Petroleum Resources Corporation (MPRC) highlighted OGA's role in supporting the industry's regional ambitions. "OGA brings together key energy industry players under one roof, creating meaningful opportunities for collaboration, innovation and business growth. As the National OGSE Development Partner, MPRC is proud to be part of the journey as Malaysia's OGSE companies take their place on the regional stage," said Mohd Yazid Ja'afar, President/CEO of MPRC . Despite volatile market conditions, the continued expansion of OGA reinforces the importance of B2B platforms in connecting businesses to new markets. Country pavilions from Australia, China, Germany, India, Italy, Singapore, South Korea and the United Kingdom will showcase technologies, engineering expertise and solutions spanning upstream, midstream and downstream operations, digitalisation and emerging energy technologies. Beyond the exhibition, OGA is where some of the industry's most important conversations take place. A comprehensive knowledge programme anchored by SPEAK OGA, EIC Connect OGA and MOGSEC will connect policy, leadership, technology and commercial opportunity. SPEAK OGA , the event's flagship free-to-attend knowledge-sharing platform, will bring industry experts and decision-makers together to explore the trends, technologies and priorities shaping the future of energy. Its C-Suite Series will put leadership stories centre stage, with senior industry figures sharing the defining moments, challenges and lessons that have shaped their journeys – and the leaders they are today. Organised in partnership with the Energy Industries Council (EIC) , EIC Connect OGA will bring a global business perspective through market intelligence, project insights and emerging opportunities, while creating connections between companies and key decision-makers across the international energy supply chain. Co-located with OGA and held in partnership with Malaysian Oil, Gas & Energy Services Council (MOGSC), MOGSEC will champion Malaysia's OGSE sector, bringing the industry together to overcome evolving challenges, unlock growth, strengthen capabilities and excel in an increasingly competitive energy landscape. Together, these platforms position OGA beyond an exhibition – it is a meeting point where business, policy, technology, knowledge and cross-border collaboration converge , connecting the right people, ideas and opportunities to move the energy industry forward. With OGA 2026 fast approaching, Kuala Lumpur is set to become the region's meeting point for the people, partnerships, technologies and investments driving Southeast Asia's energy growth. For companies looking to enter new markets, strengthen supply chains, discover new solutions or build their next partnership, OGA is where the business of energy moves forward. Visitor registration is now open. Industry professionals are encouraged to secure their participation and join the conversations shaping the region's energy future. For more information and to register, visit www.oilandgas-asia.com . Notes to Editors About Oil & Gas Asia (OGA) Oil & Gas Asia (OGA) is one of Southeast Asia's premier platforms for the oil, gas and energy sector. Organised by Informa Markets Malaysia, the exhibition and conference convene policymakers, national and international energy companies, engineering and technology providers, investors and solution partners to explore emerging opportunities, showcase innovation and drive business growth across the energy value chain. As the industry's leading meeting place for knowledge exchange, investment and technology advancement, OGA supports the development of a resilient, competitive and sustainable energy ecosystem by facilitating market access, strategic partnerships and industry insights that shape the future of energy in Southeast Asia. For more information, visit www.oilandgas-asia.com . About Informa Markets Informa Markets creates platforms for industries and specialist markets to trade, innovate, and grow. Our portfolio comprises more than 450 international B2B events and brands across markets, including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition. We provide customers and partners around the globe with opportunities to engage, experience, and do business through face-to-face exhibitions, specialist digital content, and actionable data solutions. As the world's leading exhibition organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them thrive 365 days a year. For more information, please visit www.informamarkets.com .
2026-08-24 07:42:00

ASTRI and Saint Francis University Sign MoU to Advance AI-Enabled Biomaterials and Digital Health Innovation
HONG KONG , Aug. 24, 2026 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU) have signed a Memorandum of Understanding (MoU) to establish a strategic partnership focused on advancing research and development in AI-enabled biomaterials and digital health technologies. The collaboration aims to accelerate innovation, facilitate technology transfer, and nurture the next generation of talent in applied sciences. The MoU was signed by Ir Dr Ted Suen, Chief Executive Officer of ASTRI, and Professor Stephen Cheung Yan-leung , President of Saint Francis University. Ir Dr Ted Suen said, "We are delighted to partner with Saint Francis University to advance innovation in AI-enabled biomaterials and digital health. This collaboration exemplifies both institutions' shared commitment to applied research that translates into tangible solutions addressing real-world societal challenges. By combining ASTRI's R&D capabilities with SFU's academic strengths, we can drive innovation across healthcare, smart city applications, education technology, elderly care, and more, whilst nurturing the diverse talent pipeline essential for Hong Kong's development as an international innovation and technology hub." Professor Stephen Cheung Yan-leung said, "This partnership between SFU and ASTRI will leverage their respective strengths in applied research, artificial intelligence, and health sciences. As Hong Kong's largest tertiary institution for registered nurse training, SFU offers not only nursing programmes but also programmes in physiotherapy, pharmaceutical studies, and community health. This collaboration will further drive the integration and application of AI in health sciences and related professional services. SFU is also committed to advancing AI education and research. Through this partnership, we aim to explore AI applications in digital health, elderly care, medical support, and special educational needs, uniting technology with professional expertise to meet the changing demands of society." Under the agreement, the two institutions will collaborate across three key pillars: joint research and development, technology transfer and commercialisation, and talent development. Joint R&D in AI-Enabled Biomaterials & Digital Health The partnership will focus on co-developing AI-driven biomaterial design platforms that integrate machine learning with material science to accelerate the discovery and optimisation of biocompatible materials for medical applications. Research initiatives will include nano-biomaterial-based diagnostic and therapeutic solutions, such as targeted drug delivery systems, bio-sensing platforms, and biodegradable implants, paired with AI algorithms for real-time patient monitoring and personalised treatment adjustment. The collaboration will also extend to AI-powered solutions for digital health, elderly care, special educational needs (SEN) support, smart city applications, and educational technology. Both parties will jointly submit research proposals to government funding schemes, industry sponsorship programmes, and regional innovation grants. Technology Transfer & Commercialisation ASTRI and SFU will jointly explore commercialisation pathways including technology licensing, industry partnerships, and spin-off opportunities, with particular focus on the Greater Bay Area healthcare market and the emerging Gulf Cooperation Council (GCC) health tech sector. ASTRI will provide professional technical support to facilitate SFU's research advancement and real-world commercialisation, leveraging complementary strengths to advance the commercial translation and practical deployment of research outcomes. Talent Development & Knowledge Exchange The partnership will establish student internship and attachment programmes, with ASTRI hosting SFU students for research internships in AI-related R&D teams. The institutions will co-organise AI-themed academic and industry events, including the expansion of ASTRI's "AI Empowerment" seminar series, to foster knowledge exchange between academia, industry, and the public sector. Visiting scholar arrangements will facilitate the exchange of researchers and faculty members for collaborative research and teaching activities. This partnership paves the way for collaboration in course development, internships, joint research, and specialised labs. Together, ASTRI and SFU aim to foster innovation, advance IT and digital health education, and cultivate diverse talent with expertise and industry insights to support Hong Kong's innovation ecosystem. Photos Download: bit.ly/4znxbCy Ir Dr Ted Suen, Chief Executive Officer of ASTRI (left) and Professor Stephen Cheung Yan-leung, President of Saint Francis University (right), sign a Memorandum of Understanding today (24 August) establishing a strategic partnership to advance research and development in AI-enabled biomaterials and digital health technologies. Representatives from ASTRI and SFU joined the MoU signing ceremony between the two parties. The collaboration aims to accelerate innovation, facilitate technology transfer, and nurture the next generation of talent in applied sciences. About ASTRI Founded in 2000 by the HKSAR Government, Hong Kong Applied Science and Technology Research Institute (ASTRI) is the city's largest government-funded R&D centre. Committed to transforming high-impact research into practical innovations, ASTRI drives market-driven, interdisciplinary advancements across sectors, including Smart City, FinTech, Digital Health and Life Sciences, New Industrialisation and Intelligent Manufacturing, Application-Specific Integrated Circuits (ASIC) and Advanced Electronics, New Energy and Energy Storage, and Green and ESG Technologies. Following its merger with the Nano and Advanced Materials Institute, ASTRI has further strengthened its capabilities, with over 1,500 patents and 2,200 successful cases of technology transfer. Recognised with numerous international awards, ASTRI continues to nurture top I&T talent and foster collaborations among the I&T ecosystem, contributing to Hong Kong's high-value economic development. For more information, please visit: https://www.astri.org About Saint Francis University Saint Francis University (SFU), formerly known as Caritas Institute of Higher Education, has a history of over four decades, with its origin tracing back to Caritas Francis Hsu College established in 1985. SFU was officially granted the university title in 2024 and became an applied science university in the same year. As a pioneering applied science university, SFU integrates theory and practice, offering over 40 programmes at various levels, including undergraduate and postgraduate programmes , covering academic areas including Health Sciences, Social Sciences, Humanities & Languages, Technology, and Business Management. SFU is committed to nurturing a new generation of talent equipped with solid professional knowledge and the spirit of lifelong learning. For details, please visit: https://www.sfu.edu.hk/
2026-08-24 07:40:00

2026 Taiwan Jewellery & Gem Fair to Take Place in November
International Buyers, Jewellery Brands and Suppliers Gather in Taipei to Tap into Asian Market Opportunities TAIPEI , Aug. 24, 2026 /PRNewswire/ -- Informa Markets Asia Ltd., Taiwan Branch, announced that the 9th Taiwan Jewellery & Gem Fair (TJG) will take place from November 20–23, 2026, at Taipei World Trade Center Hall 1. With three months to go, the organiser is bringing together jewellery industry resources from Taiwan and overseas. The fair is expected to attract 10,000 professional buyers, jewellery brands, manufacturers, suppliers, designers and industry professionals, offering a dedicated platform for international sourcing, business matchmaking and industry networking. 2025 Taiwan Jewellery & Gem Fair, where buyers and exhibitors engaged in active business discussions. Expanded Product Range: Fine Gem Minerals, Designer and Antique Jewellery The 2026 Taiwan Jewellery & Gem Fair will feature a diverse range of jewellery products, including coloured gemstones, diamonds, pearls, gold jewellery, jewellery design, manufacturing and metalworking. A key highlight this year is the new "Born by Nature: GemVerse" showcase, featuring fine gem minerals and exploring their journey from rough minerals and cutting to design, craftsmanship and finished jewellery. The fair will also feature designer jewellery highlighting contemporary creativity and craftsmanship, alongside antique jewellery reflecting historical heritage and period aesthetics. Together, these highlights offer buyers, jewellery enthusiasts and collectors a broader perspective on jewellery, from natural materials and design to craftsmanship and heritage. Connecting the Jewellery Value Chain Through B2B Sourcing and High-End Consumer Engagement As a leading jewellery trade platform in Taiwan, TJG connects the entire jewellery value chain, from raw materials and gemstones to manufacturing, design, brands and retail. Combining B2B sourcing and business networking with high-end consumer engagement, the fair creates opportunities for industry professionals and consumers to discover new products, build connections and explore business opportunities. For exhibitors, TJG provides a platform to showcase products, design and craftsmanship while connecting with professional buyers and potential business partners. For buyers, the fair offers access to a diverse range of suppliers and products, supporting sourcing and market discovery. Jewellery enthusiasts and collectors can also explore distinctive pieces and gain deeper insight into their design, craftsmanship and heritage. Three Months to Go: The Ideal Time to Explore Opportunities in the Asian Jewellery Market 2026 Taiwan Jewellery & Gem Fair will continue to build on its strong industry foundation by expanding international buyer engagement and business networking, while introducing collectible gem minerals to broaden the scope of the fair. With a more diverse range of products and content, the fair aims to connect exhibitors and buyers from Taiwan and overseas with new sourcing resources and business opportunities, while further raising the international profile of Taiwan's jewellery industry in Asia. The organiser warmly invites international and local jewellery brands, manufacturers, suppliers, designers and industry professionals to participate as exhibitors, while welcoming importers, wholesalers, retailers, brand buyers, designers, jewellery enthusiasts and collectors to visit the fair and discover Taiwan's jewellery manufacturing expertise, design capabilities, natural gem minerals and business opportunities across Asia. 2026 Taiwan Jewellery & Gem Fair will take place from November 20–23 at Taipei World Trade Center Hall 1. Editor's Note: Organiser Informa Markets connects buyers and sellers and supports the flow of business and trade in over a dozen specialist markets including Jewellery, Pharmaceuticals, Food, Fashion, and Infrastructure. As the world's leading market-making company, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.
2026-08-24 07:30:00

Share buybacks in Ericsson during the period August 17 - August 21, 2026
STOCKHOLM , Aug. 24, 2026 /PRNewswire/ -- During the period August 17 - August 21, 2026, Telefonaktiebolaget LM Ericsson (publ) (" Ericsson ") (LEI code 549300W9JLPW15XIFM52) repurchased own Class B shares (ISIN: SE0000108656) as follows: Date Aggregated daily volume (number of shares) Weighted average share price per day (SEK) Total daily transaction value (SEK) 17/08/2026 500,000 97.3323 48,666,150.00 18/08/2026 500,000 96.8278 48,413,900.00 19/08/2026 999,360 96.7036 96,641,709.70 20/08/2026 750,000 96.1458 72,109,350.00 21/08/2026 250,000 96.7925 24,198,125.00 Total 2,999,360 96.6970 290,029,234.70 The share repurchases are a part of the share buyback program of up to SEK 15,000,000,000 which Ericsson announced on April 16, 2026, and which runs between April 23, 2026, and March 31, 2027, at the latest. The Board of Directors intends to propose to the 2027 Annual General Meeting that the repurchased shares, other than those used to fulfil Ericsson's obligations under its share-related incentive programs, are cancelled. The share buyback program is executed in accordance with the Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing MAR (the Safe Harbour Regulation). All acquisitions have been carried out on Nasdaq Stockholm by Goldman Sachs Bank Europe SE on behalf of Ericsson. A full breakdown of the transactions is attached to this announcement. Following the repurchases above, Ericsson's holding of treasury stock amounts to 100,668,676 Class B shares. There are in total 3,371,351,735 shares in Ericsson, 261,755,983 shares of Class A and 3,109,595,752 shares of Class B. NOTES TO EDITORS: FOLLOW US: Subscribe to Ericsson press releases Subscribe to Ericsson blog posts https://x.com/ericsson https://www.facebook.com/ericsson https://www.linkedin.com/company/ericsson MORE INFORMATION AT: Ericsson Newsroom media.relations@ericsson.com (+46 10 719 69 92) investor.relations@ericsson.com (+46 10 719 00 00) Investors Daniel Morris, Vice President, Head of Investor Relations Phone: +44 7386 657217 E-mail: investor.relations@ericsson.com Lena Häggblom, Director, Investor Relations Phone: +46 72 593 27 78 E-mail: lena.haggblom@ericsson.com Media Ralf Bagner, Head of Media Relations Phone: +46761284789 E-mail: ralf.bagner@ericsson.com ABOUT ERICSSON: Ericsson's high-performing, programmable networks provide connectivity for billions of people every day. For 150 years, we've been pioneers in creating technology for communication. We offer mobile communication and connectivity solutions for service providers and enterprises. Together with our customers and partners, we make the digital world of tomorrow a reality. www.ericsson.com This information was brought to you by Cision http://news.cision.com https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-august-17---august-21--2026,c4386704 The following files are available for download: https://mb.cision.com/Main/15448/4386704/4229292.pdf Share buybacks in Ericsson during the period August 17-August 21 2026 https://mb.cision.com/Public/15448/4386704/a723320ac39583cb.xlsx Daily Ericsson Share Buyback Report
2026-08-24 07:23:00

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine Moving into Clinical Evaluation for HCC Strong Cash Position Supports Continued Strategic Execution Conference Call Scheduled: August 21 at 8:30 a.m. HKT DURHAM, N.C. and BEIJING , Aug. 21, 2026 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical need, today provided a corporate update and reported its financial results for the six-month period ended June 30, 2026. In the first half of 2026, Brii Bio generated additional clinical data supporting its differentiated hepatitis B virus (HBV) functional cure strategy while continuing to expand its internal discovery capabilities and advance its RNA-based technology platforms. In its HBV clinical program, the Company presented end-of-study data from its Phase 2 ENSURE study at the European Association for the Study of the Liver (EASL) Congress 2026. On July 3, the Company also announced topline end-of-treatment data from its Phase 2b ENRICH and ENHANCE studies. To date, findings across the ENSURE, ENRICH and ENHANCE studies have consistently supported the potential of BRII-179 to improve functional cure outcomes as part of a combination regimen. Detailed data from the ENRICH and ENHANCE studies are expected to be presented in the second half of 2026. Beyond its HBV portfolio, the Company continued to advance its internal discovery capabilities and invest in the development of RNA-based technology platforms. Subsequent to the reporting period, the first participant was dosed in a clinical study evaluating BRII-5395, an internally discovered mRNA therapeutic vaccine for advanced hepatocellular carcinoma (HCC). This milestone represents the first clinical evaluation of an RNA-based therapeutic originating from Brii Bio's internal discovery efforts. While BRII-5395 is an mRNA therapeutic vaccine, the Company's broader RNA platforms encompass multiple RNA modalities. During the first half of 2026, Brii Bio progressed multiple internally discovered candidates across various stages of discovery and preclinical development, including programs that extend the application of its technology platforms into additional therapeutic areas beyond infectious diseases. With effective cost control measures and optimized operating structure in place, Brii Bio remains well-capitalized, with a cash position of approximately US$260 million as of June 30, 2026, providing financial flexibility to support its late-stage HBV programs and early discovery initiatives. "Our progress in the first half of the year reflects meaningful advances across both our late-stage HBV portfolio and our expanding discovery capabilities," said Dr. Zhi Hong, Chairman and Chief Executive Officer of Brii Bio. "Data generated across our HBV studies continue to inform our functional cure strategy. At the same time, the initiation of clinical evaluation for BRII-5395 demonstrates our ability to translate internal discovery into pipeline assets. We look forward to sharing additional milestones later this year. Together, these efforts are building a more diversified pipeline and strengthening the foundation for sustainable innovation and long-term value creation." Corporate and Clinical Updates HBV Program Brii Bio continued to advance its HBV pipeline with a focus on achieving higher functional cure rates through novel combination regimens. The Company's differentiated HBV portfolio, including BRII-179, a recombinant protein-based HBV immunotherapeutic, and elebsiran, an HBV-targeting siRNA, has generated a growing body of clinical data supporting Brii Bio's functional cure strategy through the completed Phase 2b ENSURE study and ongoing ENRICH and ENHANCE Phase 2b studies. The Phase 2b ENSURE study was designed to assess the safety and efficacy of combination approaches aimed at improving functional cure outcomes. Cohorts 1-3 evaluated elebsiran in combination with PEG-IFNα compared to PEG-IFNα monotherapy. Cohort 4 evaluated the potential role of BRII-179 in enhancing immune responsiveness and improving hepatitis B surface antigen (HBsAg) loss rates. In the first half of 2026, end-of-study data from Cohorts 1-4 of the Phase 2 ENSURE study were presented at EASL 2026, demonstrating that: The HBsAg loss benefit observed in the elebsiran and PEG-IFNα combination cohorts resulted in a higher functional cure rate compared to the PEG-IFNα alone cohort. BRII-179-experienced participants achieved higher functional cure rates, particularly among anti-HBs responders, suggesting that BRII-179 may play an important role in achieving durable immunological control of HBV. To further define the role of BRII-179 in HBV treatment and identify an optimal combination regimen for potential registrational development, the Company is evaluating BRII-179 in two additional ongoing Phase 2b studies: ENRICH and ENHANCE studies. The ENRICH study evaluates BRII-179 as a priming therapy administered prior to elebsiran and PEG-IFNα treatment. The ENHANCE study evaluates a concurrent triple combination regimen of BRII-179, elebsiran, and PEG-IFNα to enhance the functional cure rates. In July, the Company announced topline end-of-treatment data from its Phase 2b ENRICH and ENHANCE studies. At EOT, the ENRICH study evaluating pre-treatment with BRII-179 followed by elebsiran and PEG-IFNα achieved HBsAg loss rates of 42.9% (42/98) and 40.0% (20/50) across two BRII-179 dosing schedules (five doses administered every 3 weeks and 7 doses administered every 2 weeks, respectively). These results were consistent with the 41.9% (13/31) HBsAg loss rate observed in ENSURE Cohort 4 among patients previously treated with BRII-179, supporting the potential immune-priming role of BRII-179. Subgroup analyses from the ENRICH study suggest potential differentiation in subjects with higher baseline HBsAg levels (1000-3000 IU/mL) comparing with other HBV functional cure regimens under development by other companies, consistent with prior findings from ENSURE Cohort 4, indicating that BRII-179 may induce beneficial immune responses regardless of baseline HBsAg levels in this difficult-to-treat population. At EOT, the ENHANCE (Part A-1) study evaluating a concurrent triple combination did not demonstrate improved HBsAg loss rates compared with ENSURE Cohorts 2 and 3, 29.7% (11/37), with an observed rate of 25.5% (25/98). Higher HBsAg loss rates, however, were observed compared with the PEG-IFNα control arm, 10.2% (5/49). The ENHANCE study also evaluated a sequential approach designed to potentially shorten PEG-IFNα therapy in its Part A-2 by administering BRII-179 plus elebsiran during the first 24 weeks followed by 24 weeks of elebsiran and PEG-IFNα. At EOT, this combination regimen achieved an HBsAg loss rate of 22.5% (18/80), suggesting that a full course of PEG-IFNα therapy may be important for achieving optimal functional cure outcomes. No new safety concerns have been identified across ENSURE, ENRICH and ENHANCE to date. On August 19, 2026, the Company received an email notification from one of its central laboratory service providers of a product recall involving a commercial assay kit [1] used for HBsAg testing in the ENHANCE study. Based on the information currently available and the Company's preliminary assessment, the potential impact on the clinical data of the Company's sponsored trials publicly disclosed to date appears limited to the EOT HBsAg data for Part A-2 of the ENHANCE study. The Company is working with the service provider to identify potentially affected samples and arrange retesting using unaffected assay kits. Subject to completion of the retesting and further analysis, as at the date of this announcement, the Company has not identified any indication at this stage that the matter would materially affect its overall interpretation of the study results or the program development decisions announced to date. The Company will continue to evaluate the matter and provide updates as appropriate if any material developments arise. The Company plans to present detailed data from the ENRICH and ENHANCE studies, including additional efficacy, safety and subgroup analyses, at a scientific conference in the second half of 2026. Discovery Program Update Brii Bio is expanding its RNA platforms beyond infectious diseases into new therapeutic areas. In the first half of 2026, the Company progressed multiple early-stage candidates spanning various stages of discovery and pre-clinical development, with a focus on generating differentiated therapeutic opportunities in diseases with significant unmet medical needs. BRII-5395 is a novel mRNA therapeutic vaccine internally developed by Brii Bio. It is being evaluated as part of a combination immunotherapy approach for HBV-related HCC. On August 12, 2026, subsequent to the reporting period, the first participant was dosed in a clinical study evaluating BRII-5395 in participants with advanced HCC. The study, conducted at the Cancer Hospital of the Chinese Academy of Medical Sciences, is designed to evaluate the safety, tolerability, immunogenicity and preliminary anti-tumor activity of BRII-5395 in combination with an anti-PD-1 antibody and an anti-VEGF antibody. The current standard of care of immune checkpoint inhibitors have limited efficacy against HCC. As the first internally developed mRNA-based cancer therapeutic vaccine from Brii Bio to enter clinical evaluation, BRII-5395 represents an important milestone in the advancement of the Company's internal discovery capabilities and RNA-based technology platform. While BRII-5395 is an mRNA therapeutic vaccine, the Company's broader RNA platforms encompass multiple RNA modalities. In addition, the Company has extended the application of its technology platforms into additional therapeutic areas beyond infectious diseases. Further program updates are expected throughout the remainder of 2026. The Company is actively exploring partnership opportunities to advance selected discovery programs to maximize the value of its emerging pipeline. Additional Clinical Programs Brii Bio is actively seeking strategic partnerships for long-acting anti-HIV and multidrug resistant (MDR) antibacterial therapeutic candidates to maximize the development and commercialization potential. Other Corporate Updates On April 16, 2026, the Company and Brii Biosciences Offshore Limited, a subsidiary of the Company, submitted a Demand for Arbitration to the United States-based Judicial Arbitration and Mediation Services, Inc. against Vir Biotechnology, Inc. (the "Arbitration"). The Company announced the commencement of the Arbitration on April 16, 2026 and provided a further update on May 22, 2026. As of June 30, 2026, the Arbitration remained in its early stages, and the parties had not reached a resolution of the claims. In light of the ongoing arbitration, the Company is not currently advancing elebsiran into Phase 3 development and future development plans for elebsiran remain under evaluation pending resolution of the Arbitration. The Company will continue to monitor developments and update shareholders as appropriate. Outlook Looking ahead, the Company remains focused on advancing its differentiated HBV portfolio while continuing to progress its RNA-based discovery efforts. The Company plans to continue investing in its internal discovery capabilities and RNA platform to support the advancement of future pipeline candidates. Through these efforts, Brii Bio aims to generate new therapeutic opportunities and build a sustainable pipeline of innovative medicines addressing diseases with significant unmet medical needs. With a strong balance sheet and disciplined execution, Brii Bio is well positioned to pursue value-creating opportunities and deliver on its strategic priorities. Interim 2026 Financial Results The Company maintains a strong cash position to support its operations through 2029. Our bank deposits and cash and cash equivalents were RMB1,770.8 million as of June 30, 2026, representing a decrease of RMB170.2 million or 8.8% compared with RMB1,941.0 million as of December 31, 2025. The decrease was primarily due to payout of research and development activities and daily operations. Through pipeline prioritization, resource optimization, internalization of certain clinical development activities, and cost-saving measures of third-party vendors, we have effectively controlled our operational expenses. Research and development expenses were RMB98.3 million for the six months ended June 30, 2026, representing a decrease of RMB18.7 million or 16.0%, compared with RMB117.0 million for the six months ended June 30, 2025. The decrease was primarily attributable to organizational optimization, compensation framework adjustments, and lower third-party contracting costs as Phase 2 study activities for the HBV programs wound down, partially offset by increased investment in early-stage discovery. Administrative expenses were RMB52.6 million for the six months ended June 30, 2026, representing a decrease of RMB5.6 million or 9.6%, compared with RMB58.2 million for the six months ended June 30, 2025. The decrease primarily reflected lower employee costs following organizational optimization and adjustments to the senior management compensation framework, partially offset by the increase in professional fees and the depreciation and amortization cost. Other income was RMB19.5 million for the six months ended June 30, 2026, representing a decrease of RMB8.6 million or 30.6%, compared with RMB28.1 million for the six months ended June 30, 2025. This was mainly due to the decrease in bank interest income of RMB7.9 million attributable to the declining interest rates on time deposits. Conference Call Information The Company will host a live conference call in Chinese on August 21 at 8:30 a.m. HKT (8:30 p.m. ET on August 20). For the registration link, please click here . All participants shall use the link provided above to complete the online registration process prior to the conference call. A replay of the conference call will be available after the call and can be accessed by visiting the Company's website at www.briibio.com under the Investor Relations section. This press release contains references to third-party information. Such information is not deemed to be incorporated by reference in this press release. Brii Bio disclaims responsibility for such third-party information. About Brii Bio Brii Biosciences Limited ("Brii Bio", stock code: 2137.HK) is a biotechnology company developing therapies to improve patients' health by addressing high unmet medical needs with limited treatment options. The Company is advancing a broad pipeline of unique therapeutic candidates with lead programs against hepatitis B virus (HBV) infection. The Company is led by a visionary and experienced leadership team and has operations in both China and the United States. For more information, visit www.briibio.com . Forward-Looking Statement The information communicated in this press release contains certain statements that are or may be forward-looking. These statements typically contain words such as "will," "expects," "believes," "plans" and "anticipates," and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There may be additional material risks that are currently not considered to be material or of which the Company is unaware. These forward-looking statements are not a guarantee of future performance. Against the background of these uncertainties, readers should not rely on these forward-looking statements. The Company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. [1] The relevant kit is Roche Elecsys HBsAg II quant II. For details of the product recall, please see the public recall announcement: https://qxzh.yjj.sh.gov.cn/openApi/recallDetail?recall.recallId=525e2adbd3454202bdc748ad47efb17a
2026-08-20 23:10:00

Aiper unveils next-generation smart outdoor care solutions, expanding the Aiper Smart Yard Ecosystem
Unveiling its latest generation of smart pool care and irrigation innovations in Australia, Aiper is introducing the Scuba V3 , Scuba S3 , and IrriSense N2 SE to deliver a simpler, smarter approach to outdoor maintenance The new product range builds on Aiper's Smart Yard Ecosystem, helping homeowners spend less time maintaining their outdoor spaces and more time enjoying them The latest innovations were showcased at Aiper's 2026 Pool Party on the Gold Coast, celebrating the future of smart outdoor living alongside Australia's coastal lifestyle GOLD COAST, Australia , Aug. 21, 2026 /PRNewswire/ -- Aiper , the world's No.1 smart robotic pool cleaner brand and a global leader in smart yard innovation * , is announcing the arrival of its latest generation of smart outdoor care innovations in Australia, expanding its vision for a connected and effortless backyard experience. Aiper Smart Yard Ecosystem The launch introduces the next evolution of Aiper's Smart Yard Ecosystem , featuring the Scuba V3 , Scuba S3 , and IrriSense N2 SE – a new generation of smart solutions designed to simplify pool and lawn maintenance through intelligent technology, automation, and user-focused design. The new products were unveiled on August 20th at Aiper's 2026 Pool Party on the Gold Coast, where media, creators and industry experts experienced the future of outdoor living through interactive demonstrations of Aiper's latest innovations. Building on Aiper's commitment to redefining outdoor maintenance, the new range reflects the brand's focus on creating products that are neat, reliable, and carefree, reducing the time and effort traditionally required to maintain a backyard, while helping Australians make the most of their outdoor spaces. Designed to make everyday pool care smarter and more effortless, the Aiper Scuba V3 brings Cognitive AI to an essential robotic pool cleaner. Its front-facing camera powers AI Patrol Cleaning to detect and target debris in real time, while VisionPathTM Adaptive Path Planning helps it navigate the pool efficiently and reduce unnecessary repeat cleaning. Cognitive AI NaviumTM Mode goes a step further, using pool size, weather conditions and cleaning history to build autonomous cleaning plans for more hands-free maintenance. JetAssistTM Horizontal Waterline Cleaning extends care from the pool floor to the waterline, helping Australians spend less time maintaining their pools and more time enjoying their backyard. Also joining the range is the Scuba S3 , a next-generation robotic pool cleaner designed to provide reliable, hands-free pool care. Engineered for everyday convenience, the Scuba S3 is lightweight, features quick water release, and delivers intelligent cleaning performance while eliminating the hassle of traditional manual pool maintenance. Expanding Aiper's smart yard capabilities beyond the pool, the IrriSense N2 SE brings intelligent irrigation technology to lawn care, whilst saving up to 40% of water. Designed to provide a seamless watering experience, the smart irrigation system helps homeowners maintain healthier lawns with automated scheduling and efficient water management. Together with Aiper's robotic pool cleaners, the IrriSense N2 SE extends the brand's vision of carefree outdoor living from the pool to the garden. For those looking to take pool care even further, Aiper will soon introduce the flagship Scuba V3 Ultra to Australia. Combining dual-camera AI with VisionPathTM 2.0 navigation and Cognitive AI NaviumTM Mode, it can intelligently identify and tackle areas throughout the pool, from the floor and walls to the waterline and surface. Powerful dual-pump suction and MicroMeshTM ultra-fine filtration further enhance its cleaning performance, delivering a premium, hands-free solution for keeping pools pristine with minimal effort. "At Aiper, we believe outdoor maintenance should be effortless, giving people more time to enjoy the spaces they love," says Andres Gomez, Aiper's Vice President of Sales. "Our Smart Yard Ecosystem represents our commitment to creating smarter, more sustainable solutions that take the complexity out of pool and lawn care. With our latest innovations, we're continuing to deliver products that are neat, reliable and carefree, helping Australians transform their backyards into places to relax and enjoy." The Scuba V3 is now available through Aiper's online store and selected retail partners, with the Scuba S3 and IrriSense N2 SE launching in September. For more information, visit aiper.store/au/store .
2026-08-20 23:00:00

ALL IT Hypermarket Returns with Tech The Emissions Down 2026 - Now Powered by Atome and Blueshark in Malaysia's Most Impactful Tech Retail ESG Campaign
Second edition of the groundbreaking e-waste and green mobility campaign offers Malaysians the chance to win a Blueshark Solo 1C EV Bike and MacBook Neo - simply by recycling their unwanted electronics. KUALA LUMPUR, Malaysia , Aug. 21, 2026 /PRNewswire/ -- ALL IT Hypermarket Sdn Bhd proudly presents the second edition of Tech The Emissions Down (TTED), now running until 31 December 2026, co-powered by Atome and Blueshark Malaysia. There is still plenty of time to join the green movement. From left to right: Blueshark Malaysia Head of Marketing Strategy & Communications, Mr. Eric Lim; ALL IT Hypermarket Head of Marketing, Mr. Cagen Tan; Atome Head of BNPL Malaysia, Mr. Danny Lim Returning with Purpose: A Response to Overwhelming Support The inaugural TTED 2025 exceeded all expectations, drawing over 120,000 participants across Malaysia and generating significant awareness. As a technology retailer, ALL IT recognises a responsibility beyond selling the next device. Improperly disposed electronics release toxic materials into landfills - and TTED was built on the belief that tech retail can be a force for good. "Malaysians genuinely care about the environment - they just need a platform that makes it easy and rewarding to act. We are in the business of technology, and with that comes a responsibility to ensure it does not burden our planet. By partnering with Atome and Blueshark, we are building something that goes far beyond a campaign - a long-term commitment to a greener Malaysia." - Cagen Tan, Head of Marketing, ALL IT Hypermarket Sdn Bhd Atome Joins as Preferred BNPL Partner - Making Green Choices More Accessible TTED 2026 is co-branded as Atome x TTED by ALL IT, with Atome as Preferred BNPL Partner. Through Atome's 0% interest instalment plan, Malaysians can invest in green technology without financial barriers. "At Atome, we believe that financial flexibility and sustainability go together. When we make green choices more affordable and accessible, we empower more Malaysians to make smarter and more responsible choices. Our partnership with ALL IT through TTED 2026 is a meaningful step in that direction - connecting our platform's reach with a campaign that truly matters. We are proud to play our part in driving positive environmental impact, one purchase at a time," - Danny Lim, Head of BNPL, Atome Malaysia Blueshark Malaysia Champions Green Mobility as Official EV Bike Partner As Official EV Bike Partner, Blueshark Malaysia brings its Solo 1C EV Bike as the campaign's Grand Prize. Two lucky winners will be announced on 8 January 2027. "Meaningful change happens when sustainable choices become the easiest choices. That's why this partnership is such a natural fit for Blueshark. Together with ALL IT and Atome, we're proudly mobilising that shift by bringing technology, retail and smart mobility together to encourage more Malaysians to make everyday decisions that collectively have a lasting impact. Whether it's recycling an old device, choosing cleaner, smarter transport or simply becoming more conscious of our footprint, every small action matters. We hope TTED 2026 inspires more Malaysians to take that first step towards smarter, more sustainable living." - Eric Lim, Head of Marketing Strategy & Communications, Blueshark Malaysia E-Waste Drop-Off Available at All ALL IT Outlets Nationwide ALL IT Hypermarket provides convenient e-waste collection points at all its retail outlets across Malaysia, channeling all collected items to authorised recycling partners for responsible processing. Win a Blueshark Solo 1C EV Bike or MacBook Neo - Just by Going Green Participants can earn lucky draw entries by recycling e-waste at any ALL IT outlet (1 free entry, no purchase required), spending a minimum of RM200 in a single receipt (1 stamp entry), or paying with Atome (1 additional bonus entry). Sign up as an ALL IT Rewards Lite Member (FREE) via the ALL IT Rewards web-app to collect and track stamps digitally. Prizes: 2 x Blueshark Solo 1C EV Bike - Grand Prize, 2 winners announced on 8 January 2027. 3 x Apple MacBook Neo (512GB) - Bi-Monthly Prize, 1 winner each in August, October and December 2026. Terms and conditions apply. For more information on the Atome x Tech The Emissions Down 2026 campaign, e-waste drop-off locations and prize details, visit ALL IT Hypermarket's official website and social media channels: Website: www.allithypermarket.com.my Facebook & Instagram: @allithypermarket About ALL IT Hypermarket ALL IT Hypermarket Sdn Bhd is Malaysia's largest IT retail chain, with over 14 outlets across the Klang Valley. Established in 2002, ALL IT offers a wide range of consumer electronics, computing products and smart devices, complemented by its ALL IT Rewards loyalty programme and a growing digital presence through its official webstore. About Atome Atome is one of Asia's leading Buy Now, Pay Later platforms, offering consumers flexible and interest-free installment payment options across a wide network of retail and online partners across Asia. About Blueshark Malaysia Now part of PETRONAS Dagangan Berhad, Blueshark is an innovation-driven electric mobility company redefining everyday transportation through smart, connected two-wheel mobility solutions. Proudly assembled in Malaysia, Blueshark combines advanced vehicle technology, intelligent connectivity and practical ownership solutions to make electric mobility more accessible for consumers, businesses and fleet operators alike.
2026-08-20 23:00:00

IGEL Brings Now & Next Workspace & Endpoint Security Summit to Melbourne, Australia
The event brings together customers, partners, and industry leaders to advance endpoint security, resilience, and secure workspace delivery. MELBOURNE, Australia , Aug. 21, 2026 /PRNewswire/ -- IGEL ® , a global software company delivering the IGEL Adaptive Secure Endpoint Platform TM, today announced it is bringing the IGEL Now & Next® Workspace & Endpoint Security Summit to Melbourne, Australia, for a showcase on September 17, 2026, at Park Hyatt Melbourne . The one-day program will bring together IT and security leaders to examine the endpoint security, resilience, and workspace delivery priorities shaping enterprise strategy across the region. IGEL Brings Now & Next Workspace & Endpoint Security Summit to Melbourne, Australia The Melbourne event extends IGEL's flagship Now & Next ® series following its five-city European roadshow earlier this year. It arrives as organizations across healthcare, government, transportation, and critical infrastructure weigh the cost of replacing endpoint hardware against the need to keep operations running through disruption. "What we are hearing from customers is consistent: organizations want stronger control at the endpoint, greater resilience when disruption occurs, and a practical path to support both current and emerging workspace models," said Klaus Oestermann, CEO of IGEL . "The Now & Next® summit roadshow is designed to bring those conversations closer to home, together with the customers and ecosystem partners, helping define the next phase of endpoint strategy." The summit will bring together IGEL leaders, customers, and ecosystem partners to share perspectives on secure endpoint strategy, resilience, and the future of digital work. IGEL executives and technical leaders will anchor the program, with Klaus Oestermann , CEO, and Matthias Haas , Managing Director and CTO, leading sessions on IGEL strategy and the IGEL Adaptive Secure Desktop® in contact center and healthcare environments. Sterling Wilson , Field CTO for BC&DR, will address endpoint resilience and business continuity, while James Millington , Field CTO for Healthcare, EMEA, will explore clinical workspace delivery and IT/OT convergence. Complementing the IGEL-led sessions, customers and ecosystem partners will bring real-world perspectives and expertise to the program, including event sponsors Nutanix, NVIDIA, Omnissa, and UltrArmor. "As organizations rethink the endpoint as a more controlled, resilient, and centrally governed part of the security architecture, the discussion is shifting from device management alone to recovery, governance, and continuity," Oestermann added. "That is the conversation we want to lead in Melbourne." The summit runs from morning sessions through the afternoon customer panel and networking happy hour at Park Hyatt Melbourne, 1 Parliament Square. Attendance is open to enterprise IT and security leaders across Australia and New Zealand. To review the full agenda, explore speakers, and register, visit the event page . About IGEL IGEL ® is a global software company delivering the IGEL Adaptive Secure Endpoint PlatformTM, a trusted and governed endpoint platform for secure access to cloud, VDI, DaaS, SaaS, Secure Browsers, enterprise applications, as well as OT endpoints. At its foundation is IGEL OS, an immutable operating system that helps reduce endpoint attack surface, preserve a known-good endpoint state, and support secure access across distributed work environments. Through the IGEL Preventative Security Model®, the platform adds attested workload delivery, centralized governance, and contextual enforcement, aligning endpoint security with Zero Trust and SSE/SASE architectures from key IGEL Ready partners. IGEL Business Continuity & Disaster RecoveryTM (BC&DR) helps organizations restore secure access on Windows endpoints affected by ransomware, other cyberattacks, or outages. Founded in 2001, IGEL is headquartered in Germany with U.S. offices in San Francisco and Fort Lauderdale, working with an ecosystem of 130 leading technology brands. Learn more at www.igel.com . Windows is a trademark of the Microsoft group of companies.
2026-08-20 22:35:00

SuperX's Japan Global Supply Center has Delivered Pro6000 Servers Worth US$31 Million and Secured New Orders
SINGAPORE , Aug. 20, 2026 /PRNewswire/ -- SuperX AI Technology Limited ("SuperX" or the "Company"), a full-stack AI infrastructure solutions provider, announces the latest business milestone achieved by its Japan Global Supply Center, the Company's core local hub for expanding presence in Japan's computing infrastructure market. On July 9 and August 4, 2026, the Company entered into Phase 3 procurement contracts and Phase 4 Purchase Order, respectively, with Digital Dynamic Inc. ("DDI"), a Japan-based AI infrastructure company, via its partner, for the supply of Pro6000 servers. All equipment will be warehoused, allocated and delivered locally through the Japan Global Supply Center. SuperX and DDI have secured four rounds of Purchase Orders in 2026. The first three orders were secured in January, April and July respectively, followed by a fourth new Purchase Order in August. Four successive capacity expansions within a single year fully demonstrate DDI's recognition of SuperX's product quality, delivery reliability and localized service capabilities, serving as solid evidence of the Company's strengths in overseas computing hardware delivery. SuperX expects cumulative shipments to DDI to reach approximately US$38 million by the end of August 2026, of which approximately US$31 million has been shipped to date. Projects valued at around US$28 million are under phased production and sequential delivery, while new orders worth approximately US$20 million have been secured. The Company's regional delivery capacity has been validated by the market, and its localized delivery model has entered large-scale operation. Japan's computing industry is accelerating the deployment of distributed AI infrastructure, with ongoing rollouts of data center operations, GPU cluster deployment and computing hosting projects. Market demand for bulk supply of high-performance servers, reliable product availability and rapid local response continues to climb. DDI has built a nationwide computing network across Japan, covering AI data center development and operation, hardware cluster asset management and commercial computing capacity provision. The company maintains sustained demand for stable supply of high-performance GPU hardware. This Phase 3 procurement contract and the Phase 4 Purchase Order, reflect the deepening long-term strategic partnership centered on localized delivery. As SuperX's pivotal local hub in Japan's computing sector, the Japan Global Supply Center has established an integrated service ecosystem encompassing warehousing, bulk resource scheduling and local order fulfillment. Compared with conventional cross-border long-distance shipment models, the local hub significantly shortens equipment lead times, ensures on-time delivery of large-volume AI server orders, and caters precisely to local computing operators' project schedules featuring phased rollouts and capacity expansion. Since commencing operations, the Center has continuously secured hardware orders from domestic computing service providers with steadily growing supply volumes. The new contract and new orders demonstrate the expanding operational capacity of SuperX's Japan Global Supply Center and further consolidate the Company's service footprint in Japan's local AI hardware delivery segment. Meanwhile, SuperX is actively onboarding more local computing clients, deepening regional market penetration and strengthening its market position within Japan's AI infrastructure industry. Against the backdrop of rising demand for distributed AI computing infrastructure across Japan, SuperX will continue to optimize inventory scheduling, bulk delivery and supporting service frameworks at the Japan Global Supply Center and expand the scope of local order fulfillment. Leveraging its localized supply chain capabilities, SuperX will deliver consistent, efficient hardware support for regional AI infrastructure initiatives and steadily drive the expansion of its overseas computing infrastructure business. About SuperX AI Technology Limited (NASDAQ: SUPX) SuperX AI Technology Limited is an AI infrastructure solutions provider, offering a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, 800 Volts Direct Current (800VDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. Headquartered in Singapore, the Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments. For more information, please visit www.superx.sg Safe Harbor Statement This press release may contain forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The reader is cautioned not to rely on these forward-looking statements. The forward-looking events discussed in this press release, including delivery schedules, production capacity and order values, and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. Actual delivery schedules and the value of AI servers delivered may vary based on customer data center readiness and supply chain conditions. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. Follow our social media: X.com: https://x.com/SUPERX_AI_ LinkedIn: https://www.linkedin.com/company/superx-ai Facebook: https://www.facebook.com/people/Super-X-AI-Technology-Limited/61578918040072/#
2026-08-19 20:30:00

Fleets That Get Onboarding Right See 3X Driver Buy-In on Safety Tech
New research shows that well-prepared drivers are three times more likely to rate safety coaching as highly effective — making onboarding the critical first step for fleet operators SYDNEY , Aug. 19, 2026 /PRNewswire/ -- A new Teletrac Navman study finds that safety tech onboarding for drivers is widespread across fleets, but quality is far from consistent. The 'Mobilizing the Future of Fleets Report: Driver Coaching Edition ' found that drivers who felt well-prepared were three times more likely to rate their coaching solution as highly effective (74%) compared to those whose preparation was lacking (19%), yet 1 in 5 reported technology being installed with little or no communication from management. "Technology alone doesn't drive safety outcomes, preparation does," said Alain Samaha, CEO of Teletrac Navman. "Monitoring technology is most successful when it balances fleet goals and driver needs, and that starts with strong onboarding. Organizations that prioritize the people element see the real payoff: safer drivers, fewer claims, and a workforce that sticks around." Concern over privacy Unclear data-use policies make surveillance the top concern for almost half (45%) of drivers surveyed. Almost a third (30%) said that clear evidence demonstrating that technology is used to protect them, not just watch them, would actively encourage them to stay with their current employer. This mistrust persists after rollout when rules remain vague, leaving drivers supportive of safety improvements but fearful of unfair enforcement. "If an operator finds itself in a difficult position with its drivers, providing visibility of personal data is essential to rebuilding trust," continued Samaha. "Drivers are not anti-technology, but they will be skeptical without transparency around data processing and management, and how it will affect them." Driver confidence improves significantly when they have clear data visibility: 47% state that the ability to view their own data easily would build their trust, while 43% emphasize the importance of fair and consistent use of data across all drivers. Driver apps are a highly practical access route for this, with 60% of drivers highlighting apps as their preferred option. Always-on visibility reassures drivers about what is being captured, while clear rules of engagement explain why data points matter and how they will inform constructive conversations with managers. Rewarding good driving According to the report findings, recognition remains a primary retention motivator, with 37% citing it as a factor for staying with an employer. However, a significant gap exists. While 99% of drivers receive feedback, only 51% report getting positive recognition, while 32% experience disciplinary action. Proactive feedback, such as scorecards and performance breakdowns , improves driving quality and workplace pride for 52% of drivers, more than double the impact of financial bonuses (21%). Over half of drivers (56%) who receive real-time in-cab coaching rarely experience a near miss, compared with 47% of those without real-time alerts in place. That difference – almost 1 in 5 are less likely to experience a near-miss – highlights the benefit of not just reviewing video clips days after an event but helping drivers correct risky behaviors in the moment before they escalate, supporting a reduction in claims. Accidents take a personal toll Accidents and collisions can affect a driver's confidence as well as a business's bottom line. More than a third (38%) of drivers suffer increased stress or anxiety after a negative event, and 17% report a reduction in confidence. This is particularly important given that 25% of respondents were concerned a negative event could lead to the loss of their license, while 20% feared formal disciplinary action, and 17% were concerned about financial penalties. "Drivers returning to the cab with eroded confidence, or second-guessing decisions due to feeling more anxious, may face a higher risk of future incidents," added Samaha. "Choosing the right safety system with real-time capabilities, and building trust in it, is therefore imperative for driver wellbeing as well as operational performance." The report can be downloaded here . Media Contacts FleishmanHillard for Teletrac Navman – teletracnavman@fleishman.com.au About Teletrac Navman Teletrac Navman's goal is to empower the industries that transform and sustain our futures with simple and intelligent solutions that enhance the efficiency, safety, and sustainability of their operation. As a connected mobility platform for industries that manage vehicle and equipment assets, Teletrac Navman simplifies the complex so that its customers can transform the way they work through cloud-based solutions that leverage AI to unlock the power of operational insight. The company operates globally, with offices worldwide and headquarters in Northbrook IL. For more information visit www.teletracnavman.com .
2026-08-18 19:30:00

From Qiandao Lake to the World's Finest Tables: Kaluga Queen Named Restaurant Event Partner of the MICHELIN Guide Singapore 2026
The world's largest caviar producer celebrates yet another milestone following its successful Hong Kong IPO, reinforcing its position on the global culinary stage. SINGAPORE , Aug. 13, 2026 /PRNewswire/ -- Fresh off its successful listing on the Hong Kong Stock Exchange (HKEX), Kaluga Queen , the world's leading caviar producer, has been named the Restaurant Event Partner of the MICHELIN Guide Singapore 2026 , marking another significant milestone in its international growth journey. The partnership reflects Kaluga Queen's continued commitment to culinary excellence, bringing premium Chinese caviar from the pristine waters of Qiandao Lake to some of the world's most celebrated dining tables. As the restaurant event partner of the MICHELIN Guide Singapore 2026, Kaluga Queen is also proud to present the MICHELIN Guide Singapore 2026 Young Chef Award , which recognises an outstanding rising talent shaping Singapore's dynamic culinary landscape. This year's accolade is presented to Chef Shusuke Kubota of Loca Niru , celebrating the chef's creativity, passion and dedication to advancing Singapore's vibrant dining scene. Through this partnership, Kaluga Queen reaffirms its commitment to supporting culinary excellence while championing the next generation of chefs. Kaluga Queen has grown from the pristine waters of China's Qiandao Lake into the world's largest caviar producer by sales volume, maintaining the No. 1 position globally for eleven consecutive years since 2015. Today, its caviar is enjoyed in 46 countries and regions, served by MICHELIN-starred restaurants, luxury hotels, leading international airlines and prestigious culinary events worldwide. Backed by more than two decades of expertise in sustainable sturgeon farming, innovation and craftsmanship, Kaluga Queen has become one of the world's most recognised names in premium caviar. The MICHELIN Guide Restaurant Ceremony Singapore 2026 event partnership follows another landmark achievement for the company with Xunlong Technology's successful listing on the Main Board of the Hong Kong Stock Exchange (HKEX: 06715). The IPO marks the beginning of a new chapter for Kaluga Queen, with proceeds supporting production expansion, technological innovation, international brand development, sales channel enhancement and retail growth as the company continues to strengthen its global presence and bring premium Chinese ingredients to discerning consumers around the world. From Qiandao Lake to some of the world's finest tables, Kaluga Queen's journey reflects its unwavering pursuit of quality, innovation and craftsmanship. As it continues expanding its international footprint, the brand remains committed to elevating exceptional dining experiences and connecting the world's finest chefs and diners through one of the most celebrated ingredients in gastronomy. About Kaluga Queen Kaluga Queen, the world's top-selling caviar brand for 11 consecutive years, combines time-honoured techniques with meticulous craftsmanship for dining experiences that offer gourmets worldwide a healthy, refined, and stylish culinary experience—one that epitomizes exquisite taste and prestige. Guided by a mission to curate a life of enjoyment and a vision to craft the world's best caviar and nurture a century-long legacy, it is strategically deepening its presence in the Asia-Pacific market by supplying to numerous MICHELIN-starred restaurants worldwide. Website: www.kalugaqueen.com Instagram: @kalugaqueen_official
2026-08-13 09:43:00

TOPPEN ELEVATES THE SKY PAVILION EXPERIENCE WITH IMMERSIVE "SCENES TO BE SEEN" CONCEPT
JOHOR BAHRU, Malaysia , Aug. 13, 2026 /PRNewswire/ -- Toppen Shopping Centre showcased the enhanced The Sky Pavilion at Toppen, highlighting its evolution into a versatile, experience-led event space designed to host a wide range of occasions, from corporate functions and brand activations to weddings, private celebrations and social gatherings. Officiate the unveiling of the enhanced The Sky Pavilion Toppen, marking a new chapter for the versatile event venue and its expanded event offerings. Toppen Shopping Centre has unveiled the enhanced The Sky Pavilion at Level 3, a versatile, experience-led event venue designed to accommodate a wide range of occasions, including corporate functions, conferences, brand activations, exhibitions, workshops, weddings, private celebrations and community gatherings. Offering adaptable layouts and event configurations, The Sky Pavilion provides organizers with the flexibility to transform the venue according to different event formats, capacities and creative requirements. Its supporting facilities and connection to the Toppen's garden further extend the possibilities for indoor and outdoor experiences, receptions and social gatherings. The venue's versatility was demonstrated through "Scenes to Be Seen @ The Sky Pavilion at Toppen", where guests experienced three different event settings within the space: Corporate Events, Weddings and Private Parties. A floral arrangement workshop and a balloon-sculpting challenge were incorporated to illustrate the range of experiential programmes that can be hosted at the venue. The showcase was complemented by Nanyang Seafood Restaurant, which presented its refreshed, muslim-friendly Nanyang dining experience. Inspired by more than a decade of Teochew culinary heritage, its offering brings together traditional flavours, fresh ingredients and contemporary touches, providing an additional dining and catering option for events hosted at The Sky Pavilion. The enhancement of The Sky Pavilion reflects Toppen's commitment to creating adaptable spaces that bring businesses, brands, families and communities together. With its flexible setting and range of event possibilities, the venue offers event organisers a convenient destination where ideas can be transformed into meaningful and memorable experiences For venue enquiries and bookings, please contact The Sky Pavilion @ Toppen: 601 1 - 2 088 7595 About Toppen Shopping Centre Toppen Shopping Centre is a 1.25 million square foot meeting place anchored by the first IKEA store outside of the Klang Valley. The rooftop, known as The Topp, is home to the first-of-its-kind community hub, offering something for everyone, from endless fun and entertainment to alfresco dining and cinema. The centre is one among the portfolio of centres owned by Ikano Retail. Together with IKEA Tebrau, Toppen delivers a fun day out for the many people of Southern Malaysia and beyond.
2026-08-13 09:42:00

SingHealth Launches Global Network for World-Class Healthcare Administrator Immersion and Development
SingHealth is working alongside nine leading academic medical centres and health systems worldwide to formalise a structured exchange programme for healthcare administrators. Administrators will spend six to eight weeks embedded inside these institutions across North America, Europe and Asia, working shoulder-to-shoulder with peers at some of the world's most advanced health systems. SingHealth will also host administrators from these institutions, offering first-hand exposure into the ecosystem of an integrated, globally benchmarked public healthcare cluster that offers the full continuum of care under a single system. SINGAPORE , Aug. 12, 2026 /PRNewswire/ -- SingHealth launched the SingHealth International Administrators Fellowship Network at the opening ceremony of the Singapore Healthcare Management (SHM) 2026 congress today. The event was graced by Dr Tan See Leng, Minister for Trade and Industry (Energy and Industry), as Guest of Honour. SHM is an annual three-day congress bringing together healthcare leaders and experts from Singapore and abroad to exchange insights and best practices in healthcare administration. The SingHealth International Administrators Fellowship Network marks the first of its kind – a consortium of ten leading academic medical centres and health systems dedicated to advancing knowledge exchange on a global stage through the establishment of a structured exchange programme for healthcare administrators. Selected administrators from these institutions will have the opportunity to be immersed in exchange programmes with other world-class health systems, bring back new ideas and best practices that strengthen their own institutions and build a global community of collaborative innovation and excellence. Building a Global Community of Future-Ready Healthcare Leaders Through the Network, selected administrators will undertake a structured programme of six to eight weeks in one of these institutions across North America, Europe and Asia. Together with SingHealth, the participating institutions include: University Health Network, Canada NYC Health + Hospitals, USA Johns Hopkins Health System, USA Stanford Health Care, USA Northwell Health, USA Methodist Le Bonheur Healthcare, USA Karolinska University Hospital, Sweden Beijing Tsinghua Changgung Hospital, China CUHK Medical Centre, Hong Kong, China During the attachment, administrators work alongside their peers to exchange insights on leadership, transformation and innovation strategies, gaining first-hand exposure to the challenges and solutions shaping healthcare systems around the world, with lessons that resonate both today and in the years ahead. "The establishment of the SingHealth International Administrators Fellowship Network signals SingHealth's continued investment in developing our people as a strategic workforce that leads and thrives in an increasingly complex healthcare landscape. It also strengthens our position as a global platform for collaboration, knowledge exchange and innovation, as well as an employer and healthcare partner of choice," said Mr Tan Jack Thian, Group Chief Operating Officer, SingHealth. SingHealth plans to send 40 administrators through this programme over the next five years. Administrators from Johns Hopkins, Stanford and the other institutions will also come to Singapore to experience being part of one of the world's few fully integrated public healthcare clusters, where acute hospitals, specialty centres, polyclinics and community hospitals operate as one seamless system. For many, it will be their first encounter with a model of care that the world is increasingly looking to as a blueprint. Dr Chung Kin Lai, CEO of CUHK Medical Centre, said, "Joining the SingHealth International Administrators Fellowship Network reflects our belief in the strategic importance of administrators in healthcare. This innovative initiative, led by SingHealth and supported by an international network of peers, will help broaden perspectives, exchange best practices, and develop administrators who are ready to grow with adaptability and insight." From Individual Attachments to an International Network The SingHealth International Administrators Fellowship Network represents the next chapter in SingHealth's commitment to international healthcare collaboration. Since its launch in 2023, the SingHealth Administrators Exchange Programme has built connections in different disciplines between administrators across institutions. The SingHealth International Administrators Fellowship Network now deepens those connections into a sustained, multilateral network across borders. Under the previous SingHealth Administrators Exchange Programme, 16 administrators from SingHealth's network of acute hospitals, specialty centres, polyclinics and community hospitals visited major overseas academic medical centres and health systems, returning with perspectives and practices that have shaped the way they work. One such administrator is Mr Song Jiahui, Senior Assistant Director, Operations, Outram Community Hospital, who was attached to Northwell Health, USA. "I had the privilege to tour restricted sites such as the Northwell Health Central Sterile Facility and Integrated Distribution Center and even witnessed a decontamination exercise simulating a highway industrial accident. I also applied what I learnt from their Greenhouse Gas Inventory Management Plan when I contributed as a SingHealth representative in the nation's first comprehensive study of healthcare system emissions , published in 2025. What struck me was how closely aligned SingHealth and Northwell Health are in their fundamental goals to deliver appropriate, high-quality care to the patients and communities we serve," he said. Please refer to the Annex for the experiences of former participants of the SingHealth Administrators Exchange Programme, and how their learnings have since been put to work across the organisation. A National Congress by Healthcare Professionals, for Healthcare Professionals The SHM Congress, now in its 15 th edition, is Singapore's premier conference bringing together healthcare administrators, professionals and thought leaders for dedicated learning and exchange. This year's congress line-up features Adjunct Professor Adam Horsburgh, Chief Executive Officer, Bayside Health, Australia, who shared his experience on hospital mergers and AI use in healthcare; Dr Benjamin Granger, Chief Workplace Psychologist, Qualtrics Experience Management Institute, USA, who will provide insights on how to enhance patient experience through the experience of the care teams; as well as Mr Lian Ghim Hua, Commissioner, Immigration & Checkpoints Authority, Singapore, who will share about how ICA redefines border security and service delivery. This year, the congress adds a dedicated Innovation track, where healthcare professionals from the Singapore National Eye Centre, Singapore General Hospital and the National University of Singapore Yong Loo Lin School of Medicine discuss the healthcare innovation journey and what goes behind each breakthrough that impacts clinical care. The congress drew over 2000 local and international delegates representing a range of expertise from healthcare management to supply chain management and patient experience. More than 500 posters of innovative initiatives were sent in by healthcare institutions across Singapore on topics ranging from Healthcare Engineering to Human Resource, a testament to the breadth and depth of ideas and practices that have contributed to the advancement of healthcare in the management and administration fields. ### About Singapore Health Services (SingHealth) SingHealth, Singapore's largest and leading public healthcare cluster, puts patients at the heart of all we do. Through our network of acute hospitals, national specialty centres, polyclinics and community hospitals, SingHealth delivers integrated care across every stage of life, from prevention and diagnosis to treatment, rehabilitation and long-term health management, offering multidisciplinary expertise across a wide range of specialties. Beyond hospital walls, SingHealth partners community care providers to enable the population to keep well, get well and live well. As an academic medical centre, SingHealth partners Duke-NUS Medical School and forms strategic collaborations across industries and the academia to advance research, innovation and education. Our goal is to drive impactful care outcomes, enhance patient experience and transform healthcare delivery, here and on the global front. For more information, please visit: www.singhealth.com.sg Members of the SingHealth group Hospitals (Tertiary Specialty Care): Singapore General Hospital, Changi General Hospital, Sengkang General Hospital, KK Women's and Children's Hospital, and Eastern General Hospital (expected completion around 2029 to 2030) National Specialty Centres (Tertiary Specialty Care): National Cancer Centre Singapore, National Dental Centre Singapore, National Heart Centre Singapore, National Neuroscience Institute, and Singapore National Eye Centre SingHealth Polyclinics (Primary Care): Bedok, Bukit Merah, Eunos, Marine Parade, Outram, Pasir Ris, Punggol, Sengkang, Tampines, Tampines North and Kaki Bukit (upcoming) SingHealth Community Hospitals (Intermediate and Long-term Care): Sengkang Community Hospital, Outram Community Hospital, and Eastern Community Hospital (expected completion around 2029 to 2030) Annex Song Jiahui Senior Assistant Director, Operations, Outram Community Hospital Attachment with Northwell Health | September – October 2024 Jiahui's attachment with Northwell Health broadened his perspective on operational planning and sustainability. Across 10 departments, he engaged with issues ranging from waste audits to business continuity planning and toured restricted facilities including Northwell's Central Sterile Facility and Integrated Distribution Center. Witnessing a live decontamination exercise simulating a highway industrial accident was among the more striking highlights. What surprised him was the sheer breadth and complexity of scenarios that Northwell's Business Continuity department planned for, including union agreement expiries, energy crises, adverse climate events disrupting staff commutes, the cascading effects of disasters in neighbouring states and cybersecurity threats. The teams meticulously mapped out contingency plans for each, including how multiple crises might unfold simultaneously and compound one another. It reinforced for Jiahui that effective continuity planning must be deeply attuned to the social, political, and environmental context in which a health system operates. Back at SingHealth, Jiahui put his learnings to work. Drawing on Northwell's Greenhouse Gas Inventory Management Plan, he contributed as a SingHealth representative to Singapore's first comprehensive study of healthcare system emissions, published in 2025. He also worked with SingHealth's Office of Sustainable Health to implement an eco-checklist to share easy, actionable sustainability tips with staff, making it simple to adopt greener behaviours in their day-to-day work. The team also developed seasonal festive guides to educate staff on simple ways to be more sustainable during festive periods, a timely and relatable way to nudge behavioural change without being prescriptive. Together, these initiatives have helped embed a stronger culture of environmental responsibility across the SingHealth campus. Lee Hui Quan Director, Business Office, KK Women's and Children's Hospital Attachment with Stanford Health Care | May – June 2025 For Hui Quan, the attachment offered an exposure into advanced financial management practices within one of the United States of America's leading healthcare institutions. Through various strategic senior management, stakeholder and workgroup meetings, as well as one-to-one conversations with Finance leaders, he gained insight into the financial planning and management practices of a complex healthcare system, as well as training in a range of business intelligence tools for data-driven decision-making and finance analytics. Returning to SingHealth, Hui Quan brought fresh perspectives that strengthened ongoing efforts to build a more sophisticated financial management ecosystem. As Co-Lead of SingHealth's National Billing System (NBS) implementation and Lead for SingHealth Payment Solutions, he deepened the team's understanding in leveraging data-driven financial management tools across cost accounting, contract analytics, budgeting, forecasting, and benchmarking. His leadership supported SingHealth's financial transformation agenda by advancing the automation of financial analysis and reporting, enhancing operational insights, and enabling more timely, data-driven decision-making. Ong Li Wen Deputy Director, Facilities Management, Changi General Hospital Attachment with NYC Health + Hospitals Design Planning & Facilities Development and Facilities Management | September – October 2025 Li Wen's attachment at NYC Health + Hospitals placed her at the heart of real-world facilities management challenges. A highlight was her involvement in managing a live major incident affecting the hospital's incoming electrical supply — visiting switch rooms, monitoring voltage fluctuations, reviewing contingency measures, and contributing to the response team's decision-making. It was a masterclass in high-stakes infrastructure management under pressure. Beyond the incident, she gained exposure to critical systems including water treatment, boilers, and generators, as well as climate-resilient infrastructure designed to withstand natural disasters and environmental disruptions, broadening her perspective on what robust, future-ready facilities management looks like. Back at SingHealth, Li Wen translated these experiences into tangible improvements. As lead for Digitalisation and Innovation within SingHealth's Facilities Management Engineering Shared Services, the attachment sharpened her thinking on how to strengthen SingHealth's critical infrastructure. It sparked innovative engineering solutions for utility plants, including more energy-efficient approaches to heat recovery solutions for water systems and enhanced water quality management strategies, reinforcing SingHealth's commitment to building a resilient, sustainable healthcare campus for staff and patients alike.
2026-08-12 07:35:00

MiTAC Computing Showcases Diversified Infra for Agentic Workloads at OCP APAC Summit
TAIPEI , Aug. 12, 2026 /PRNewswire/ -- MiTAC Computing Technology Corporation, a global leader in high-performance, energy-efficient server solutions and a subsidiary of MiTAC Holdings Corporation (TSE:3706), today showcased its diversified rack-scale infrastructure engineered for Agentic AI workloads at the OCP APAC Summit. Highlighting the event is the world premiere of MiTAC's latest OCP-compliant HPC servers—the C2810Z6 and C2610Z6—developed in collaboration with AMD to harness the all-new 6th Gen AMD EPYCTM Server CPUs on the advanced SP7/SP8 platforms with PCIe Gen 6 connectivity. To meet the demands of continuous Multi-Agent Reasoning Loops and extreme data throughput, MiTAC has engineered comprehensive rack-scale solutions centered around its flagship 52U high-density AI liquid-cooled rack. By incorporating integrated AI servers that span AMD and Intel platforms alongside the NVIDIA accelerated computing platform—featuring compute, networking, and software—MiTAC provides a seamless upgrade path from underlying silicon to a ready-to-deploy 'AI Factory'. Premiering Next-Gen OCP Compute Nodes for Agentic Execution As autonomous agents transition from simple prompts to dynamic multi-step workflows, foundational compute nodes require unprecedented I/O bandwidth and power efficiency. At OCP APAC, MiTAC is debuting two ORv3 compute platforms powered by 6th Gen AMD EPYCTM Server CPUs . Featuring AMD's "Zen 6" architecture, PCIe Gen 6 connectivity, and CXL 3.1 support, these platforms are engineered to process massive parallel agent requests while optimizing data center footprint and energy density. MiTAC leads this architectural transition with two world-premiere platforms: C2810Z6 : An ORv3 multi-node server engineered for high-density cloud and HPC workloads. Powered by 6th Gen AMD EPYCTM Server CPUs (SP7 socket, up to 256 cores and 512 threads,supporting default CPU power up to 600W), it supports up to 4TB DDR5-8000 memory per node. This platform delivers massive PCIe Gen 6 I/O throughput alongside versatile NVMe storage (12x E3.S-1T or 6x U.2), such as Micron 9650 NVM e TM G en 6 SSDs . Integrated with a 48Vdc busbar and DC-SCM 2.0 module, it ensures extreme performance, security, and power efficiency for dense compute clusters. C2610Z6 : A next-generation ORv3 compute platform optimized for scalable cloud, enterprise IT, and edge applications. Powered by 6th Gen AMD EPYCTM Server CPUs (SP8 socket, up to 128 cores and 256 threads, supporting default CPU power up to 400W ), it supports up to 4TB DDR5-8000 memory per node. Equipped with PCIe Gen 6 connectivity, flexible NVMe storage, such as Micron 9650 NVM e TM Gen 6 SSDs. Integrated with a 48Vdc busbar and DC-SCM 2.0 management, it provides a highly efficient, versatile architecture for enterprise AI scaling. Diversified Rack-Scale Infrastructure for Agentic Workloads Beyond raw node performance, powering autonomous Agentic AI introduces complex architectural demands. Unlike static single-prompt AI, multi-agent systems rely on continuous reasoning loops, dynamic tool calling, real-time memory retrieval, and multi-agent orchestration. To eliminate thermal, storage, and cluster governance bottlenecks across these execution pipelines, MiTAC Computing delivers a complete spectrum of diversified rack-scale infrastructure: High-Density AI Racks (Liquid-Cooled & Air-Cooled): Engineered to sustain the continuous multi-step reasoning loops of agentic workloads. By packing maximum GPU density—such as 96x AMD InstinctTM MI355X GPUs in a single 52U liquid-cooled rack—MiTAC provides the low-latency, unthrottled compute engine required for real-time agent execution. OCP HPC Racks (Modular & Scalable): Delivering open ORv3 standards, energy-efficient 48Vdc power distribution, and modular flexibility, MiTAC's liquid- and air-cooled OCP racks allow data centers to scale execution nodes seamlessly as autonomous agent worker teams expand. Agentic Memory & Orchestration Ecosystem (DDN, Rafay, and Canonical Ubuntu): An autonomous agent is only as fast as its access to enterprise memory and task delegation. Partnering with DDN for ultra-high-throughput vector/session storage and Rafay for automated multi-agent cluster governance, MiTAC delivers an ultra-low latency storage-to-compute pipeline that keeps multi-agent workflows running at full speed. From Chips to Applications: MiTAC's Full-Stack AI Factory Vision To bring these diversified components together into an operational environment, MiTAC aligns its entire rack-scale portfolio across ecosystem layers to transform modular silicon into deployment-ready enterprise AI factories: MiTAC platforms maximize the raw compute of next-generation silicon, offering the flexibility to integrate high-density accelerators—including AMD InstinctTM MI355X GPUs , AMD InstinctTM MI350X GPUs , AMD InstinctTM MI350P PCIe® cards —as well as multi-workload enterprise GPUs such as the NVIDIA RTX PRO 4500 and RTX PRO 6000 Blackwell Server Edition GPUs, ideally suited for AI, simulation, and visual computing. Infrastructure Layer: We deliver hyper-efficient physical foundations—highlighted by our 52U AI liquid-cooled rack housing G4826Z5 servers alongside versatile compute nodes like the TN85-B8261 and G4520G6 (powered by dual Intel® Xeon® 6 processors with up to 8,192GB DDR5 memory)—backed by MiOBMCTM / MiOPFTM open firmware and enterprise Linux OS. Orchestration & Data Pipeline Layer: Bridging physical servers with upper-layer intelligence, MiTAC collaborates with leading ecosystem partners including DDN, Rafay, and Kubernetes, alongside our proprietary MiCoreViewTM POD management suite, to deliver high-throughput data delivery and automated cluster management across modern AI factories. Models Layer: Our throughput-optimized compute and parallel storage pipelines satisfy the demands of diverse architectures—accelerating massive LLMs, VLMs, MMLLMs, and Mixture-of-Experts (MoE) models without data bottlenecks or hardware idling. Applications Layer: From multi-step Agentic AI and RAG workflows to generative AI and large-scale HPC simulations, MiTAC provides resilient, rack-scale foundations purpose-built to execute real-world enterprise AI at scale. About MiTAC Computing Technology Corporation MiTAC Computing Technology Corp., a subsidiary of MiTAC Holdings, delivers comprehensive, energy-efficient server solutions backed by industry expertise dating back to the 1990s. Specializing in AI, HPC, cloud, and edge computing, MiTAC Computing employs rigorous methodologies to ensure uncompromising quality—across barebones, systems, racks, and cluster levels—fully achieving performance and integration. This commitment to quality at every level sets MiTAC Computing apart in the industry. With a worldwide presence and end-to-end capabilities—from R&D and manufacturing to global support—MiTAC Computing provides agile, customized platforms for hyperscale data centers, HPC, and AI applications, ensuring optimal performance and scalability to meet unique business needs. By leveraging the latest advancements in AI and liquid cooling, and unifying the MiTAC brand with Intel DSG and TYAN server products, MiTAC Computing stands out for its innovative, efficient, and reliable server technology as well as its hardware and software integrated solutions—empowering businesses to meet future challenges. MiTAC Computing Technology Corporation website: https://www.mitaccomputing.c om/ .
2026-08-12 07:33:00

THOUSANDS RAISED A TIGER ACROSS 61 LOCATIONS IN AN ISLANDWIDE TOAST TO SINGAPORE'S 61ST BIRTHDAY
From the Kallang waterfront to the heartlands, bars and supermarkets, the Singapore-born beer brought thousands of Singaporeans together for an unforgettable Tiger Time SINGAPORE , Aug. 12, 2026 /PRNewswire/ -- This National Day, born in Singapore Tiger Beer turned Singapore's 61st birthday into a collective islandwide toast, bringing thousands together at 61 locations, from the Kallang waterfront and neighbourhood gathering spots to bars, restaurants and supermarkets. Tiger's National Day celebrations at Kampong Bugis More than a celebration of the day itself, Tiger's National Day activation showed how a Singapore-born beer could bring people together in the places where they naturally gather, creating shared moments of pride, connection and Tiger Time across the island. At the heart of the celebrations was Kampong Bugis, where more than 3,000 people gathered throughout the evening along the Kallang waterfront. The riverside precinct became Tiger's flagship National Day gathering spot with complimentary Tiger, roving cargo bikes, National Day fun packs, photo moments and live music setting the tone for an evening that built towards the fireworks over the city skyline. Soundtracked by a live DJ set from Singapore vinyl duo HeavyItch, the festivities culminated in a shared toast as crowds raised a Tiger to the nation. Among the crowd were visitors experiencing Singapore's National Day for the first time, one of whom commented "This was my first time experiencing Singapore's National Day, and it's definitely a memory I'll bring home with me. Sharing a Tiger while celebrating such an important occasion made it a memorable way to experience Singapore's spirit and hospitality." Tiger also gave more than 60 fans a different view of the celebrations aboard its National Day bumboat and a private Singapore Flyer capsule, offering front-row views of the fireworks from two Singapore icons. "National Day is always special because it brings Singaporeans together, and for as long as I can remember, Tiger Beer has been at the heart of those moments. Whether it's catching up with close friends or gathering for a big celebration, cracking open a Tiger is our way of marking the occasion. There's a real sense of pride in seeing a brand born on our streets make such a massive mark across the world and raising a toast with it this National Day makes the celebration feel all the more meaningful," said content creator, Chow Jia Hui who joined Tiger's National Day bumboat. Guests enjoying Tiger's National Day celebrations on a bumboat and Singapore Flyer capsule The celebrations reached the heartlands too, where crowds gathered at Sengkang Grand Mall for a National Day Parade watch party. As the first fireworks lit up the sky at around 8.15pm, Tiger also surprised those celebrating at selected coffee shops, bars and restaurants across the island, including The Tuckshop and Al Capone Kallang. Those enjoying a beer received a complimentary Tiger, just in time to raise a toast to the nation's birthday. At participating supermarkets and hypermarkets, consumers also received complimentary Tiger cans with any purchase, to join in the celebrations. These moments brought Tiger's National Day celebrations to 61 locations across Singapore, from large-scale gatherings to the neighbourhood spots where people were already celebrating with friends and family. "Singapore is home for Tiger, and as a beer born here more than 90 years ago, we're proud of the journey we've shared with the nation and how far we've travelled around the wor ld," sa id Tanya Lubis, Marketing Manager, Tiger Beer. "Seeing thousands of people across 61 locations come together and raise a Tiger to Singapore made this National Day even more special." About Tiger ® Tiger ® was born in 1932 on the streets of Singapore. Today, Tiger ® is the number one international premium beer from Asia and is available in more than 60 markets across the globe. Defying the odds to create the ultimate brew, a perfect balance between bold and refreshing, Tiger ® has been uncaging new ways to take refreshment to the next level and make the impossible possible for decades. Tiger ® believes that there is a tiger inside each of us, a version of ourselves that knows no limits to what is possible. For more information, please visit www.tigerbeer.com .
2026-08-12 07:32:00

LX Pantos Strengthens Global ESG Leadership Through Its 2026 Sustainability Report
Completes calculation and third-party verification of Scope 1 and 2 GHG emissions across Korea and key overseas operations Expands ESG disclosures to cover human rights, safety, working conditions, and training for global employees SEOUL, South Korea , Aug. 11, 2026 /PRNewswire/ -- LX Pantos (President & CEO: Lee Yong-ho) has released its 2026 Sustainability Report, highlighting progress in advancing ESG management across its domestic and global operations. LX Pantos recently released its 2026 Sustainability Report. The report covers nine material ESG issues identified through a double materiality assessment, including climate change adaptation and mitigation, energy, eco-friendly logistics services, customer value management, human resources management, information security, risk management, business conduct, and new growth engines and business diversification. A key highlight of this year's report is the expanded reporting scope, which now includes global worksites. The expansion reflects LX Pantos's strong international footprint and the growing scale of its overseas operations. On the environmental front, the company calculated Scope 1 direct greenhouse gas emissions and Scope 2 indirect greenhouse gas emissions from its domestic operations and key overseas sites. Third-party verification further strengthened the reliability of its environmental disclosures. In the social area, LX Pantos collected and analyzed employee data from nine subsidiaries in Europe, covering human rights and labor, occupational health and safety, working conditions, education, and career development. In governance, the report highlights progress in Jeong-do Management, the company's ethics- and compliance-based management philosophy. LX Pantos recorded zero significant legal violations related to anti-corruption and fair trade rules and achieved a 100% completion rate for Jeong-do Management training in 2025. The report was prepared in accordance with the GRI Standards 2021 and references global ESG frameworks including SASB, the UN SDGs, the UNGC, and the TCFD. An independent third-party assurance agency verified the report for accuracy and reliability. In 2025, LX Pantos also earned a Bronze rating from EcoVadis, a B rating from the Carbon Disclosure Project (CDP), LEED Gold certification for the MegaWise Cheongna Center, and an A+ rating under the Regional Social Contribution Recognition System administered by the Korean Ministry of Health and Welfare. Commenting on the release of this report, Lee Yong-ho, President & CEO of LX Pantos said, "LX Pantos is further advancing its sustainability management by expanding the scope of ESG management beyond Korea to our overseas operations. Under our ESG vision, 'Value Deliverer for People and the Planet,' we will continue to communicate with stakeholders in a transparent manner." ■ About LX Pantos Established in 1977, LX Pantos is a leading global logistics provider headquartered in Korea. It delivers comprehensive logistics solutions across sea, air, rail, and contract logistics through a worldwide network spanning more than 40 countries. Learn more about LX Pantos online and follow it on LinkedIn .
2026-08-10 22:00:00

GreenCore Solutions Corp. (GSC) Appoints Former Walmart Director Julia Turley to Board of Directors
US$2 billion annual P&L buyer expertise, now paired with the sustainability edge of GSC's AI Agents for Beauty & Personal Care (BPC) with the CPG Knowledge Graph VANCOUVER, BC and SYDNEY , Aug. 11, 2026 /PRNewswire/ -- GreenCore Solutions Corp. ("GSC" or the "Company"), AI Agents that sell Consumer Packaged Goods (CPG) and Beauty & Personal Care (BPC) brands into retail grocery procurement, today announced the appointment of Julia Turley to its Board of Directors. Across the world's ten largest retailers, only a handful of executives at any time hold a Beauty & Personal Care buying P&L at the director level. Turley held one — at the largest of them all — for years. She spent more than 20 years at Walmart U.S. — Bentonville, Arkansas, inside a retailer with fiscal 2026 global revenues of US$713 billion — in Beauty & Personal Care buying and merchandising leadership, most recently as Director of Merchandising — Beauty, running a US$2 billion P&L. She made the decision GSC's AI Agents are built for: what gets bought. Only a handful of executives across the world's largest retailers hold Beauty & Personal Care buying expertise at the level Turley brings — more than 20 years at Walmart U.S. (fiscal 2026 revenues US$713 billion), most recently as Director of Merchandising — Beauty, running a US$2 billion P&L. She now pairs that expertise with the fastest-scaling AI Agent procurement platform in CPG — GSC's AI Agents and the CPG Knowledge Graph, carrying brands into retail procurement at 11.5 million+ transactions a month. Her buyer judgment lands on an AI Agent stack already engineered for the buy side — deterministic, procurement-ready, and sustainable by design, resolving answers once instead of burning compute guessing. "Everyone wins. GSC's makers get AI Agents built against real buyer judgment. Retail buyers get a sell side engineered for their gates — deterministic, procurement-ready, and sustainable by design, resolving answers once instead of burning compute guessing. And the GSC board gains a leader and a mentor — two decades of building winning categories and developing top merchant talent, now guiding the company that sells to the desk she ran. GSC is the first AI Agent company in CPG to appoint a Walmart U.S. merchandising leader to its Board of Directors," said Matthew Keddy, CEO, GreenCore Solutions Corp. "For more than 20 years at Walmart, I evaluated brands through the lens of the customer, the category and the business—what earns distribution, what creates incremental growth and what ultimately deserves space on the shelf. AI is changing how brands and retailers find, evaluate and transact with one another, but strong retail decisions still require sound merchant judgment. I'm excited to bring that perspective to GSC as it builds technology designed around how retailers actually buy," said Julia Turley. GSC supplies AI Agents to CPG makers, mounting a maker's SKUs onto GSC AI Agent infrastructure so those products become machine-discoverable, machine-orderable and procurement-ready for retailer, ERP and AI procurement systems. The Company's architecture combines its proprietary CPG Knowledge Graph powered by SPARKS with deterministic classification, sovereign resolution and commerce execution infrastructure — with a human in the loop on every purchase order. About Julia Turley Julia Turley is Founder of JT Retail Solutions LLC (Bentonville, Arkansas) and an Independent Director of GreenCore Solutions Corp. A retail and CPG executive with more than 20 years of experience at Walmart U.S., Turley has led merchandising, category strategy, assortment and supplier partnerships across major consumer categories. Most recently, she served as Director of Merchandising — Beauty, with responsibility for a US$2 billion business. Today, through JT Retail Solutions, she brings that merchant perspective to companies with AI orderability seeking to better understand retail strategy, consumer and category opportunities, product commercialization and scalable retail growth. About GreenCore Solutions Corp. (GSC) GreenCore Solutions Corp. (GSC) builds AI Agents that sell Beauty & Personal Care (BPC) brands into retail grocery procurement, powered by the CPG Knowledge Graph with SPARKS and delivered on MCP + A2A + ACM-68000. GSC carries 11.5 million+ inbound AI Agent transactions a month — 4.2 every second — across the CPG Knowledge Graph's 2 billion datapoints spanning 38,350 BPC brands, 15,688 retail grocery banners and 3.29 million points of sale in 50 global markets. GSC AI Agents run sustainable, transact safe, human in the loop, and live on Microsoft Azure and Google Cloud. GSC is a Microsoft AI Cloud Partner — Crunchbase Global Rank #151 of 5 million companies . D-U-N-S 24-336-6774. About GSC Agentic Pty. Ltd. GSC Agentic Pty. Ltd., headquartered in Sydney, Australia, is the Asia-Pacific joint venture delivering the GSC AI Agent Stack across APAC markets.
2026-08-10 21:56:00

KOWIN Showcases full-line Storage Portfolio at FMS 2026: High-performance Storage Products Drives AI Innovation
SAN JOSE, Calif. , Aug. 8, 2026 /PRNewswire/ -- At FMS 2026 (Future of Memory and Storage), KOWIN showcased its full-line storage portfolio: covering Embedded Storage, SSD, DRAM Module, Removable Storage. The company delivers high-reliability storage solutions for a comprehensive range of AI-powered terminals and industrial devices. KOWIN at Future of Memory and Storage 2026 Embedded Storage: KOWIN offers Small PKG. eMMC tailored for AI smart glasses, ePOP for smart watches, and industrial-grade eMMC for rugged industrial control system. These products enable ultra-compact, low-power and long-lasting performance for diverse AI scenarios. Solid-State Drives (SSDs): High-capacity SSDs are optimized for Mini PCs, supporting fast system booting and instant data access. They ensure stable and efficient AI computing for desktop and edge deployment environments. DRAM Modules: SODIMM and UDIMM modules that significantly upgrade the computing power of AI laptops and desktops, accelerating AI model training, rendering, and multitasking. Removable Storage: microSD cards and USB flash drives that meet the needs for portable storage and fast data transfer, ideal for AI data logging, field updates, and content transfer. With this premium storage lineup, KOWIN effectively covers AI wearables, AI PCs, and industrial control systems, driving performance and reliability to facilitate global AI industry growth. KOWIN's participation at FMS 2026 reaffirmed its commitment to providing ultra-reliable and innovative storage solutions that drives the intelligent world. About KOWIN KOWIN specializes in the research, design, and sales of embedded storage, memory modules, and Removable Storage. The company's product portfolio spans eMMC, eMCP, ePOP, nMCP, UFS, LPDDR, DDR, SSD, portable SSD, DRAM Modules, Memory cards, and USB flash drives. These products are widely adopted across smart terminals, smart home, smart wearables, AI devices, IoT, network communication equipment, industrial control system, and smart learning / education, smart surveillance applications.
2026-08-07 17:01:00

SweetNight Announces Brand Renewal Ahead of the Debut of the CoolNest® Ultra, the Latest Addition to Its CoolNest® Series
WILMINGTON, Del. , Aug. 8, 2026 /PRNewswire/ -- SweetNight, a sleep wellness brand focused on accessible premium comfort solutions, today announced a comprehensive brand renewal—including an updated logo, redesigned visual identity system, and upgraded official website —alongside the upcoming launch of the CoolNest® Ultra Memory Foam Mattress this August. Designed as the latest addition to the brand's CoolNest® Series, the CoolNest® Ultra represents SweetNight's continued commitment to advanced cooling technology, delivering improved temperature regulation and support for a more refreshing sleep experience, particularly for hot sleepers. SweetNight The brand renewal follows a period of continued business development, portfolio expansion, and evolving consumer expectations. "As consumers increasingly seek solutions to nighttime overheating and sleep discomfort, we see significant opportunities to innovate around cooling sleep experiences," said Amber Zhu, Marketing Director at SweetNight. "Our refreshed brand identity represents not only who we are today, but also where we are heading. Through our Cooling Sleep Technology strategy and upcoming innovations, including new additions to the CoolNest® Series, we remain focused on creating products that help people sleep cooler, more comfortably, and more consistently." Brand Renewal: A Clearer and More Consistent Identity The new visual system is designed to provide greater consistency across SweetNight's products, digital platforms, and consumer communications. The upgraded website will serve as an integrated destination for product information and brand content, creating a clearer and more cohesive experience for U.S. consumers as they explore sleep solutions. Beyond its visual changes, the renewal reflects SweetNight's broader strategy of investing in sleep research and product innovation centered on practical consumer needs. For SweetNight, Cooling Sleep Technology represents a holistic approach that combines advanced materials, mattress construction, and airflow optimization to help create a more comfortable sleep environment. Introducing the CoolNest® Ultra Memory Foam Mattress The upcoming CoolNest® Ultra Memory Foam Mattress marks the next step in SweetNight's efforts to enhance cooling sleep solutions. As an upgraded addition to the CoolNest® Series, it is designed to further improve comfort, support, and overall sleep quality while addressing the growing demand for better temperature management. SweetNight plans to approach cooling as an integrated product-development direction rather than a standalone surface treatment. Its research and development efforts continue to explore material innovation, structural optimization, and the interaction between cooling performance and other aspects of sleep comfort. The brand also intends to expand and update its cooling product portfolio over time, offering solutions for a broader range of preferences and sleep environments. Aligning with Evolving Consumer Priorities The strategic focus aligns with shifting priorities in the sleep category. As more consumers recognize how temperature affects nighttime comfort and sleep quality, cooling performance is emerging as a key factor in purchasing decisions. For hot sleepers in particular, effective temperature regulation is no longer viewed as an optional feature, but as an essential element of a comfortable and restorative sleep experience. Together, the refreshed brand identity and the CoolNest® Series launch open a new chapter for SweetNight in the United States. With a unified visual presence and a clearer technology strategy, the brand plans to continue developing its U.S. operations while strengthening the connections among consumer needs, product innovation, and brand communication. About SweetNight SweetNight is a modern sleep brand dedicated to making high-quality, intelligent sleep solutions accessible to everyday families. The company addresses the biggest challenges in smart sleep by delivering technology that is simple, intuitive, and fairly priced. Its mission is to become the world's leading Self‐Adjusting Sleep Wellness Partner, bringing thoughtful, health‐focused innovation to households everywhere. For more information, please visit www.SweetNight.com .
2026-08-07 16:52:00

Bybit Expands UTA Loan Interest-Free Borrowing to 24 Assets, Empowering More Capital-Efficient Trading
DUBAI, UAE , Aug. 8, 2026 /PRNewswire/ -- Bybit , the world's second-largest cryptocurrency exchange by trading volume, has expanded its UTA Loan Interest-Free Borrowing program, extending interest-free borrowing eligibility to 22 additional major crypto assets. Combined with USDT and USDC, the program now covers 24 assets in total . The expansion helps reduce funding costs for traders using Perpetual and Futures products , giving avid traders greater flexibility in capital management under Bybit's Unified Trading Account (UTA) framework. Under the new framework, asset coverage for interest-free loans now supports 24 assets, including BTC, ETH, SOL, XRP, ADA, OP, NEAR, DOT, DOGE, LINK, SUI, LTC, UNI, MNT, AAVE, BCH, HYPE, XLM, ETC, FIL, APT and AVAX, alongside USDT and USDC . This significantly broadens the scope of supported assets from two mainstream stablecoins to over a dozen cryptocurrencies. The new mechanism balances cost efficiency and flexibility for qualified traders on Bybit: Lower Borrowing Costs: Traders no longer need to absorb interest charges on automatic borrowing triggered by unrealized losses on Perpetual or Futures positions. Zero interest rate applies for eligible borrowing under this scenario, as long as the amount stays within the applicable limit. Greater Capital Efficiency: With financing costs reduced across a wide set of 24 assets, traders can hold and adjust positions with less drag from borrowing expenses, freeing up capital that would otherwise go toward interest payments. Tailored VIP Benefits: The higher a trader's VIP tier, the more borrowing capacity they unlock at zero interest. Because each account, including subaccounts, is assessed independently, traders running multiple accounts benefit from separate limits rather than a shared cap. The interest-free benefit is specific to scenarios where unrealized losses on Perpetual or Futures positions activate automatic UTA borrowing. Manual borrowing, Spot Margin borrowing, Options borrowing and other borrowing types are excluded. Once the borrowed amount exceeds the limit for an asset, interest applies to the full balance. Borrowing limits across VIP tiers are pegged to the USD equivalent value of the borrowed asset at real-time prices and may shift with market conditions, with advance notice given before any change. Bybit Expands UTA Loan Interest-Free Borrowing to 24 Assets, Empowering More Capital-Efficient Trading Bybit's expanded UTA Loan Interest-Free Borrowing program gives traders across VIP tiers more flexibility to manage positions without added costs. Committed to building the New Financial Platform for all, Bybit continues to introduce capital-efficient trading tools that support traders' evolving risk management needs. Terms and conditions apply. For details on availability and eligibility, and specific limits by VIP tier and asset type, users may visit: UTA Loan futas expands interest-free borrowing to 22 more assets #Bybit / #NewFinancialPlatform About Bybit Bybit is The New Financial Platform. We believe every person should have access to every financial opportunity on earth. That's why we're building the first intelligent platform that connects anyone, anywhere to the world's finance. Trusted by more than 80 million users worldwide, Bybit brings together investing, trading, payments, and wealth-building in a single secure and intelligent ecosystem. Through the combination of AI-powered technology, deep global liquidity, robust security, and transparent operations, Bybit makes global finance more accessible, efficient, and empowering for everyone. Built for everyone. Powered by intelligence. Open to the world. Learn more at Bybit.com For more details about Bybit, please visit Bybit Press For media inquiries, please contact: media@bybit.com For updates, please follow: Bybit's Communities and Social Media Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube
2026-08-07 16:11:00

GLG's AI-Moderated Calls Unlock Expert Insights at New Speed and Scale
Clients can engage trusted experts with conversational AI agent, capturing qualitative depth and quantitative data in 10 languages NEW YORK , Aug. 6, 2026 /PRNewswire/ -- GLG , the world's leading platform for trusted human expertise, today announced its enhanced AI-Moderated Calls offering, enabling clients globally to engage experts through autonomously conducted calls in 10 languages. The AI Moderator is purpose-built to guide structured calls with nuanced conversational capabilities, gathering qualitative and quantitative insights with greater speed and scale. "Trusted human expertise has never been more valuable – and our AI-Moderated Calls help make access to it more scalable than ever for our clients, letting them conduct critical research on any timeline," said GLG CEO Gemma Postlethwaite. "This tool is another step toward the future we're building, where our clients can harness the power of our network together with AI to get more out of every expert interaction, without sacrificing nuance, depth, or trust." GLG is continuing to roll out innovative capabilities that power the research experience for clients, experts, and service professionals alike. The enhanced AI Moderator is agentic, multi-modal, and compliant – emulating a human researcher that operates within the industry's most trusted environment. It probes for nuance and follows up on experts' answers, while adhering closely to client-set discussion guides and keeping each conversation on track. Clients can also program the AI Moderator to garner quantitative feedback through multiple choice, scale, and matrix-style questions – with data exported directly to Excel so clients can focus on uncovering insights rather than extracting metrics. With no need for calendar coordination, AI-Moderated Calls can occur simultaneously across time zones. Experts have the flexibility to complete these engagements at their convenience – removing barriers to gathering insights from hard-to-reach experts. After calls conclude, clients can synthesize transcripts with a single click to surface key, actionable themes – with all outputs traceable to named experts and timestamps. "We design all our products to empower GLG clients and experts to do their best work within a frictionless experience – so we partnered with them directly to build and enhance a tool that understands how a great research conversation unfolds," said GLG Chief Product Officer John Londono. "So far, experts tell us it's easy to use with the Moderator conducting a natural and engaging conversation, and clients say it accelerates time-to-insight to just hours. We're excited to continue developing this offering alongside our broader suite of AI-powered capabilities." AI-Moderated Calls can be conducted in English, Spanish, French, Italian, Portuguese, German, Russian, Japanese, Korean, and Mandarin, all under GLG's industry-leading compliance framework. Learn more about GLG's AI-Moderated Calls here , and reach out to your GLG service representative for a demo. About GLG GLG is the world's leading platform for trusted human expertise, connecting decision makers to the precise intelligence they need to gain a strategic edge. Leveraging decades of experience and proprietary data, GLG's global teams recruit and engage hard-to-access experts across every industry – delivering fresh, authoritative insights, events, advisors, and board placements to the world's most recognized and influential companies. Visit GLG.com. CONTACT: press@glgroup.com
2026-08-06 14:43:00

HTX Launches TradFi Trade to Earn #2: Trade TradFi Assets with Negative Fee Rates and Share an $80,000 Prize Pool
APIA, Samoa , Aug. 6, 2026 /PRNewswire/ -- On August 5, HTX officially launched the second phase of its TradFi Trade to Earn campaign. The event brings together 28 selected TradFi perpetual futures trading pairs across four major asset categories: stocks, indices, commodities, and precious metals. Through a dual-track incentive structure, users can trade with negative fee rates and support $HTX buybacks. With a total prize pool of $80,000, the event allows users to trade popular global TradFi assets while earning substantial rewards. For full event details, please visit: https://www.htx.com.hr/en-us/support/45040173530399/ Trade U.S. Stock Perps on HTX with Negative Fee Rates From now until August 15, 11:59 (UTC), users who complete event registration and trade the designated TradFi futures pairs will receive $HTX rewards, calculated as the actual trading fees multiplied by an order reward ratio: 110% for Maker orders and 105% for Taker orders. This means users can trade popular TradFi assets at negative fee rates — the higher the trading volume, the greater the rewards. For high-frequency traders in particular, the trading cost structure and overall trading experience can be significantly improved. HTX debuted its first TradFi Trade to Earn campaign in July. The campaign received a strong market response and achieved great success, generating over 63 million USDT in trading volume across selected pairs and distributing over 23,000 USDT in rewards within 10 days. To give back to global users, TradFi Trade to Earn #2 further expands the prize pool, offering daily rewards of up to $8,000 equivalent $HTX rewards. Notably, all fee revenue generated by users on designated TradFi futures pairs during the event period will be used for $HTX buybacks. The repurchased tokens will be burned as part of the quarterly $HTX burn, supporting the stable, long-term appreciation of $HTX. A Curated Selection of High-Quality Assets HTX's TradFi zone brings global core assets into the crypto exchange framework, freeing users from the trading hours and geographical restrictions of traditional markets. Users can now participate in TradFi asset trading 24/7, seizing opportunities from global macro events, industry catalysts, and price movements to achieve more efficient asset allocation and risk management. This phase of the campaign features 28 high-liquidity trading pairs across four asset categories: Precious metals: XAU, XAUT, XAG, PAXG. Commodities: USOIL, BRENTOIL. Indices: SPX500, QQQ, SOXL, EWY. Stocks: SNDK, SKHYNIX, SPCX, MU, SKHY, TSLAX, GOOGL, AAPL, APP, INTCX, NVDA, ZHIPU, MSTRX, AMD, MSFT, CXMT, MRVL, CRCLX. Closing Thoughts As one of the early pioneers expanding into the crypto-TradFi intersection, HTX continues to deepen its strategic focus on this sector through ongoing Trade to Earn initiatives and ongoing token listings. Building on its TradFi strategy, HTX plans to introduce more asset classes, advanced trading instruments, and targeted user campaigns, giving users worldwide richer investment options and a seamless one-stop trading experience.
2026-08-06 14:36:00

നീ എന്ത് ചെയ്യുന്നു?

0.24224305152893


വാർത്ത
വാർത്ത
തുർക്ക്മെനിസ്ഥാൻ
ഏറ്റവും പുതിയ വാർത്തകളും തലക്കെട്ടുകളും
തുർക്ക്മെനിസ്ഥാൻ
വാർത്ത